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ABSTRACT 
Stem cell biology is a collection of multivariate phenomena with strict regulatory 
mechanisms.  These regulatory mechanisms assemble biological systems that coordinate 
growth and differentiation during development and remain in determined stem cells of adult 
tissues.  In order to control these complex systems, biologists can, on the one hand, 
investigate how individual mechanisms affect global responses in stem cells, and on the other 
hand, explore how multiple mechanisms act in coordination to control the behavior of 
developing tissues.  The types of stimuli traditionally studied in stem cell biology are 
biochemical; however, mechanics of stem cell environments also influence stem cell biology. 
The objective of this thesis is to survey roles of mechanical variables in directing 
mechanisms of stem cell biology and growth of developing tissues.  This inspection uses two 
approaches: an experimental system (in vitro) that controls a small set of variables to reveal 
their roles in stem cell biology; and a biomathematical model (in silico) that defines a 
biological system to study the effects of interactions between multiple variables on growth of 
developing tissues.  The in vitro model shows that the mechanical properties of three-
dimensional (3D) environments regulate phenotype of determined stem cells from the human 
liver.  The in silico model reveals that growth of spheroids with properties of developing 
tissues exhibits two morphogenetic regimes, and explains quantitatively how expansion stops 
in growing spheroids that degrade their surroundings. 
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Each of these two models has strong implications for tissue engineering.  Both models 
unveil paradigms of stem cell and developing tissue behavior, which researchers can use to 
optimize experimental conditions.  Furthermore, this thesis evaluates stem cell biology from 
two distinct perspectives, which brings empirical and predictive aspects of tissue engineering 
one step closer to each other and creates useful models to close this gap. 
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Figure 25. Morphogenetic bifurcation surface in parameter space. Data correspond to 1 
day except for CA models that are displayed in A-C until time of encapsulation. 
(A) Smooth surface describes the relations among the non-dimensional ratios for 
epithelium growth and mesenchyme removal 
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Figure 26. Growth and expansion of a spheroid distinguish between steady growth and 
encapsulation mechanics.  Square markers correspond to examples from Figure 24.  
(A) Measured at the core, epithelium expansion 
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"# $e v( )  matches the mitotic rate 
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EG
C  during steady bulk growth (BG); surface growth (SG) models show no growth 
or epithelium flux at the core; capsule formation (CF) both breaks down and 
compresses core until encapsulation halts transport and growth, when 
! 
"  reaches 
100% (CA). Superconfluent models (CF, CA) have 
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! 0  as a result of the 
logistic form of growth (carrying capacity defined as the confluence limit 
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between BG and SG.  The transition between BG and SG corresponds to 
decreasing growth rate at the spheroid core. All observations from SG models 
result exclusively from maximal growth at the surface (
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> 0 ). All data 
corresponds to 1 day, except for CA models halted at time of encapsulation. ...............98 
Figure 27. Surface velocity and volumetric change during steady spheroid growth.  (A) 
The surface velocity is linear in the growth ratio 
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= p "K
EG
  (p = 8.1 µm/day, R2 = 
0.93) during steady growth (BG, SG and CF models).  CA models yield piecewise 
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! e
S  (Figure 24 and Figure 25D) that halt at complete encapsulation (
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= 100% ). 
(B) The total cellular content of a growing spheroid, represented in terms of the 
volumetric change  !E , increases with a relationship characteristic of a sphere 
dilating at constant epithelial surface velocity 
 
V
! e
S  (dotted red line, R2 = 0.99). All 
data corresponds to 1 day.............................................................................................99 
Figure 28.  Expanded outputs of model examples from Figure 24.  Epithelium (top, red), 
mesenchyme (top, blue), cellularity (middle) and cell phase velocity v (bottom).  In 
Surface Growth regime, epithelila growth matches mesenchyme proteolysis.  
Capsule Formation and subsequent Complete Arrest regimes have epithelium 
growth overriding mesenchyme proteolysis, leading to localized densification at 
the interface.  This densification imposes physical constraints on the epithelium, 
which in turn exhibits backward motion (v<0) and further condensation, driving 
cellularity above the epithelium confluence limit.  Since backward cell motion 
requires forward aqueous transport (w>0) this encapsulation mechanism is 
irreversible; Capsule Formation leads to Complete Arrest.  Solid curve: initial 
conditions (same for all models, as described in Figure 23); dashed reference line: 
confluence limit 
 
! = !
C
= 90% .  Curve spacing 2 hours; all plots show 1 day except 
CA halted at arrest (thick curve). ...............................................................................100 
Figure 29.  KM-HA hydrogels exhibit a creep response under fixed compressive load 
with a porous platen.  Raw data from confined compression testing on a sample of 
KM-HA hydrogels (formulation C, Table 4) illustrates how these hydrogels do not 
to reach strain equilibrium under a fixed compressive load for hours and exhibit a 
creep response characteristic of fluid-like behavior.  The confined compression 
uses a fixed setup load of 5 grams.  Testing is performed with the experimental 
sample setup submerged in Kubota’s medium (KM) throughout testing, which 
 xix 
prevents loss of fluid from samples and ensures that samples maintain isotonic 
balance.  The geometry of the sample, obtained with a circular biopsy punch from a 
KM-HA hydrogel cast in a 35-mm Petri culture plate, was a cylindrical plug 
approximately 6 mm in diameter and 2 mm thick.  Points in plot correspond to data 
acquired from experimental setup at regular intervals; solid curve is the analytical 
solution to the confined compression problem, fitted by optimized least-squares 
regression to experimental data (R2 = 0.989).  Optimized regression for this sample 
determined aggregate modulus HA = 3.22 kPa and hydraulic permeability k = 5.84 
× 10-15 m4/N-s............................................................................................................138 
CHAPTER 1. INTRODUCTION 
The critical characteristics distinguishing tissues and their function arise from cells that 
establish maturational lineages during development.  Cells define these maturational lineages 
with regulatory signaling mechanisms that define gradients of phenotypic properties within 
tissues.  These regulatory mechanisms fit particular functions that fetal, childhood, adult and 
geriatric stages require throughout life.  Each tissue specializes to perform specific functions, 
mediated by characteristic gene expression profiles, through lineage progression, a paradigm 
of stem cell and maturational lineage biology in vivo [1].  Differentiation mechanisms 
correspond to specific paracrine signaling at each stage; therefore, it is not surprising that 
differentiation studies traditionally focus on biochemical signals in stem cells from all stages 
in development (embryonic stem cells to determined ones) and each of the embryonic germ 
layers (endoderm, mesoderm, ectoderm). 
The extracellular matrix (ECM) is a complex insoluble composite found outside of all 
cells that stabilizes their lineages within three-dimensional (3D) arrays.  The ECM maintains 
each cell within appropriate configurations of antigens, receptors, transporters and ion 
channels, thus enabling them to respond optimally to their neighbors.  The ECM components, 
along with bound soluble signals, present a solid-state apparatus for signaling that optimizes 
cells responses to their microenvironment.  However, the extracellular matrix (ECM) 
composition also operates as a biological signal because it transitions with differentiation to 
assemble functional environments that cells physically need.  The nature of ECM molecules, 
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with binding affinity to soluble signals, turn gradients in ECM chemistry into differential 
signaling sources, as seen in glycosaminoglycan (GAG) chains of proteoglycans (PGs) [1-4]. 
Each cell type in a tissue experiences mechanical forces differently, even when the 
tissue receives homogeneous mechanical stimulation, because the physical 
microenvironment evolves across the tissue’s maturational gradient.  Historically, researchers 
have overlooked this aspect when studying endodermal tissues (i.e. soft organs) that they 
considered mechanically unresponsive. However, limits in intercellular and diffusive 
transport demand that mechanical forces participate in tissue function and direct cellular 
activity (even if it is difficult to isolate their effects).  In other words, mechanical forces help 
secretory organs respond quickly to systemic and local variations in physiology during 
healthy conditions. 
Stem cell biology is a collection of multivariate phenomena.  It requires carefully 
designed experiments with strict multivariate control to study interactions between 
differentiation mechanisms.  Some of these tasks can be optimized by mathematical schemes.  
However, other multivariate conditions cannot be reproduced experimentally.  It is possible 
to define differentiation paradigms and use them in mathematical models by quantifying 
cellular processes in stem cell biology with targeted experimental models.  The research 
presented here discusses two methodologies that investigate roles of mechanics in stem cell 
biology.  With that end, this work defines two models, one in vitro (experimental) and one in 
silico (computational), which lay initial groundwork to determine differentiation paradigms 
in response to mechanical input.  Future research can enrich our knowledge of 
mechanotransduction in stem cell biology by transitioning between both models. 
 
CHAPTER 2. UNDERSTANDING LIVER PHYSIOLOGY AS A ROADMAP TO 
STEM CELL BIOLOGY 
Liver is formed by thousands of functional units called acini, which in histological 
sections appear hexagonal.  Each acinus has terminal branches of the portal vein, hepatic 
artery and bile duct at each vertex – called the portal triad – and a central vein discharging to 
the hepatic veins on their way to the inferior vena cava.  Blood flows from the portal triad to 
the pericentral vein across fenestrated capillaries, called hepatic sinusoids, which are lined by 
liver cells.  In liver, the periportal-to-pericentral direction down the hepatic sinusoids maps 
the hepatic maturational gradient. 
The Reid lab has studied hepatic maturational gradients extensively.  In humans, the 
hepatic maturational gradient starts with a stem cell niche hosting hepatic stem cells 
(hHpSCs) around the portal triads.  Cells in the next lineage stage, hepatoblasts (hHBs), are 
adjacent to them, operate as transit amplifying cells and can differentiate to biliary fates.  
From here on, hepatic sinusoids cross plaques of hepatocytes differentiated into later 
maturational stages with increasing size and ploidy, decreasing expression of stem cell genes 
and low-to-null cell division potential.  Mesenchymal companion cells match lineages in 
hepatic epithelial cells across the hepatic maturational gradient, from angioblasts (ABs) at the 
portal triad down to endothelial and hepatic stellate cells (hHpSTCs) at later stages. 
The ECM composition evolves within the hepatic maturational gradient.  In liver, 
GAGs and PGs in the periportal region with poor to no sulfation, such as hyaluronan (HA) 
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and chondrotin sulfate proteoglycan (CS-PG), transition into highly sulfated ones like 
heparin proteoglycan (HP-PG) and heparan sulfate proteoglycan (HS-PG).  Higher sulfation 
levels could make PGs more susceptible to chemical interactions like disulfide bridging (e.g. 
cross-linking) at the pericentral regions of the maturational gradient.  In other words, the PG 
sulfation gradient in hepatic maturational gradients could suggest a concomitant stiffness 
gradient that also participates in homeostatic regulation and differentiation.  Profiles of 
glycoprotein distribution – from laminin to fibronectin – as well as collagens – from network 
collagens in basal membranes (collagens III and IV) to fibrillar ones (collagen I) – also 
support this stiffness-dependent interpretation for intrahepatic differentiation. 
The coming chapter discusses, in further detail, how the hepatic maturational gradient 
relates to gradients in paracrine signaling, phenotype, epithelial-mesenchymal interactions 
and matrix composition that dictate hepatic lineage specification.  Later, we use this 
information to explore the role of mechanical properties of the microenvironment in hepatic 
stem cell differentiation. 
CHAPTER 3. HUMAN HEPATIC STEM CELL AND MATURATIONAL LIVER 
LINEAGE BIOLOGY1 
3.1. ABSTRACT 
Livers are comprised of maturational lineages of cells beginning extrahepatically in the 
hepato-pancreatic common duct near the duodenum and intrahepatically in zone 1 by the 
portal triads. The extrahepatic stem cell niches are the peribiliary glands deep within the 
walls of the bile ducts; those intrahepatically are the canals of Hering in postnatal livers and 
that derive from ductal plates in fetal livers. Intrahepatically, there are at least 8 maturational 
lineage stages from the stem cells in zone 1 (periportal), through the midacinar region (zone 
2), to the most mature cells and apoptotic cells found pericentrally in zone 3. Those found in 
the biliary tree are still being defined. Parenchymal cells are closely associated with lineages 
of mesenchymal cells, and their maturation is coordinated. Each lineage stage consists of 
parenchymal and mesenchymal cell partners distinguishable by their morphology, ploidy, 
antigens, biochemical traits, gene expression, and ability to divide. They are governed by 
changes in chromatin (e.g. methylation), gradients of paracrine signals (soluble factors and 
insoluble extracellular matrix components), mechanical forces, and feedback loop signals 
derived from late lineage cells. Feedback loop signals, secreted by late lineage stage cells 
into bile, flow back to the periportal area and regulate the stem cells and other early lineage 
                                                
1 Turner R, Lozoya OA, Wang Y, Cardinale V, Gaudio E, Alpini G, Mendel G, Wauthier E, Barbier 
C, Alvaro D, Reid LM.  Human hepatic stem cell and maturational liver lineage biology. Hepatology.  
In press, 2011; ©John Wiley and Sons; appears as this chapter with permission from publisher. 
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stage cells, in mechanisms dictating the size of the liver mass. Recognition of maturational 
lineage biology and its regulation by these multiple mechanisms offers new understandings 
of liver biology, pathologies, and strategies for regenerative medicine and treatment of liver 
cancers. 
 
Figure 1. Schematic image of liver, the biliary tree, and pancreas and their connections 
with the duodenum. The blue stars indicate sites at which there are high numbers of 
peribiliary glands, the stem cell niches of the biliary tree. 
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3.2. THE LIVER’S MATURATIONAL LINEAGES 
Hepatic stem cells and their mesenchymal partners, angioblasts, give rise to daughter 
cells maturing into lineages of parenchymal and mesenchymal cells with stepwise changes in 
cell size, morphology, ploidy, gene expression, growth potential and signaling [3, 5-7]. 
Currently, there is evidence for at least 8 intrahepatic lineage stages (Figure 1 and Figure 2) 
[8, 9]. Continued efforts to characterize the liver’s lineage biology should result in 
recognition of additional stages. This overview focuses on early intrahepatic lineage stages in 
human livers and includes aspects of their regulation. Information on later lineage stages of 
cells, additional background and references is included in the online supplement. 
Stage 1. Hepatic stem cells (hHpSCs) are multipotent stem cells located within the 
liver’s stem cell compartment, the ductal plates of fetal and neonatal livers, and canals of 
Hering in pediatric and adult livers [9-15]. The compartment represents the anatomic and 
physiological link between the intralobular canalicular system of hepatocytes and the biliary 
tree and resides along sites that project starlike from the portal tracts. They constitute ~0.5-
2% of the parenchyma of livers of all age donors. The hHpSCs cells range in size from 7-
10µm in diameter and have a high nucleus-to-cytoplasm ratio. Tolerant of ischemia, they can 
remain viable in cadaveric livers for up to ~6 days after asystolic death [13, 15]. 
The hHpSC phenotypic profile includes epithelial cell adhesion molecule (EpCAM), 
neural cell adhesion molecule (NCAM), CD133, CXCR4, SOX9, SOX17, FOXA2, 
cytokeratins(CK) 8/18/19, Hedgehog proteins (Sonic and Indian), intranuclear telomerase 
protein, claudin 3, MDR1, weak expression of albumin and MHC antigens. They do not 
express α-fetoprotein (AFP), intercellular adhesion molecule (ICAM-1), P450s, or markers 
for hemopoietic (e.g. CD34/38/45/90, glycophorin), endothelial (e.g. VEGFr, CD31, von 
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Willebrand factor) or mesenchymal cells (e.g. CD146, desmin, vitamin A, CD105) [8, 12, 
16]. It remains unclear whether C-kit (CD117), expressed in the liver’s stem cell niches [14, 
17, 18], is on hHpSCs or associated angioblasts, as CD117+ flow cytometry selects for 
angioblasts [12, 16]. 
 
Figure 2. Schematic image of intrahepatic maturational lineages. 
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Some proteins, such as CK19, are synthesized and found in punctuate form, but not 
converted to filaments, as seen in hepatoblasts [12]. Similarly, little albumin is synthesized 
but not packaged as in later lineage stages, implicating lineage-dependent distinctions in 
post-transcriptional and translational protein processing. 
The hHpSCs are isolated by dual immunoselection for EpCAM+/NCAM+ cells from 
livers of all donor ages. In adult livers, which have scarce hepatoblast populations, EpCAM+ 
selection alone results in predominant hHpSCs isolation [8, 12].  
In culture, the hHpSCs form colonies capable of self-replication [19] and of 
differentiation to mature cells in culture and in vivo [12, 16]. Cells expand ex vivo if cultured 
in Kubota’s Medium, a serum-free medium containing only insulin, transferrin/fe, lipids, no 
copper, and low calcium [20, 21] or if co-cultured with angioblasts. These feeders are 
replaceable with purified type III collagen substrates, low cross-linking hyaluronan hydrogel 
embedding or a mixture of both [16, 22]. If transplanted in vivo, they yield mature liver 
tissue. If cultured under distinct conditions (see below) they lineage-restrict into hepatoblasts 
[23]. 
Stage 2. Hepatoblasts (hHBs) are diploid bipotent cells giving rise to hepatocytic and 
cholangiocytic lineages, associated with precursors of both endothelia and hepatic stellate 
cells, and the liver’s probable transit amplifying cells [16]. They reside throughout 
parenchyma of fetal and neonatal livers or as single cells and small cell aggregates tethered 
to the ends of canals of Hering in adult livers [14]. With donor age, hHBs decline to <0.01% 
of the parenchymal cells in postnatal livers [12, 14]. They expand during regenerative 
processes associated with certain diseases such as cirrhosis. Previously, hHBs were referred 
to as “intermediate hepatobiliary cells of the ductular reactions” [24]; extensive 
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characterization enabled us to update their nomenclature with hepatoblasts [14]. They can be 
isolated by dual immunoselection for EpCAM+/ICAM-1+. They have enormous expansion 
potential cultured in Kubota’s Medium, especially if supplemented with EGF and HGF, or on 
feeders of stellate cell precursors replaceable by substrata of type IV collagen, laminin, 
hyaluronans or mixtures of these, albeit without proven self-replication [16, 25, 26]. 
The hHBs, larger (10-12µm) and with higher amounts of cytoplasm than hHpSCs, have 
an antigenic profile that overlaps with hHpSCs [8, 12, 18]. Shared phenotypic traits include 
CXCR4, CD133, SOX17, MDR1, cytokeratins(CK) 8/18 and 19, Hedgehog proteins (Sonic 
and Indian), and null expression of late P450s (e.g. P450-3A) or markers for hemopoietic, 
endothelia or mesenchymal cells (as in hHpSCs). Protein expression changes include 
reduction in EpCAM levels with primary localization to plasma membrane surfaces; 
filamentous CK14 and CK19 [9, 14, 27]; elevated albumin levels with discrete cytoplasmic 
packaging [12]; switch from NCAM to ICAM-1; expression of early P450s (e.g. P450-A7) 
and CK7; and strong positive expression of hepatic-specific AFP, distinct from a 
hemopoietic progenitor variant form with alternative splicing of exon 1, a probable clue of 
mesendoderm to endoderm differentiation [28]. They have approximately 5X the telomerase 
activity of hHpSCs and telomerase protein localized both in the nucleus and in the cytoplasm 
[29]. A comparison of the phenotypic profiles of HpSCs and HBs can be found in Table 1, 
Figure 3 and Figure 4. 
Stage 3. Committed progenitors are ~12-15µm diploid, unipotent, immature cells. 
These precursors give rise to only one adult cell type. They lose most stem cell gene 
expression (e.g. NCAM, Hedgehog proteins), express either hepatocytic or biliary markers, 
and abound in fetal and neonatal tissues or chronic liver diseases (viral, alcoholic and non-
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alcoholic fatty liver diseases, autoimmune hepatitis, cholangiopathies), unlike normal adult 
tissues [30].  
Table 1.  Phenotypic profiles of multipotent cell populations in human livers. 
Property Human Hepatic Stem Cells (hHpSCs) 
Human Hepatoblasts 
(hHBs) 
Average diameter (measured by 
forward scatter in flow 
cytometric analyses of isolated 
cells)  
7-9 µm 10-12 µm  
Nucleus to cytoplasmic ratio  
Highest observed of all 
parenchymal progenitor 
subpopulations evaluated  
Intermediate between that in 
hHpSCs and mature 
parenchymal cells  
>80% (fetal livers)  
~50% (neonatal livers) 
[percentages change rapidly day 
by day postnatally]  
Percentage of parenchymal 
cells [12] 
0.5-1.5 % in livers of all donor 
ages and with minimal 
ischemia; percentages higher 
in ischemic livers  <0.01% (adult livers)  
Survival after cardiac arrest 
(tolerance for ischemia) [12] 
Viable cells for several days 
after cardiac arrest  
Viable for more than a day, but 
not as long as hHpSCs  
Morphology of colonies in vitro 
[12] 
Uniform; densely packed; look 
similar to ES cell colonies  
Cord-like colonies interspersed 
with clear channels that are 
presumptive canaliculi  
Evidence for Self-renewal [31] 
 
Clonogenic expansion with 
stability of phenotype; 
doubling times of ~36 hours 
on plastic; can be passaged 
repeatedly; fastest doubling 
times (~20-24 hours) for 
hHpSCs on substrata of type 
III collagen  
Significant expansion potential 
but not yet evidence for self-
replication (under the conditions 
tested to date). Probable transit 
amplifying cells  
Pluripotency [12] Multipotent Bipotent 
Anaerobic metabolism 
(metabolomic studies) [22]  +++ +++ 
Conditions for clonogenic 
expansion [20] 
 
Kubota’s Medium plus feeders 
of angioblasts replaceable with 
type III collagen (monolayers) 
or hyaluronans into which is 
mixed type III collagen (3-D)  
Kubota’s Medium plus feeders 
of hepatic stellate cells 
replaceable with type IV 
collagen/laminin (monolayers) 
or hyaluronans into which is 
mixed type IV collagen/ laminin 
(3-D)  
CD44  
(hyaluronan receptor) [26]  High concentrations High concentrations 
Claudin 3 [8] +++ Negative 
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Indian Hedgehog [9] 
+++  
Highest level in cells in the 
center of the colonies  
++ 
Lower levels, but pattern of 
distribution is the same 
Sonic Hedgehog [9] 
++ 
Located at edge of cells; 
concentrated in cells at edge of 
colonies at sites of high 
concentration of angioblasts  
+ 
Lower levels, but pattern of 
distribution is the same  
Patched  
(Hedgehog receptor) [9] 
+++ 
Found in all cells and in 
colonies throughout the colony  
++ 
Levels lower, but still evident  
Telomerase [29] 
+ 
mRNA encoding telomerase 
and the protein found in 
nucleus. No telomerase protein 
in the cytoplasm 
+++ 
mRNA encoding telomerase and 
the protein found in nucleus; 
with differentiation, increasing 
numbers of the cells have it in 
the cytoplasm; 5X higher 
activity than in hHpSCs  
P450s [8] Negative for all assayed P450 A7 but not late forms of P450s 
CK 8 and 18 [8] ++ ++ 
CK 19 [8, 12] ++ (not in filament form) ++ (filaments evident) 
E-cadherin [12] ++ ++ 
EpCAM [12, 14] +++  (throughout the cells)  
++ 
(plasma membrane) 
NCAM /ICAM-1 [12, 14] ++ /- -/++ 
Albumin [12] ± ++ 
α-fetoprotein [12, 14] Negative +++ 
Mesenchymal Markers2  Negative Negative 
Angioblasts/ 
Endothelial Cell Markers3  Negative Negative 
Hemopoietic markers4 Negative Negative 
 
                                                
2 Mesenchymal markers found on hepatic stellate cells and myofibroblasts: α-smooth muscle actin 
(ASMA), desmin, CD146 )MeICAM), vitamin A, VCAM, HGF, and SDF-1α.  The precursors to the 
stellate cells express lower levels of these markers. 
3 Angioblasts/Endothelial cell markers: CD31, VEGFr, von Willebrand factor, VCAM, and on 
hemangioblast subpopulations: CD34.  Note: CD117 was found inconsistently on cells within hHpSC 
colonies and was never observed on hHB colonies.  Flow cytometric sorting for CD117+ cells from 
fetal liver cell suspensions yielded angioblasts.  Therefore, we assume that it is on angioblasts closely 
associated with the hHpSCs. 
4 Hemopoietic markers: CD14, CD34, CD38, CD45, CD90, glycophorin A (red blood cell antigen). 
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Figure 3. Human hepatic stem cell and hepatoblast phenotypes in vivo. a,b) EpCAM 
expression in fetal liver: EpCAM expressed in the ductal plate is not only at the cell 
surface but also in the cytoplasm. EpCAM expressed in the hepatoblasts is specific to 
the cell surface. d,e) EpCAM expression in adult liver: one end of the Canal of Hering 
connects to the bile duct, the other end connects to hepatoblasts (arrow), indicating that 
the hepatoblasts are derived from primitive hepatic stem cells harbored in Canals of 
Hering. c) Double staining for CK-19/AFP and f) EpCAM/AFP of human fetal liver in 
the portal triad area and analyzed by confocal microscopy. CK-19 (c, green) is 
expressed not only by remodeling ductal plates but faintly expressed by some of the 
hepatoblasts. EpCAM (f, green) is detected in all the parenchymal cells and biliary 
epithelial cells forming bile duct and ductal plate (DP). AFP (red) is expressed by 
hepatoblasts throughout the fetal liver and undetectable in the ductal plate.  PT: Portal 
triad; DP: Ductal Plate.  Originally published in Hepatology, DOI:10.1002/hep.22516 
[14]5 and J Exp Med, DOI:10.1084/jem.20061603 [12]6. 
Committed hepatocytic progenitors, also called intermediate hepatocytes, express 
albumin, enzymes associated with glycogen synthesis (e.g. glucose-6-phosphate), and lack 
biliary markers (e.g. CK19) and AFP. They are associated with endothelial cell precursors 
and are located in vivo in the liver plates between the HBs and the diploid adult hepatocytes.  
                                                
5 ©John Wiley and Sons.  Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human 
livers: symmetry between development and regeneration. Hepatology. 2008; 48:1598-607 
6 ©Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al.  Originally published in J 
Exp Med. 204:1973-87. doi:10.1084/jem.20061603 
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“Small cholangiocytes” are diploid biliary cells, 6-8µm with cuboidal shape, a high 
nucleus-to-cytoplasm ratio, small endoplasmic reticulum [32, 33], and are associated with 
hepatic stellate cell precursors [16]. They co-localize with hHpSCs in the stem cell niche, 
lining the canals of Hering, intrahepatic bile ducts and bile ductules with internal diameters 
below 15µm. Direct links between the canals of Hering and bile ductules, which may traverse 
the limiting plate and thus may have an intralobular segment (periportal) in addition to their 
intraportal location, support current hypotheses that point to small cholangiocytes as 
committed biliary progenitors [34]. In human and rodent livers, they express high levels of 
the anti-apoptotic proteins annexin V and bcl2 (B-cell lymphoma 2 protein). At a functional 
level, they express endothelin receptors type A (EDNRA) and type B (EDNRB), endogenous 
opioid peptides, insulin, histamine (H1), acetylcholine (M3), and α-1-adrenergic agonists, 
aquaporin 4; they are negative for the Cl-/HCO3- exchanger and receptors for secretin or 
somatostatin. During chronic feeding with bile salts taurocholate and taurolithocholate, small 
cholangiocytes express otherwise negative Na+-dependent apical bile acid transporter 
(ABAT) de novo, suggesting a role in the cholehepatic recirculation of bile salts in conditions 
of overload [35]. Finally, cystic fibrosis transmembrane conductance regulator (CFTR) is 
present in human, but not rodent, small cholangiocytes [34]. 
Stages 4-6. Diploid adult cells are the only parenchymal cells with significant 
proliferative capacity under all known in vitro or in vivo conditions. Exceptions are in 
conditions potentially involving genetic reprogramming through chromatin demethylation, 
the only known mechanism for restoring cytokinensis, as occurs in tyrosinemia [36] or with 
massive loss of mature parenchymal cells (e.g. >80%) due to a transgene [37]. Diploid adult 
hepatocytes (“small hepatocytes”), partnered with endothelia, can undergo 6-7 rounds of 
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division within 3 weeks in culture but have limited subcultivation capacity [20]. Large 
cholangiocytes, partnered with stellate cells, are columnar shape, display a small nucleus and 
conspicuous cytoplasm, an abundant Golgi apparatus between the apical pole and the 
nucleus, and rough endoplasmic reticulum more abundant than small cholangiocytes [33, 38, 
39]. Large cholangiocytes line interlobular ducts located in the portal triads. The connections 
of hHpSCs in canals of Hering to the septal and segmental bile ducts has not yet been 
investigated, and markers in septal ducts, segmental ducts and larger ducts are found also in 
cells in peribiliary glands, the stem cell niches of the biliary tree [40]. Large cholangiocytes 
express CFTR and Cl-/HC03- exchanger, aquaporin 4 and aquaporin 8, secretin and 
somatostatin receptors other than receptors for hormones and neuropeptides. In addition, they 
express the Na+-dependent bile acid transporter ABAT (apical bile acid transporter), MDR 
(multidrug transporter) and MRP (multidrug resistance associated proteins). When large 
cholangiocytes are damaged by acute carbon tetrachloride (CCl4) or GABA administration, 
small cholangiocytes proliferate, and acquire phenotypical and functional features of large 
cholangiocytes [41, 42], suggesting that the population of small cholangiocytes lining the 
canals of Hering and ductules may represent precursors of large cholangiocytes lining larger 
ducts. The integrated differential gene expression between small and large normal 
cholangiocytes demonstrate through microarray that the proteins related to cell proliferation 
tend to be highly expressed by small cholangiocytes, whereas large cholangiocytes express 
functional and differentiated genes [39]. This is consistent with studies showing, either with 
bile duct injury due to CCl4 and GABA administration or with bile duct regrowth following 
partial hepatectomy, that small cholangiocyte proliferation is activated presumably to 
repopulate bile ducts. These findings suggest that small cholangiocytes are less mature, have 
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a high resistance to apoptosis, and have marked proliferative activities, while large 
cholangiocytes are more differentiated contributing mainly to ductal bile secretion and 
absorption. Therefore, while hepatocytic cell lineages proceed from periportal areas toward 
the central vein, cholangiocytes proceed in the opposite direction from canals of 
Hering/ductules toward larger ducts. See the online supplement (Section 3.5) for further 
information.  
 
Figure 4. Human hepatic stem cell and hepatoblast phenotypes in culture. a) 
Morphology of human hepatic stem cells and b) human hepatoblasts in culture on 
plastic. c) Albumin staining of human hepatic stem cells, transitioning to hepatoblasts. 
d) The border between the hepatic stem cell colony and hepatoblast outgrowths is 
marked by arrowheads by phase microscopy; this border is also distinguishable by e) 
fluorescence microscopy of hepatic stem cells stained with NCAM (green) and 
hepatoblasts stained with ICAM (red).  Originally published in Hepatology, 
DOI:10.1002/hep.22516 [14]7 and J Exp Med, DOI:10.1084/jem.20061603 [12]8. 
 
 
                                                
7 ©John Wiley and Sons.  Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human 
livers: symmetry between development and regeneration. Hepatology. 2008; 48:1598-607 
8 ©Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al.  Originally published in J 
Exp Med. 204:1973-87. doi:10.1084/jem.20061603 
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3.3. REGULATION OF THE PARENCHYMAL CELL LINEAGES 
3.3.1. Paracrine Signaling between Epithelial-Mesenchymal Partners 
Paracrine signaling is the primary form of regulation between parenchymal cells and 
partnering mesenchymal cells and represents classic epithelial-mesenchymal relationships 
widely described in developmental biology since the 1930s. A new facet is that coordinate 
maturation of these [parenchymal]:[mesenchymal] cell associations, starting with 
[hHpSCs]:[angioblasts] and splitting into lineages of [hepatocyte]:[endothelia] and 
[cholangiocyte]:[stellate cells], gives rise to lineage-dependent gradients of paracrine signals 
[16] that govern the biological responses of cells at each lineage stage. Defined subsets of 
these lineage-dependent paracrine signals, soluble and insoluble matrix ones, can be used to 
establish cells at a specific lineage stage in culture (Figure 5).  
The intrahepatic stem cell niche contains type III collagen, α6β4 integrin-binding form 
of laminin, hyaluronans and a minimally sulfated chondroitin sulfate proteoglycan (CS-PG) 
[16]. Transition to [hHBs]:[endothelia and stellate cell precursors] results in changes to type 
IV collagen, αVβ1 integrin-binding laminin, hyaluronans, more sulfated CS-PGs and forms 
of heparan sulfate-PGs (HS-PGs). The [hepatocyte]:[endothelia] lineages are associated with 
network collagens (e.g. type IV and VI) and increasingly sulfated forms of HS-PGs ending, 
in zone 3, in heparin-PGs (HP-PGs). The [cholangiocyte]:[stellate cell] lineages are 
associated with fibrillar collagens (e.g. types I and III) and progression from CS-PGs towards 
highly sulfated PGs, including dermatan sulfate-PGs (DS-PGs) [16, 26, 31]. Many soluble 
signals bind to and work synergistically with matrix components to regulate the cells, 
particularly PGs and their glycosaminoglycan chains (GAGs). Matrix-bound soluble signals 
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are biphasic, yielding mitogenic versus differentiative responses depending on the specific 
matrix chemistry with which they are associated. 
3.3.2. Feedback Loop Signaling  
Late lineage stage cells produce positive and negative signaling regulators, including 
bile salts, various soluble factors and matrix components [43]. Positive regulators include 
hepatopoietin, released by dying zone 3 cells that stimulate stem/progenitors expansion (M. 
Roach, J. Hambor, unpublished observations).  Negative regulators include ecto-
nucleotidases expressed by portal hepatoblasts like NTPDase2, which inhibits purinergic 
activation of basolateral P2Y receptors in periportal cholangiocytes under homeostatic 
conditions.  Conversely, loss of NTPDase2 expression after experimental cholestasis in 
portal hepatoblasts allows activation of periportal P2Y receptors and increases cholangiocyte 
proliferation [44]. 
Another facet of regulation is mediated by acetylcholine. It stimulates proliferation of 
stem/progenitor cells and cholangiocytes expressing M3 acetylcholine receptors [45]. In 
normal liver and even after partial hepatectomy, late lineage stage hepatocytes lacking M3 
receptors release acetyl cholinesterase into the bile that delivers it to zone 1 where it destroys 
acetylcholine in the stem cell niche, thus blocking proliferation of stem/progenitor cells and 
cholangiocytes. In contrast, during conditions of pericentral damage, the acetyl 
cholinesterase is not released, resulting secondarily in induction by acetylcholine of 
stem/progenitor cell expansion. Denervated transplanted livers lack acetylcholine modulation 
of proliferation of cells lining the canals of Hering. Hepatitis-injured transplanted livers also 
exhibit lower numbers of progenitor and reactive ductular cells than innervated matched 
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controls. Experiments in rats with galactosamine-damaged livers confirm that vagotomy 
induces impaired regeneration of progenitors and ductal reaction in cholangiocytes [46].  
Mechanotransduction mechanisms are another major set affecting lineage biology, 
most involving cytoskeletal rearrangements. The cytoskeleton is a ubiquitous cellular 
component with characteristics of amplification systems and connections with matrix. Some 
of these connections allow cells to sense microenvironment rigidity through non-muscle 
myosin II, which directs stiffness-dependent differentiation in mesenchymal stem cells [47]. 
Germ layer organization and cell sorting depends on cell adhesion forces and cortex tension 
relying on actomyosin network activity [48]. Integrins connect the cytoskeleton to matrix 
substrata, recruit focal adhesions that adapt cells to mechanical stresses, bind ligands and 
regulate intracellular signaling [49]. Mechanical stretch in liver cells induces activation and 
synthesis of morphogens in the TGF-β family of Activin/Nodal signaling [50]. SMAD 
transcription factors regulate TGF-β signaling pathways and regulate gene expression 
through kinesin-mediated nucleocytoplasmic shuttling along intact microtubules [51, 52]. 
Primary cilia in cells from soft organs also participate in mechanotransduction by 
probing and amplifying the effects of intraluminal flow above cell apical surfaces. They 
mediate polarized signal transduction pathways that use the cytoskeleton to ensure specific 
and non-diffusable signal trafficking to the nucleus [53]. PDGRα and Hedgehog signaling 
take place in primary cilia [54, 55] in livers of all ages [9] through dynein-mediated shuttling 
of Gli transcription factors [56]. Some chromatin targets of Gli transcription factors include 
PTCH, WNT and BMP genes, all involved in embryonic development and differentiation 
mechanisms [57-59]. Hedgehog expression gradients also demarcate the extension of 
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endodermal organs during development [55, 60]. In conjunction, this information suggests 
primary cilia are relevant participants in endoderm maturation and differentiation. 
 
Figure 5. Schematic image indicating the coordinate maturation of the epithelia 
(parenchymal cells) and their mesenchymal partners and some of the identified 
extracellular matrix components found at the particular lineage stages. Not shown in 
the figure are the soluble signals that are also lineage dependent. Some of the lineage 
dependent soluble signals identified are noted in parentheses beside the lineage stage at 
which they are found: hepatic stem cells (LIF, IL-6, IL-11, and acetylcholine); 
hepatoblasts (HGF, EGF, bFGF, IL-6, IL-11, and acetylcholine); hepatocytes (HGF, 
EGF, bFGF, T3, glucagon, and hydrocortisone); cholangiocytes (VEGF, HGF, bFGF. 
and acetylcholine). 
Bile secretion is an important mechanism for homeostatic control of tissue mass, 
operating as an inductor in mechano-transduction. Bile is a Newtonian fluid in normal 
physiological conditions with salt concentration-dependent viscosity [61]. Bile tonicity 
increases while flowing in the pericentral-to-periportal direction as hepatic parenchyma 
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perform secretory functions. Abnormal bile tonicity is characteristic of pathological 
conditions [62]. Shear forces from bile flow, proportional to bile viscosity, function as long-
range mechanical signals communicating states of hepatic function across the entire liver 
maturational gradient to cholangiocytes in the proximal biliary tree through primary cilia 
bending. This bending triggers stress-induced Ca2+, cAMP signaling cascades and receptor-
mediated PDGRα and Hedgehog signaling, which makes bile a mechanical probe for liver 
homeostatic control [45]. 
 Liver Regeneration. Two distinct forms of liver regeneration take place after: a) 
partial hepatectomy, and b) selective loss of pericentral cells. After partial hepatectomy, 
feedback loop signaling is essentially intact. DNA synthesis occurs in cells across the liver 
plates but only a portion of the cells undergo cytokinesis, yielding increased numbers of 
polyploid cells, higher numbers of apoptotic cells, and more rapid turnover of the liver with 
restoration of the normal ploidy profiles within weeks [63]. Feedback loop signaling is the 
explanation for liver cells in culture in which secreted signals from late lineage stage cells 
inhibit the growth of any early lineage stage cells [21]. 
Selective loss of pericentral cells with toxic injury to zone 3 cells (and sometimes also 
to zone 2) results in muting of the feedback loop signaling that activates rapid cell division of 
early lineage stage cells [15, 64]. In response, periportal cells undergo rapid hyperplastic 
growth (complete cell division) followed by differentiation. These phenomena, the classic 
“oval cell response” in rodents and the “ductular reactions” seen in human massive hepatic 
necrosis (e.g. acetaminophen toxicity, acute hepatotropic viral infection), have long been 
recognized to involve extensive expansion of the stem/progenitor cell populations [15]. 
Chronic injury to the liver, as occurs with repeated drug exposures, radiation, or certain viral 
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infections like hepatitis B or C, result in loss of late lineage stage cells, eliciting chronic 
regenerative responses. 
3.3.3. Relevance to Clinical Programs 
Hepatic lineage biology and mechanisms of its regulation will have relevance for many 
clinical programs. Examples include tissue sourcing for clinical programs, strategies for liver 
cell therapies, immunological issues, and most profoundly an understanding of liver tumors 
and logical strategies by which to treat liver cancers. 
Sourcing of tissue for any clinical therapy is dictated by the proportion of cells at the 
different lineage stages in tissue of a given donor age.  Fetal and neonatal tissues with 
lineages skewed towards early stages will be ideal for stem/progenitor cell therapies, whereas 
adult livers will be ideal for programs requiring rapid need for late lineage stage functions.  
Liver cell therapies for inborn errors of metabolism will be affected by feedback loop 
signaling, since there will be no selection for the transplanted cells over endogenous cells 
necessitating higher numbers of cells to be transplanted. By contrast, patients with liver 
failure due to virus, drugs or radiation (involving a loss of feedback loop signals) can be 
transplanted with smaller numbers of cells given the strong selective pressure for 
transplanted cells to expand quickly to reconstitute liver mass. 
Concerns regarding a need for immunosuppression will be affected by lineage biology. 
Non-immunogenic stem/progenitors can acquire immunogenicity with maturation that 
potentially can be managed by use of stellate cells, known to produce immunomodulatory 
signals.  Liver cell therapies should also use grafting methods that optimize liver engraftment 
and prevent cell loss to ectopic sites unlike vascular route delivery, especially for 
stem/progenitors [65]. 
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3.3.4. Liver Cancer Stem Cells 
The idea that cancers are transformed stem/progenitor cells originated with the 
pioneering work of Van Potter in the 1960s, who proposed that hepatomas contain cells 
undergoing “blocked ontogeny” [66]. This idea was further elucidated for all types of cancers 
by Barry Pierce and Stewart Sell [67] who clarified that many functions thought to be related 
to cancer (e.g. AFP expression) are normal functions of an expanded stem/progenitor cell 
population and that identification of key distinctions must involve comparison of cancer cells 
to their normal stem cell [64, 68]. Indeed, normal stem/progenitor cells are strikingly similar 
to tumor cells in morphology, gene expression, and growth properties, and tumors can be 
identified as an expanded lineage stage [64, 69]. The clinical use of stem cells may come 
with an increased risk of tumors depending on the donors (e.g. if there are undiagnosed 
tumor cells among the endogenous stem cells) and on the patient’s medical condition (e.g. 
severe immunosuppression). 
Strategies for cancer therapies will be revolutionized if revamped with lineage biology 
knowledge. Treatments with drugs or radiation are known to affect later lineage stages 
preferentially. If a specific treatment also targets the lineage stage(s) containing malignantly 
transformed cells, then the treatment can be curative. If they fail to target that stage, there 
will be a lethal rebound effect: the treatment kills cells in later lineage stages, mutes feedback 
loop signaling, and secondarily unhinges early lineage stages where malignant cells reside. 
Therefore, future cancer therapies should involve strategies identifying the lineage stage of 
the tumor and whether the treatment targets that stage or, alternatively, uses lineage 
mechanism regulation, such as feedback loop signals, to control the rate of growth of tumor 
cells. 
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3.4. CONCLUSIONS 
The intrahepatic maturational lineages begin within the stem cell compartments, located 
periportally, and progress through the midacinar region and ending near the central vein. The 
parenchymal cells, along with their mesenchymal cell partners, are governed by gradients of 
paracrine signals, including sets of soluble factors and insoluble extracellular matrix 
components, and by specific mechanical forces. Feedback loop signals regulate the 
stem/progenitors, controlling liver mass and tissue regeneration. Understanding stem cell and 
lineage biology in the liver and their regulation offers new considerations for basic and 
industrial investigations and for more biologically rational clinical program strategies. 
3.5. ONLINE SUPPLEMENT 
While the review focuses on summarizing the literature regarding the earliest lineage 
stages that comprise the hepatic stem cells, hepatoblasts and committed progenitors, this 
online supplement provides additional information and references on what is known of 
normal cells. For information on the many studies on oval cells, cells that expand in hosts 
exposed to one or another oncogenic insult, or in progenitors occurring in disease states, we 
refer you to several excellent articles and reviews [70-77].  The supplement online figures 
(Figure 6 to Figure 13) also complement those used within the review (Figure 1 to Figure 5). 
3.5.1. Ploidy 
All tissues are organized with a stem cell niche containing stem cells and committed 
progenitors that give rise to daughter cells, maturing step-wise to adult cells, and 
transitioning to apoptotic cells [78]. The kinetics of the lineage and tissue turnover is tissue-
specific and correlates inversely with the extent of polyploidy [79-82].  Rapidly regenerating 
tissues have lineages with fast kinetics and typically have only 5-10% polyploid cells [83]. 
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Newly recognized lineages are those associated with quiescent tissues (e.g. liver, pancreas, 
lung, kidney), with turnovers estimated to be months to years [3]. The extent of polyploidy in 
these tissues in adults is from 20% to 95% [5].  
Fetal and neonatal tissues are entirely diploid.  The transition to an adult ploidy profile 
occurs within 3 weeks in mice; within 4 weeks in rats; and by late teenage years in humans 
[5].  The adult profile is also distinct in different species.  Humans are mostly diploid and 
with the remainder being tetraploid.  The livers of adult rats are only ~10% diploid, ~80% 
tetraploid, and ~10% octaploid.  Mice have livers with cells that are only 5% diploid and 
95% polyploid with the ploidy levels going from tetraploid to 32N.  In all mammalian 
species the diploid cells are found periportally transitioning to polyploidy cells with 
progression towards the central vein.  
With increasing age in all mammals, the percentage of diploid cells steadily declines. In 
humans, the percentage of diploid cells in liver decreases from over 70% in young adults to 
less than 50% in the elderly, a presumed variable in the age-dependent loss of regenerative 
capacity of the tissues [82].  
3.5.2. Extrahepatic Lineages in the Biliary Tree 
Multipotent stem cell populations have been identified recently in the peribiliary glands 
of the biliary tree, giving rise to liver, bile duct, and pancreas under specific culture 
conditions or with transplantation in vivo [16, 84]. The antigenic and biochemical profiles of 
the biliary tree stem cell populations at different sites in the extrahepatic bile ducts are 
suggestive of multiple lineage stages with the most primitive ones being within the hepato-
pancreatic common duct near to the duodenum. Later stages are found in the cystic duct and 
hilum. Related cells, possibly transit amplifying cells, are found within the gallbladder that 
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does not have peribiliary glands. Further characterization of these cells should elucidate 
possible precursor-descendent relationships including if they are precursors to intrahepatic 
lineages. A review summarizing the extant knowledge of these newly discovered lineages is 
given elsewhere [85]. 
3.5.3. Comments on intrahepatic lineage stages 
The zonal distribution of the liver’s known heterogeneity of functions has been 
described extensively in the past. Below and in Table 1 and Table 2, we summarize these 
past studies on functions occurring preferentially in specific zones (periportal, midacinar, and 
pericentral) within the liver acinus. 
Intrahepatic Lineage Stage 4. Periportal parenchymal cells (zone 1) are comprised 
of “small hepatocytes” and intrahepatic biliary epithelia, or “large cholangiocytes”. The 
hepatocytes are ~18 µm and the large cholangiocytes are ~14 µm in diameter.  The 
hepatocytes form plates or cords of cells bound on their lateral borders to each other by a mix 
of lateral matrix components (cell adhesion molecules, proteoglycans), tight junctions 
(cadherins), and gap junctions (connexins). The proteoglycans on the lateral borders are 
known to regulate multiple aspects of gap junction functions as well as to be essential for 
transcription (mRNA synthesis) of tissue-specific genes [86-88]. In the center of the lateral 
border of connection between two hepatocytes is the bile canaliculus, a region of undulating 
membrane studded with enzymes and pumps that transfer hepatocyte-derived products into 
bile in the canaliculus. 
Hepatocytes are unique among epithelia in having two basal surfaces, the “top” and 
“bottom”, that are bound to extracellular matrix components (collagens, proteoglycans, 
adhesion molecules) in the Space of Disse and produced by the hepatocytes and their 
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mesenchymal cell partners, endothelial cells. The periportal hepatocytes peak in the zone 1 
metabolic activities (see Table 2 and Table 3). In brief, they produce factors and enzymes 
associated with gluconeogenesis, amino acid and ammonia metabolism, urea synthesis, and 
glutathione peroxidase [89-94]. 
Intrahepatic Lineage Stage 5. Midacinar hepatocytes (Zone 2) are diploid in 
humans, tetraploid in rats, and 4-8 N in mice, ~22-25 µm in diameter [5]. The past strategies 
for studying zonation of functions, selective destruction of periportal or pericentral cells with 
detergents followed by characterization of the surviving cell suspensions, are not able to give 
precise definition to the functions of zone 2 cells [95]. Recognition of some unique features 
of the midacinar parenchymal cells has emerged with immunohistochemical and in situ 
hybridization studies on sections of livers. The midacinar hepatocytes are the first stages to 
have peak levels of certain transcription factors regulating albumin enabling these cells to 
produce especially high levels of the protein [92, 93]. In addition, transferrin mRNA is 
expressed in earlier lineage stages, but it does not translate to protein at detectable levels until 
zone 2 (midacinar), correlating with production of specific elongation factors associated with 
translation of transferrin mRNA to protein [8]. It is unknown whether this is true for other 
proteins. There must be distinctions in posttranscriptional and translational regulation of 
certain mRNAs for early lineage stage cells versus later ones, an hypothesis yet to be fully 
explored. 
Intrahepatic Lineage Stage 6. Pericentral diploid hepatocytes (zone 3) are found in 
small numbers in human livers, but in rats and mice there are none; they have only polyploid 
cells in zone 3. The diploid parenchymal cells in humans decline with age in parallel with an 
increase in polyploidy. In culture, they are able to undergo DNA synthesis but with limited, if 
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any, ability to undergo cytokinesis, and no capacity to be subculture [21]. In addition to 
albumin, tyrosine aminotransferase, and transferrin, they also strongly express a number of 
the P450s that handle xenobiotic metabolism (e.g. P450-3Aa), glutathione transferases, and 
UDP-glucuronyl-transferases [96, 97]. 
Intrahepatic Lineage Stage 7. Pericentral polyploid parenchymal cells (zone 3) in 
all species can undergo DNA synthesis but are unable to undergo cytokinesis [5]. In humans 
they are tetraploid; in rats they are octaploid; and in mice they are 16-32 N. They are much 
larger (>30 µm in diameter in humans and up to 75 µm in rodents) due to the hypertrophy 
associated with polyploidy. They express high levels of the late genes including the late 
P450s, glutathione transferases, UDP-glucuronyl-transferases, glutamine synthetase and 
heparin proteoglycans [63, 98]. These cells have never been observed to divide in culture or 
in bioreactors under all conditions tested and do not divide if transplanted in vivo into 
quiescent livers. However, if transplanted into hosts with very severe liver failure such as 
occurs in tyrosonemia or following death of most parenchymal cells due to a suicide 
transgene, murine tetraploid and octaploid hepatocytes have been shown capable of division 
[36, 37, 99].  This has been claimed evidence that all hepatocytes are stem cell-like [100]. 
The more likely interpretation is that these are examples of reprogramming phenomena in 
which demethylation events are occurring. Thus, it is not logical to imagine using such late 
lineage stage parenchymal cells for reconstitution of livers in most forms of liver cell 
therapies.  
Intrahepatic Lineage Stage 8. Apoptotic cells are found in highest numbers near the 
central vein. It is also the site for high numbers of macrophages, long known to be involved 
in apoptosis. The macrophages secrete tumor necrosis factor (TNF), triggering apoptosis 
 29 
through the Fas ligand binding to the Fas receptor, and activating caspases, a family of 
proteins mediating apoptosis through multiple targets that include poly-ADP ribose 
polymerase, nuclear lamins, and DNA fragmentation factor [63, 101-105]. 
Table 2. Zonal Distribution of Cellular Subpopulations.  Table 2 and Table 3 have been 
prepared from data in reviews on heterogeneity of functions in liver by Gebhardt [106] 
(see Figure 3, Figure 4, Table 2 and Table 3) and by Jungermann and Kietzmann [95] 
(see Figure 2, Figure 3, Table 2 and Table 3) and from diverse, more recent studies [43, 
46, 107, 108].  Nomenclature: ++++ = strong signal; + = weak signal ;  -- = no signal. 
Cellular Subpopulations Stem Cell Niche9 Zone 1 Zone 2 Zone 3 
Parenchymal Cell Populations 
Hepatic stem cells (HpSCs)  ++ - - - 
Hepatoblasts (HBs) ++ - - - 
Committed progenitors (small 
cholangiocytes, hepatocytic 
progenitors 
++ - - - 
Hepatocytes - +++ +++ +++ 
Cholangiocytes (large 
cholangiocytes; later lineage 
stages of biliary cells are 
extrahepatic) 
- +++  - - 
Mesenchymal/Endothelial Cell populations 
Angioblasts (CD117+, CD133+, 
CD31-)  ++ (with HpSCs) - - - 
Endothelial cell precursors 
(CD133+, CD31+) ++ (with HBs) 
++ (with 
committed 
hepatocytic 
progenitors) 
- - 
Endothelia cells (few, large 
fenestrations)   - ++ + - 
Endothelia cells (numerous, 
small fenestrations) - - ++ +++ 
Hepatic stellate cell (HpSTC) 
precursors (CD146+, ASMA+,  
vitamin A ±, GFAP-) 
++  
(with HpSCs and 
hHBs) 
- - - 
Hepatic stellate cells  
(CD146++, ASMA++, 
Vitamin A++, GFAP +) 
+ 
(with committed 
biliary progenitors or 
small 
cholangiocytes) 
+++ 
(with large 
cholangiocytes) 
+/- 
(+ in 
disease 
states) 
-  
(+ in disease 
states) 
Stromal cells - 
++ 
(most are part of 
extrahepatic 
biliary tissue) 
- - 
Hemopoietic Cells 
Hemopoietic progenitors 
(CD34+ ) ++ - - - 
                                                
9 Stem cell niche: ductal plates (also called limiting plates) in fetal and neonatal livers; canals of 
Hering in pediatric and adult livers. 
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Kupffer Cells (monocytes) - ++ (phagocytosis) ++ 
+++ 
(cytotoxicity) 
Lymphocytes - ++ ++ ++ 
Pit cells (liver natural killer 
cells)  - ++ ++ ++ 
 
Table 3. Intrahepatic Zonation of Functions.  Table 2 and Table 3 have been prepared 
from data in reviews on heterogeneity of functions in liver by Gebhardt [106] (see 
Figure 3, Figure 4, Table 2 and Table 3) and by Jungermann and Kietzmann [95] (see 
Figure 2, Figure 3, Table 2 and Table 3) and from diverse, more recent studies [43, 46, 
107, 108].  Nomenclature: ++++ = strong signal; + = weak signal ;  -- = no signal. 
 
Protein or 
Activity/ 
mRNA10 
Zone 1 
Periportal 
Zone 2 
Mid-Acinar 
Zone 3 
Perivenous 
Carbohydrate Metabolism 
Protein +++  + Phosphoenolpyruvate carboxykinase 
(glycogen from pyruvate) mRNA ++++  + 
Protein +  + 
Fructose-1,6-bisphospatase mRNA +++  + 
Gluconeogenesis (from lactate, amino acids)  +++  + 
Gluconeogenesis (from pyruvate)  +++  + 
Glycogen Synthesis (from lactate)  +++  ++ 
Glycogen Synthesis (from glucose)  ++  +++ 
Pyruvate kinase Type L  +  +++ 
Glycolysis (glucose to pyruvate)   -- +++ 
Protein +  ++ Glucokinase (glycogen from glucose) 
mRNA +  + 
Amino Acid and Ammonia Metabolism 
Tyrosine aminotransferase  ++ + + 
Serine dehydratase  +++  + 
Glutamine synthetase (glutamine from 
ammonia; also from glutamate, α-
oxoglutarate, ornithine) 
 --  +++ 
Ureogenesis (from ammonia, amino acid 
nitrogen via carbamoyl phosphate 
synthetase) 
 +++  + 
Lipid Metabolism 
Protein +++  -- HMG-CoA reductase mRNA ++  -- 
β-Oxidation  +++  + 
Liponeogenesis Ketogenesis  +  +++ 
Cholestrol Biosynthesis  +++ -- -- 
Bile Acid Synthesis  -- + ++ 
                                                
10 Information in this column is given only when expression of the mRNA and the protein are distinct 
(e.g. mRNA is found, but not protein); if nothing is listed, then it means that both mRNA and protein 
were found. 
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Sulfation  +++  + 
Glucuronidation  +  +++ 
Glutathione Content  +++  + 
Glutathione-S-Transferases  +  +++ 
Glutathione Peroxidase  +++  + 
Na+ dependent +++ + -- Bile Acid Uptake 
Na+ independ. ++  ++ 
without ++ + -- Uptake of many organic anions and cations 
in presence (with) or absence (without) of 
albumin with ++  ++ 
Oxidative Energy Metabolism 
Succinate dehydrogenase  ++  -- 
O2  uptake  ++++  ++ 
Mixed Function oxidation (NADPH 
cytochrome c reductase, epoxide hydrolase)  -- ++ ++++ 
Cytochrome P450 Isozymes 
Cyp 3A7   +++  - 
CYP 1A, IIA, IIB, IIE, 3ª  - ++ ++++ 
Specific Proteins 
Protein +/- ++ +++ Transferrin mRNA +++ +++ +++ 
ICAM-1 (HBs, sinusoidal endothelia and 
parenchyma associated with them)  ++ +++ ++++ 
NCAM  (only HpSCs)  ++ (niche)  - -- 
EpCAM (HpSCs, HBs, intrahepatic 
cholangiocytes  +++ (niche) - - 
α-Fetoprotein (only HBs)  ++ (niche)  -- 
Albumin  ++ 
++++ 
(full transcriptional 
regulation) 
Connexin 26  +++  + 
Connexin 32  +  +++ 
Extracellular Matrix Components 
FIbronectin (tissue)  ++ ++ ++ 
Fibronectin (plasma)  --  ++++ 
Collagen I  + + + 
Collagen III  ++ ++ ++ 
Collagen IV  ++++ ++ ++ 
Collagen V  ++++ ++ ? 
Collagen VI  ++++ ++ ++ 
Collagen XVIII  ++ ++ ++ 
Laminin  ++++  -- 
Hyaluronans (produced by hHpSTCs and 
endothelia)  ++++  --- 
Chondroitin sulfate-PGs  ++++ ++ + 
Heparan sulfate-PGs  + ++ +++ 
Heparin-PG  - - +++ 
Dermatan sulfate-PGs  ++ + + 
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Figure 6. Phase micrographs of colonies of hHpSCs and hHBs from fetal versus adult 
human livers. The cultures are on culture plastic and in serum-free Kubota’s Medium. 
Originally published in J Exp Med, DOI:10.1084/jem.20061603 [12]11. 
 
Figure 7. Cultures of hHpSCs (a) and hHBs (b) that were assayed for expression of 
EpCAM (green) and for NCAM (red in hHpSCs) and AFP (red in hBs).  The nuclei in 
all of the cells are blue from staining with DAPI. Originally published in Hepatology, 
2010;52: 1443-1454 [16]12. 
                                                
11 ©Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al.  Originally published in J 
Exp Med. 204:1973-87. doi:10.1084/jem.20061603 
12 ©John Wiley and Sons. Wang Y, Yao H-L, Cui C-B, Wauthier E, Barbier C, Costello MJ, et al. 
Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of 
human hepatic stem cells to adult liver fates. Hepatology. 2010; 52:1443-54 
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Figure 8. Immunohistochemistry demonstrating the change in expression of cytokeratin 
19 (red) and of albumin (green) in hHpSCS versus hHBs versus committed progenitors.  
Note that CK19 is punctuate in hHpSCs and filamentous in hHBs and committed 
progenitors.  Albumin is particulate in hHpSCS but transitions into the classic albumin 
aggregates found in all later lineage stages of parenchymal cells from hHBs to mature 
hepatocytes. Originally published in J Exp Med, DOI:10.1084/jem.20061603 [12]13. 
                                                
13 ©Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al.  Originally published in J 
Exp Med. 204:1973-87. doi:10.1084/jem.20061603 
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Figure 9. Phase microscopy of a colony of hHpSCs (a).  The colony was then assessed 
for Indian Hedgehog (red) (b), sonic Hedgehog (c) that is found at the edges of the 
colony, and patched (d) that is the Hedgehog receptor and found throughout the colony. 
Originally published in Amer J Physiol Gast Liver Physiol 2005; 290: G859–G870 [9]14. 
 
Figure 10. Immunohistochemistry demonstrating expression of hyaluronan receptors. 
Originally published in J Biomed Mater Res B Appl Biomater 2007; 82: 156-168 [26]15. 
                                                
14 Sicklick JK, Li YX, Melhem A, Schmelzer E, Zdanowicz M, Huang J, et al. Am J Physiol 
Gastrointest Liver Physiol. 2006. Hedgehog signaling maintains resident hepatic progenitors 
throughout life. 290(5):G859-70. doi:10.1152/ajpgi.00456.2005. 
15 ©John Wiley and Sons. Turner WS, Schmelzer E, McClelland R, Wauthier E, Chen W, Reid LM. 
Human hepatoblast phenotype maintained by hyaluronan hydrogels. J Biomed Mater Res B Appl 
Biomater. 2007; 82:156-68 
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Figure 11. Lineage restriction of hHpSCs to hHBs after plating on a feeder layer that 
contributes paracrine signals inducing differentiation.  Phase microscopy of both 
hHpSCs and hHBs.  (b) magnified image of the edge of the colony at which hHBs are 
located; (c) immunohistochemistry of the cells in (b) assessing expression of alpha-
fetoprotein (AFP). 
 
Figure 12. Schematic illustration of the parenchymal cell lineages and noting some of 
the changes in gene expression with maturation to either hepatocytes or cholangiocytes. 
Originally published in Hepatology 2010; 52: 1443-1454 [16]16. 
                                                
16 ©John Wiley and Sons. Wang Y, Yao H-L, Cui C-B, Wauthier E, Barbier C, Costello MJ, et al. 
Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of 
human hepatic stem cells to adult liver fates. Hepatology. 2010; 52:1443-54 
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Figure 13. Schematic illustration of the mesenchymal cell lineages and noting some of 
the changes in gene expression as they mature to either endothelia or stromal cells. 
Originally published in Hepatology 2010; 52:1443-1454 [16]17. 
                                                
17 ©John Wiley and Sons. Wang Y, Yao H-L, Cui C-B, Wauthier E, Barbier C, Costello MJ, et al. 
Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of 
human hepatic stem cells to adult liver fates. Hepatology. 2010; 52:1443-54 
CHAPTER 4. PHYSICAL SIGNALING AND PRINCIPLES OF 
MECHANOTRANSDUCTION: TRANSITIONING FROM MECHANICAL 
FORCES TO CELL BEHAVIOR 
The mechanical context of tissue function dictates the mechanical forces cells 
experience within tissues.  Cells obey a “principle of compliance” in which they adapt their 
individual function to their environment, but cells also adapt their environment dynamically 
to function collectively as a tissue.  Mechanotransduction signaling pathways that operate in 
specific cell types depend on mechanical contexts in tissues and are a footprint of cell 
adaptation to their tissue environment.  Cells experience diverse mechanical stimuli with a 
collection of distinct mechanosensory libraries and assemble them into modules of 
mechanotransduction to comply with changing physical conditions.  In essence, by creating 
multiple modules that respond to mechanical forces, cells can combine them to address 
multiple modalities that involve mechanical induction [109, 110]. 
In general, mechanotransduction mechanisms obey the “function follows form” 
principle because these mechanisms operate via intracellular structures with mechanical 
function that determine the physical integrity of the cell.  Transducing forces into signaling 
cascades and cellular activity involves focal and cell-cell adhesions, cytoskeletal and 
actomyosin networks, ion-exchange channels and transmembrane receptors to ECM 
molecules.  Cells transmit physical cues to the nucleus through these structures and convert 
them to post-transcriptional processes that cellular machinery can interpret, inducing multiple 
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cellular mechanisms.  Some recognized mechanisms with mechanical features include cell 
shape changes, migration, ciliary beating, cell cortex tension, cell adhesion to ECM 
molecules, motor protein trafficking, flagellar motility and cellular spreading [111]. 
There are particular features that make mechanotransduction radically different from the 
more widely studied ligand-receptor signaling.  All signaling depends explicitly on transport.  
Autocrine and paracrine ligand-receptor signaling is limited in time and space by the physics 
of diffusion, whereas mechanical forces can propagate – and consequently induce cellular 
activity – across much larger scales, quickly.  In addition, physical contact between cells and 
their surroundings implies that complex cellular phenomena without obvious mechanical 
participants, such as differentiation and intercellular signaling, occur under characteristic 
physical conditions. These features of mechanotransduction have radical implications in 
understanding cellular development and stem cell biology [112]. 
A biological consequence of mechanotransduction is cell differentiation, which arises in 
maturational tissue gradients within evolving ECM compositions and signaling gradients.  
However, cell differentiation also takes place when evolving mechanical properties of the 
ECM transmit forces differently to the cells as the ECM changes mechanically.  Mechanical 
properties of tissues are different across distinct locations in maturational gradients, in which 
ECM compositions vary by distributing glycoproteins, collagens or degrees of PG sulfation 
heterogeneously across tissues [1, 107, 113-115]. 
Mechanotransduction operates in all tissues, including soft organs like liver.  We 
hypothesize that the adult liver, with heterogeneous but well organized composition, 
responds to mechanical stimuli differentially across the maturational gradient.  Within this 
gradient, the effects of mechanical forces on differentiation vary as cells across hepatic 
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lineages adapt to their microenvironment, and correlate with the progression in the hepatic 
ECM profile.  In agreement with this notion, the hypothesis which drives our experimental 
approach is that local mechanical properties of the ECM are not only a consequence of 
lineage-dependent specification within the hepatic maturational gradient, but also a driving 
stimulus to differentiation. 
 
CHAPTER 5. MECHANICAL STIFFNESS OF THE MICROENVIRONMENT 
REGULATES PHENOTYPE OF HUMAN HEPATIC STEM CELLS18 
5.1. ABSTRACT 
Human livers are comprised of maturational lineages of parenchymal and mesenchymal 
cells beginning in stem cell niches, the canals of Hering, and ending in polyploid cells at the 
central vein.  The stem cell niche contains hepatic stem cells (hHpSCs) in partnership with 
angioblasts embedded in a microenvironment of soluble signals and matrix components that 
includes hyaluronan (HA). In our work, we investigated whether matrix mechanics dictates 
differentiation in hHpSCs by surveying changes in their phenotype and hepatic functions 
when cultured in three-dimensional (3D) environments with known mechanical properties. 
We mimicked the stem cell niche by embedding isolated hHpSCs in 3D HA hydrogels 
prepared with Kubota’s Medium (KM), cross-linked with poly(ethylene glycol)-bis-acrylate 
(PEGDA) and containing soluble signals tailored for hepatic stem cells. It provided cell 
attachment, matched diffusion properties of cell suspensions, possessed shear thinning 
properties, showed a perfectly elastic response to mechanical loading, and exhibited 
predictable mechanical stiffness (shear modulus |G*|) depending on HA and PEGDA 
concentrations. Increased stiffness/rigidity controlled hHpSC expansion and induced 
differentiation to an intermediate state between hHpSCs and the next maturational stage, 
                                                
18 Lozoya OA, Wauthier E, Turner RA, Barbier C, Guilak F, Superfine R, Reid LM.  Mechanical 
stiffness of the microenvironment regulates phenotype of human hepatic stem cells.  Article, in 
preparation for submission to peer-reviewed journal, appears as this chapter with authors’ permission. 
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hepatoblasts (hHBs).  The mRNA and protein expression levels of differentiation markers, 
such as alpha-fetoprotein (AFP) and E-cadherin (CDH1), decreased with increasing hydrogel 
rigidity below an apparent stiffness bifurcation region around |G*| = 200 Pa.  Matrix rigidity 
proved a significant regulatory variable even within the stem cell niche microenvironment.  
To our knowledge, this is the first study of its kind on a determined stem cell population with 
endodermal origin. 
5.2. INTRODUCTION 
The liver is one of the most complex organs in the body and is responsible for toxin 
removal, production of bile and hormones, regulation of nutrients, and the synthesis of serum 
proteins [116].  After acute injury, liver can regenerate rapidly within a few weeks [63].  
However, for patients in severe conditions resulting in liver failure, organ transplantation is 
the only established treatment.  Some alternative therapeutic strategies under development 
include transplantation of liver cells in patients, bioartificial livers as assist devices and cell 
grafting [65]. Grafting technologies use a 3-dimensional (3D) microenvironment that 
mimicks paracrine signaling between epithelial and mesenchymal cells in liver and contains 
mixes of extracellular matrix (ECM) components that bind specific soluble signals.  We 
pursue forms of liver cell therapies that use purified hepatic stem cells (hHpSCs) transplanted 
by grafting technologies. Cell grafting helps hHpSCs localize to the target tissue, expand and 
differentiate to adult fates, and facilitates graft vascularization [65]. 
Liver is organized in functional unit (acini) hosting all hepatic maturational lineages.  In 
histological sections, acini have hexagonal shape and six sets of portal triads at the vertices, 
each containing a hepatic artery, portal vein and bile duct. A central vein connected to the 
vena cava occupies the center of each acinus.  By convention, three zones delineate liver 
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acini: zone 1 is periportal; zone 2 is midacinar; and zone 3 is pericentral [117].  Changes in 
matrix chemistry are concomitant with progression of cell maturity within liver zones. The 
hepatic stem cell niche, located in the periportal zone 1 contains HAs, laminin forms that 
bind to α6β4 integrin, type III collagen, unique forms of minimally sulfated chondroitin 
sulfate proteoglycans (CS-PGs), limited amounts of type IV collagen and no type I collagen. 
This matrix composition permits a few stable interactions of growth factors with hHpSCs.  It 
transitions to different matrix chemistry in the pericentral zone 3, containing type 1 collagen, 
fibronectin, and unique forms of heparin proteoglycans (HP-PGs) [118-121].  As cells 
emerge from the niche and into the hHB-associated matrix, they encounter type IV collagen, 
laminin, and more highly sulfated forms of CS-PGs that stabilize continuous binding of 
growth factors.  These proteoglycan/growth factor complexes are critical to dictate 
differentiation of cells towards adult fates [122]. 
Successful cell expansion ex vivo requires cultures mimicking paracrine signals from 
the original epithelial-mesenchymal relationship in tissues, where soluble and insoluble 
signals bound to the lateral and basal forms of ECM mediate dynamic interactions between 
epithelium and mesenchyme [12, 16, 93, 122-125].  However, the role of the mechanical 
properties of the ECM environment remains undefined.  This aspect is relevant to tissue 
engineering: if intrahepatic differentiation is also a response to mechanical induction, then 
we can regulate maturation of hepatic progenitors within hydrogels by controlling culture 
conditions ex vivo at the macroscopic level before in vivo engraftment. 
We assessed the effects of mechanical properties of HA hydrogels with diverse 
concentrations of HA and PEGDA on embedded hHpSCs cultured in a serum-free medium.  
Our work defines a method to prime hHpSC differentiation in static cultures that uses a 
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single mechanical input – the mechanical properties of the 3D environment.  Our method 
also defines a culture model that is predictable and repeatable in experimental conditions. 
5.3. MATERIALS AND METHODS 
Sourcing and processing of human livers. Human fetal liver tissue was provided by 
an accredited agency (Advanced Biological Resources, San Francisco, CA) from fetuses 
between 16-20 weeks gestational age obtained by elective terminations of pregnancy. The 
research protocol was reviewed and approved by the IRB for Human Research Studies at the 
UNC.  The processing of the tissue was done as described previously [12, 16, 21]. 
Kubota’s Medium (KM). KM consists of any basal medium, here being RPMI 1640 
(Gibco /Invitrogen, Carlsbad, CA), with no copper, low calcium below 0.5 mM (here being 
0.3 mM), trace elements (zinc--10-12M and selenium—10-9M), insulin (5 µg/ml), 
transferrin/fe (5 µg/ml), high density lipoprotein (10 µg/ml) and a mixture of free fatty acids 
bound to bovine serum albumin.  Detailed methods for its preparation are given in a methods 
review [21]. 
Hyaluronans (HA) and their cross-linker, PEGDA. All HA materials were obtained 
from a commercial source, Glycosan Biosciences (Salt Lake City, Utah) and consist of thiol-
modified carboxymethyl HA (or CMHA-S), a chemically modified HA derivative with 
disulfide bridges for cross-linking by an oxidative reaction into hydrogels using 
poly(ethylene glycol)-bis-acrylate (or PEGDA) as cross-linking catalyst.  The level of cross-
linking activity and stiffness of the hydrogel can be regulated by the amounts of CMHA-S 
and PEGDA added [126-130].  Specific concentrations of CMHA-S and PEGDA dry 
reagents were mixed separately in KM at pH 7.4 at a specific concentration of CMHA-S and 
of PEGDA, and were warmed for 30 minutes at 37°C to enhance dissolution of dry reagents 
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(as instructed by manufacturer).  Separate formulations of mixtures of CMHA-S and PEGDA 
were prepared as summarized in Table 4. 
Table 4. Formulations used in mechanical characterization experiments for KM-HA 
hydrogels in terms of their pre-mix CMHA-S and PEGDA solutions.  Final KM-HA 
hydrogel composition for each formulation was achieved by mixing the CMHA-S and 
PEGDA solutions at a 4:1 ratio.  All KM-HA hydrogel formulations shown were used in 
diffusion coefficient measurements; only lettered formulations (A, B, C, D, E, F) were 
used for rheometry and seeding of hHpSC colonies. 
PEGDA initial solution content (1 part) 
Final contents 
(4:1 apportionment) 
2.0% (w/v) 4.0% (w/v) 6.0% (w/v) 8.0% (w/v) 
1.0% 
(w/v) 
Formulation A 
CMHA-S 0.8% (w/v) 
PEGDA 0.4% (w/v) 
CMHA-S 0.8% (w/v) 
PEGDA 0.8% (w/v) 
CMHA-S 0.8% (w/v) 
PEGDA 1.2% (w/v) 
Formulation B 
CMHA-S 0.8% (w/v) 
PEGDA 1.6% (w/v) 
1.5% 
(w/v) 
CMHA-S 1.2% (w/v) 
PEGDA 0.4% (w/v) 
Formulation C 
CMHA-S 1.2% (w/v) 
PEGDA 0.8% (w/v) 
Formulation D 
CMHA-S 1.2% (w/v) 
PEGDA 1.2% (w/v) 
CMHA-S 1.2% (w/v) 
PEGDA 1.6% (w/v) 
CMHA-S 
initial 
solution 
content 
(4 parts) 
2.0% 
(w/v) 
Formulation E 
CMHA-S 1.6% (w/v) 
PEGDA 0.4% (w/v) 
CMHA-S 1.6% (w/v) 
PEGDA 0.8% (w/v) 
CMHA-S 1.6% (w/v) 
PEGDA 1.2% (w/v) 
Formulation F 
CMHA-S 1.6% (w/v) 
PEGDA 1.6% (w/v) 
 
HA hydrogel rheometry. Multiple hydrogel formulations, prepared as indicated above, 
were immediately homogenized by vortexing and delivered as liquids within less than 10 
minutes post-mix in individual 9.5 mm x 6.2 mm sterile cloning cylinders (Cole-Parmer) 
placed inside individual wells as casts in a multi-well plate (500 µl of HA hydrogel per 
sample, 4 samples per tested formulation).  Maximum hydrogel cross-linking occurred 
without additional media for 1 hour under sterile conditions in an incubator at 5% CO2/air 
mix and 37°C.  Afterwards, hydrogels were supplied with 2.5 ml of HK media and incubated 
overnight prior to testing. 
Rheological properties of cell-free HA hydrogels were measured at the Center for 
Computer Integrated Systems for Microscopy and Manipulation (CISMM) at UNC Chapel 
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Hill.  The testing system made use of an AR-G2 stress- and temperature-controlled rheometer 
(TA Instruments, oscillation torque and velocity tolerances: 1% and 5%, respectively; 
temperature tolerance: 0.2°C) with a cone-and-plate (CAP) geometry setup at a constant 26-
µm cone-to-plate truncation gap, a 40-mm diameter 1° angle stainless steel cone, a Peltier 
plate equilibrated at 37°C and equipped with a H2O-filled solvent trap (minimum required 
sample volume: approximately 300 µl per individual sample).  HA hydrogel is loaded for 
testing by uniform cone-and-plate compression down to the truncation gap distance, ensuring 
full contact with the cone surface area, and with system locked until normal pre-stress 
response from the compressed HA hydrogel sample equilibrates.  The testing system uses 
negative feedback controls to equilibrate sample pre-stress before tests and maintain 
equilibrated sample pre-stress in real time throughout tests.  The testing system software 
accounts for compressive pre-stress in samples when calculating shear responses from 
measurements.  After HA hydrogel setup, a frequency sweep test was performed with an 
oscillatory shear stress amplitude of 0.6 Pa and forcing frequencies ranging from 0.01 Hz to 
100 Hz (increasing logarithmic frequency ramp mode at 10 points per decade with 3 seconds 
of stress conditioning and 3 seconds of sampling under controlled flow).  Data were recorded 
separately for each individual sample, and experimental variables were calculated directly 
from measurements using post-processing tools from the testing system software, including 
regression analysis routines for rheological constitutive models [131]. 
Diffusivity assays. Multiple hydrogel formulations, prepared as indicated above, were 
immediately homogenized by vortexing and a single 200-µl volume was delivered as a liquid 
inside an individual well in a 24-well plate for each formulation (sample thickness: ~ 1 mm) 
within less than 10 minutes post-mix.  HA hydrogels were incubated without additional 
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media for 1 hour under sterile conditions in an incubator at 5% CO2/air mix and 37°C to 
allow maximum cross-linking after mixing.  Samples were then supplemented with equal 
volumes (200 µl) of additional KM supplied with 2.5 mg/ml (0.036 mM) fluorescein-
conjugated 70-kDa Dextran molecules (D70, Invitrogen), allowed to diffuse into samples 
during overnight incubation by swelling prior to testing. 
Diffusion coefficients of HA hydrogels were measured using a fluorescence recovery 
after photobleaching (FRAP) system in the Orthopaedic Bioengineering Laboratory at the 
Duke University School of Medicine.  “In-well” testing was performed on samples after 
equilibration to room temperature for imaging purposes without prior aspiration of D70-
supplemented KM.  FRAP was performed with a laser scanning confocal microscope (Zeiss 
LSM 510) using an effective 20x amplification objective (10x/0.3 NA Plan-Neofluor air lens 
objective with additional 2x scanning control zoom).  A total of 5 individual 30-second 
photobleaching spots (13.5-mW 458/488 nm excitation Argon laser, bleached geometry: 35-
um diameter circle) were tested per sample, and a single unidirectional scan pre-bleaching 
image, a single unidirectional scan image immediately after the end of photobleaching, and 
28 unidirectional scan time-series images at 4.0-second delay intervals afterwards (256 x 256 
pixels frame size, 0.9 um/pixel resolution) were acquired for post-processing through a single 
channel (LP 505 nm, green emission channel).  A fiducial mark at the bottom of an unused 
well was used as height reference datum and imaging data were recorded separately for each 
individual sample at a distance into the bulk of the hydrogel of 400 µm from the reference 
datum.  Diffusion coefficients were calculated for all samples with curve-fitting analysis 
post-processing routines [132] of fractional fluorescence recovery of the bleached region, 
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measured by spatial Fourier transformation decay of normalized images, plotted against the 
frequency-scaled time. 
Culture selection for hHpSCs and seeding of HA hydrogels. Freshly processed 
human fetal livers were cultured in serum-free KM in an incubator at 5% CO2/air mix and 
37°C to allow for culture selection of hHpSCs during 3 weeks, yielding colonies each 
containing approximately 2,000 – 5,000 cells per colony.  The hHpSC colonies were isolated 
by pipette aspiration from culture plates and resuspended again in serum-free KM.  The 
collected hHpSC colonies were pelleted by slow centrifugation and resuspended in pre-mix 
PEGDA solutions (Table 4) immediately after supernatant aspiration.  PEGDA solutions with 
resuspended hHpSC colonies were then homogenized by vortexing with separate CMHA-S 
solutions.  Samples consisted of 0.15-ml volumes of HA hydrogels with a seeding density of 
80 hHpSC colonies/ml (100 hHpSC colonies per 1.25 ml) of HA hydrogel, delivered as 
liquids immediately after hydrogel mixing into 10-mm diameter 0.4-µm polycarbonate 
membrane tissue inserts (Nunc) and placed in individual wells of a 24-well culture plate. 
Samples were incubated without additional media for 1 hour under sterile conditions in a 5% 
CO2/air mix and 37°C incubator to allow maximum cross-linking after mixing (sample 
thickness: ~ 2 mm).  Samples were then supplemented with 1 ml of KM each and allowed to 
swell with media in culture for 24 hours, which also allows hHpSC colonies to adapt to their 
new 3D environment within HA hydrogels.  Medium was replaced daily during the length of 
the experiment (1 week). 
Viability assays. Viability was assessed using alamarBlue® (AbD Serotec, Kidlington, 
UK), an indicator of enzymatic reduction activities, by measurements of absorbance at 530 
nm and 600 nm with a cytofluor Spectramax 250 multi-well plate reader (Molecular Devices, 
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Sunnyvale, CA).  The cultures of hHpSCs in the HA hydrogels (4 samples per formulation, 
0.15 ml sample volume) were incubated for 1 week in serum-free KM.  Samples were 
supplemented with 10% volume of alamarBlue® reagent (AbD Serotec) every other day 
starting on day 2 post-seeding, collected after a 24-hour incubation period and stored at 4°C 
in the dark under sterile conditions until testing. 
Quantitative Real Time PCR (qRT-PCR) analyses. Total RNA from monolayer 
cultures (positive control cell lines, hHpSC colonies) and freshly isolated hHBs was 
extracted with the RNeasy Mini Plus kit (QIAGEN); total RNA from 3D cultures in HA 
hydrogels was extracted using TRI Reagent (Invitrogen). Gene-specific primers (Table 5) 
were validated using cDNA templates generated from relevant cell lines expressing each 
gene of interest. Gene expression baselines were defined using cDNA templates generated 
from hHBs and 2-dimensionally grown hHpSCs colonies obtained from 3 different fetal 
livers. The hHBs were isolated from initial fetal liver preparations and constituted ~99% of 
the parenchymal cell fraction [8, 12, 21, 133].  Colonies of hHpSCs were isolated by pipette 
aspiration from monolayer cultures 3 weeks after plating freshly isolated parenchymal cell 
fractions; the parenchymal cells of these colonies were essentially 100% hHpSCs [12, 16, 
21].  Gene expression levels of hHpSCs in HA hydrogels were measured for 6 different 
hydrogel formulations (4 samples per formulation, 0.15 ml sample volume, seeding density: 
80 colonies/ml HA hydrogel) with hHpSCs obtained from the same fetal liver source, 
incubated in parallel with daily medium changes of KM, collected after 1 week of culture and 
fully repeated for 2 different fetal livers. Quantitative Real Time PCR (qRT-PCR) 
measurements were performed with an Applied Biosystems® 7500 Real-Time PCR System 
available in the Functional Genomics Core Facility at UNC Chapel Hill for the following 
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genes: AFP, EpCAM, NCAM, E-cadherin (CDH1) and Hyaluronan Receptor CD44 (Table 
5).  All measurements of relative expression were normalized with respect to GAPDH by the 
absolute quantification method described elsewhere [134, 135]. 
Analysis of secreted protein production. Concentration levels of secreted AFP, 
albumin and urea in culture media were measured to determine hepatic functions of hHpSC 
in the different hydrogel formulations throughout 1 week of culture.  Media supernatant was 
collected daily from samples of 6 different hydrogel formulations (4 samples per 
formulation, 0.15 ml sample volume, seeding density: 80 colonies/ml HA hydrogel) starting 
on day 2 post-seeding and stored frozen at -20°C until analyzed.  Secretion of AFP was 
measured by enzyme-linked immunosorbent assays (ELISA) using human AFP ELISA kits 
(ALPCO Diagnostics, Salem, NH).  Albumin production was measured by ELISA using 
human albumin ELISA quantitation sets (Bethyl Laboratories, Montgomery, TX).  Urea 
production was analyzed using blood urea nitrogen colorimetric reagents (Bio-Quant 
Diagnostics, San Diego, CA). All assays were measured individually with a cytofluor 
Spectramax 250 multi-well plate reader (Molecular Devices, Sunnyvale, CA). 
Histology and sectioning. Samples of hHpSC-seeded HA hydrogels in each of 6 
different hydrogel formulations and cultured for a week (4 samples per formulation, 0.15 ml 
sample volume, seeding density: 80 colonies/ml HA hydrogel) were fixed for at least one 
hour with 4% buffered paraformaldehyde.  Fixed samples were embedded in HistoGel™ 
specimen medium, with the resulting construct transferred into a cryomold and embedded in 
Tissue-Tek OCT compound (Sakura Finetechnical, Tokyo, Japan) for flash freezing.  
Samples were submitted to the Histology Research Core Facility at UNC Chapel Hill for 
serial cryosectioning at 15 µm – 20 µm section thickness.  Thinner sections were not feasible 
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due to the hydrogel handling properties.  Frozen sections were stored at -80°C until staining, 
at which time they were stabilized to room temperature before PBS washing at the beginning 
of immunochemistry protocols. 
Table 5. Primer sequences used in gene expression assays for hHpSC differentiation. 
Gene 
(NCBI 
ID) 
Description Primer Sequence (5’ →  3’) 
NCBI Ref. 
Seq. 
(Accession) 
Positive Control 
Cell Line 
Forward: CCATGAAGTGGGTGGAATCAA 
AFP 
α-fetoprotein 
(hepatic-
specific 
variant) Reverse: TCTGCAGTACATTGGTAAGAATCCA 
NM_001134.1 
Forward: TCACAGTCACTGACACCAACGA 
CDH1 E-cadherin 
Reverse: GGCACCTGACCCTTGTACGT 
NM_004360.3 
Forward: GACTTTTGCCGCAGCTCAGGAAG 
EPCAM 
Epithelial cell 
adhesion 
molecule Reverse: GCCAGCTTTGAGCAAATGACAGTATTTTG 
NM_002354.1 
Hep3B 
(hepatoblastoma) 
Forward: TGCCGCTTTGCAGGTGTAT 
CD44 Hyaluronic acid receptor 
Reverse: GGCCTCCGTCCGAGAGA 
NM_000610.3 
MDA-MB-231 
(metastatic 
breast 
adenocarcinoma) 
Forward: GCGACCATCCACCTCAAAGT 
NCAM 
Neural cell 
adhesion 
molecule Reverse: CTCCGGAGGCTTCACAGGTA 
NM_000615.5 SK-N-SH (neuroblastoma) 
Forward: AAGGTGAAGGTCGGAGTCAA 
GAPDH 
Glycerine 
aldehyde-3-
phosphate 
dehydrogenase Reverse: AATGAAGGGGTCATTGATGG 
NM_002046.3 Endogenous housekeeping 
 
Immunohistochemistry. Histological sections were washed with PBS, bordered using 
a PAP-PEN, and blocked with 1X PBS + 0.1% Triton + 10% goat serum.  Primary antibodies 
 51 
for hHpSC differentiation markers AFP, EpCAM, NCAM, E-cadherin (CDH1) and 
Hyaluronan Receptor CD44 (Table 6) were applied and incubated overnight at 4°C, followed 
by washing and incubation of fluorophore-conjugated secondary antibodies for 2 hours at 
room temperature.  Once labeled, fluorescence mounting media supplemented with DAPI 
was applied.  Slides were imaged using fluorescence or laser confocal microscopy. 
Established cancer cell lines were used as positive controls for primary antibody validation of 
differentiation markers using secondary antibody fluoroprobes.  Primary antibody specificity 
was confirmed by negative staining in isotype controls with secondary antibody fluoroprobe 
incubation. 
Table 6. Antibodies used in immunochemistry assays for hHpSC differentiation. 
Marker Description Manufacturer (Cat. No.) 
Source 
(Isotype/Emission) 
Stock 
Concentration Titer 
Positive  
(Cell Line) 
AFP 
(human) α-fetoprotein 
Santa Cruz 
Biotechnology®, Inc. 
(sc-8399) 
mouse anti-human 
(IgG2A) 
200 µg/ml 1:100 
CDH1 
(human) E-cadherin 
Abcam® Inc. 
(ab8993) 
mouse anti-human 
(IgG2B) 
1 mg/ml 1:100 
EPCAM 
(human) 
Epithelial 
cell adhesion 
molecule 
Lab 
Vision/Neomarkers 
(MS-181-P1) 
mouse anti-human 
(IgG1) 
200 µg/ml 1:500 
Hep3B 
CD44 
(human) 
Hyaluronan 
receptor 
Abcam® Inc. 
(ab6124) 
mouse anti-human 
(IgG2A) 
100 µg/ml 1:100 MDA-MB-231 
NCAM 
(human) 
Neural 
cell adhesion 
molecule 
BD Pharmingen™ 
(559043) 
mouse anti-human 
(IgG2B) 
1 mg/ml 1:500 SK-N-SH 
IgG2A 
(mouse) 
Alexa Fluor® 
488 
Invitrogen™ 
Molecular Probes® 
(A21131) 
goat anti-mouse 
(488 nm) 
IgG2B 
(mouse) 
Alexa Fluor® 
488 
Invitrogen™ 
Molecular Probes® 
(A21141) 
goat anti-mouse 
(488 nm) 
IgG1 
(mouse) 
Alexa Fluor® 
568 
Invitrogen™ 
Molecular Probes® 
(A21124) 
goat anti-mouse 
(568 nm) 
2 mg/ml 1:800 
Nuclear 
stain 
UltraCruz™ 
fluorescence 
mounting 
medium with 
DAPI  
Santa Cruz 
Biotechnology®, Inc. 
(sc-24941) 
N/A 1.5 µg/ml N/A 
N/A 
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Fluorescence microscopy. Histological sections of hHpSC-seeded HA hydrogels 
stained with secondary antibody fluoroprobes were identified using fluorescence microscopy.  
Negative controls were used to normalize backgrounds and eliminate image acquisition 
noise.  Microscopy equipment consisted of an Olympus IX70 Inverted Fluorescence 
Microscope equipped with a Hg/Xe arc lamp for epi-illumination and an Olympus DP72 
Digital Camera controlled with cellSens™ Digital Imaging Software for image acquisition. 
Laser confocal microscopy. Histological sections of hHpSC-seeded HA hydrogels 
stained with secondary antibody fluoroprobes were identified using laser confocal 
microscopy.  Negative controls were used to normalize backgrounds and eliminate image 
acquisition noise.  Microscopy equipment consisted of a Leica SP2 Laser Scanning Confocal 
Microscope equipped with a Hg/Xe arc lamp for epi-illumination, excitation lasers at 
wavelengths of 350/364 nm (UV), 488/476/488/514nm (blue Ar laser), 561 nm (green solid-
state diode pump laser) and 633 nm (visible red HeNe laser).  LCS Software was used for 
image acquisition and processing. 
Statistical analysis.  Mechanical characterization experiments were displayed within a 
95% confidence interval per engineering practice conventions.  Experimental quantitative 
data were displayed in a mean ± standard error format in charts or displayed within a 99% 
confidence interval in plots for side-to-side comparison (as indicated).  Significance of gene 
expression levels (logarithmically transformed) with respect to both hHpSCs and hHBs (p-
value: * < 0.05, ** < 0.01, *** < 0.001) was determined by two-tailed Student’s t-test. For 
immunohistochemistry studies, marker expression was qualitatively assessed by fluorescence 
or laser confocal microscopy.  All individual sample measurements were performed at least 
in duplicate. 
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Principal Component Analysis (PCA) of gene expression was performed on data 
from hHpSCs and hHBs for all markers.  The data from each marker was logarithmically 
transformed, followed by mean-centering and scaling with respect to the standard deviation 
of its transformed data.  The covariance matrix was computed and used to calculate 5 
eigenvalues with corresponding eigenvectors describing the principal components of the 
phenotype changes in hHpSC –to-hHB differentiation.  For overall gene expression analysis, 
principal component scores were calculated for the first two eigenvalues (PC1 and PC2) and 
projected onto a two-dimensional plane defined by their eigenvectors for all data, including 
KM-HA-grown hHpSCs. Significance of gene expression levels with respect to both hHpSCs 
and hHBs (p-value: * < 0.05, ** < 0.01, *** < 0.001) and across KM-Ha formulations was 
determined on PC scores by two-tailed Student’s t-test. 
5.4. RESULTS 
5.4.1. Mechanical properties of cell-free HA hydrogels. 
5.4.1.1. Rheological properties across diverse formulations of CMHA-S and PEGDA 
All HA-based hydrogels in the proposed research were assembled from equivalent 
components mixed in different proportions (Table 4).  Under these experimental conditions, 
any differences in the behavior of hHpSCs across diverse 3D culture formulations should 
result from differences in the mechanical properties and composition of the HA hydrogels. 
We used serum-free KM to assemble our hydrogels, since our culture hydrogels would 
require embedded hHpSCs to have access to nutrients in KM throughout the experiment. To 
indicate that our hydrogels are distinct from those described elsewhere [130], we will refer to 
them as KM-HA hydrogels. 
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Our data shows that stiffness, viscoelastic properties and viscosity of KM-HA hydrogels 
depend on CMHA-S and PEGDA content (Table 4). KM-HA hydrogels maintained a 
constant stiffness across a broad forcing frequency range while exhibiting a perfectly elastic 
behavior (Figure 14a) and exhibited shear thinning, as their viscosity decreased with 
increasing forcing frequency (Figure 14b).  Most importantly, the contents of CMHA-S and 
PEGDA controlled the mechanical properties of KM-HA hydrogels predictably (Figure 15a). 
5.4.1.2. Diffusion in KM-HA hydrogels 
We measured diffusion in KM-HA hydrogels using fluorescence recovery after 
photobleaching (FRAP) technology.  Our tests showed that the differences in diffusivity 
between KM-HA hydrogels and serum-free KM are negligible and statistically insignificant, 
with diffusion coefficients ranging between 8 and 10 µm2/s (Figure 15b). 
5.4.2. Effects of stiffness of the KM-HA hydrogels implicate mechanical properties as 
critical for the regulation of the maturational lineage stage of hHpSCs 
5.4.2.1. Size, morphology, viability and proliferation of KM-HA-grown hHpSCs 
Colonies of hHpSCs resemble embryonic cell colonies in plastic cultures: they have a 
roughly round shape, are well delimited at their edges and host cells with small sizes.  We 
lifted 2D-grown hHpSC colonies by pipetting and mixed them with KM-HA hydrogels.  As 
they adapt to their new 3D environment, hHpSC colonies abandon their flat configurations 
and can either agglomerate to spheroid-like structures or fold into complex 3D structures 
(Figure 16a).  After 1 week of culture, cell morphology becomes diverse and some cells 
enlarge to about 15 um in size, which is characteristic of hHBs.  This occurs at different 
degrees in all KM-HA formulations, and can be observed by immunostaining with antibodies 
for cell surface markers for hHpSCs and hHBs like EpCAM, CD44 and CDH1 (Figure 16b 
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and Figure 16c).  Viability, measured as metabolic efficiency by alamarBlue® reduction, is 
only enriched for certain KM-HA hydrogel formulations after 1 week of culture (Figure 16d), 
even though nuclei shape does not suggest cell death or apoptosis. 
5.4.2.2. Functional Assays of Hepatic Metabolism for KM-HA-grown hHpSCs 
We sustained hHpSCs in KM-HA hydrogels for 1 week in static cultures with KM, 
replaced and collected daily after 24-hr incubation.  We performed immunosorbent assays to 
determine absolute concentrations in collected KM of secretory proteins that define hepatic 
function.  Throughout culture, hHpSCs in all tested compositions for KM-HA hydrogels 
(lettered formulations, Table 4) secreted AFP and albumin at increasing concentrations, 
while urea synthesis equilibrated to comparable levels in all KM-HA hydrogels by day 7 
(Figure 17). 
We obtain a more distinctive picture of hHpSC function in each KM-HA hydrogel 
when we normalize our data with respect to levels of viability at selected intervals (Figure 
16d).  This normalization yields rates of metabolic efficiency, which we interpret in terms of 
apparent number of functional colonies.  This calculation reveals that the minimum secretion 
rates per colony at the end of culture for all assays (AFP, albumin and urea) correspond to 
KM-HA hydrogels with 1.6% CMHA-S contents (lettered formulations E and F, Figure 17). 
Secretion rates of AFP, albumin and urea from hHpSCs in KM-HA hydrogels also vary 
in time throughout culture.  Secretion rates always increase for AFP and albumin, and do so 
with distinctively faster paces in KM-HA formulations with 1.2% CMHA-S or less (lettered 
formulations A, B, C, and D).  In contrast, urea secretion rates only increase throughout 
culture in KM-HA hydrogels with contents of 1.2% CMHA-S or less, while equilibrating or 
even decreasing in KM-HA hydrogels with 1.6% CMHA-S (lettered formulations E and F, 
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Figure 17).  Moreover, the minimum secretion rates across all assays at the experimental 
endpoint correspond to KM-HA hydrogels with 1.6% CMHA-S and 0.4% PEGDA (lettered 
formulation E), which also exhibit the highest levels of viability (Figure 16d). 
 
Figure 14.  Rheological measurements on KM-HA hydrogels.  a) The shear modulus 
|G*| of HA hydrogels, a measurement of mechanical gel stiffness, remains constant 
while viscoelastic damping |G’’/G’|, a measurement of deformation response delay upon 
external forcing, is negligible within the 0.1 Hz – 10 Hz forcing frequency range for 
each of the formulations tested; error bars: 95% confidence interval of measurements 
at each frequency tested.  b) HA hydrogels exhibit shear thinning, i.e. decrease in 
viscosity with increasing forcing frequencies, across experimental 0.6 1/s – 60 1/s shear 
rate range [0.1 Hz – 10 Hz forcing frequency]; upper and lower limits: power law 
model-based 95% confidence interval (Cox-Merz rule assumption, R2 > 0.993 for all 
formulations in the 0.3 1/s – 30 1/s shear rate range [0.05 Hz – 5 Hz forcing frequency]).  
Rheological measurements performed only on lettered formulations shown in Table 4. 
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Figure 15.  Mechanical characterization of KM-HA hydrogels.  a) Stiffness of KM-HA 
hydrogels is controllable and depends on CMHA-S and PEGDA contents. The average 
shear modulus |G*| increases with increasing CMHA-S and PEGDA contents following 
a power-law behavior, thus providing direct control of the final mechanical properties 
of KM-HA hydrogels during the initial hydrogel mixing; rheological measurements 
performed only on lettered formulations shown in Table 4.  Error bars: ± 1 standard 
deviation for measurements in the 0.05 Hz – 5 Hz forcing frequency.  b) Diffusion in 
KM-HA hydrogels.  Measurements of diffusivity within HA hydrogels by FRAP (70 
kDa fluorescein labeled dextran) do not differ significantly from Kubota’s medium 
alone; diffusivity measurements performed on all formulations shown in Table 4.  
Error bars: 95% confidence interval of measurements. 
 58 
 
Figure 16.  Size, morphology and proliferation of hHpSCs in KM-HA hydrogels.  
Colonies of hHpSCs acquire three-dimensional configurations and exhibit a) spheroid-
like agglomeration (bottom left) or folding (middle, top right) upon seeding in KM-HA 
hydrogels [image frame: 900 µm × 1200 µm].  Confocal microscopy on histological 
sections of hHpSC-seeded KM-HA hydrogels reveals mixed cell morphology 
phenotypes after 1 week of culture, with cell sizes of b) about 7 µm, or c) up to 10-15 µm 
amongst parenchymal cells [cell nuclei in blue from DAPI counterstaining, EpCAM in 
red for both b) and c), green for either b) CD44, or c) CDH1; image frames b) and c): 
150 µm × 150 µm; white highlight in b) and c): 15 µm × 15 µm].  d) Viability of hHpSCs 
in KM-HA hydrogels, measured by alamarBlue metabolic reduction, reveals functional 
recovery and proliferation in KM-HA hydrogels with 1.6% CMHA-S and 0.4% 
PEGDA (formulation E, Table 4) throughout 1 week of culture; alamarBlue reduction 
measurements after 24-hr incubation, normalized with respect to measurements at 2-3 
days post-seeding. 
5.4.2.3. Gene expression of differentiation markers in hHpSCs within KM-HA hydrogels 
After 1 week of culture, levels of mRNA expression of EpCAM in hHpSC colony cells 
seeded within KM-HA hydrogels were significantly higher than those of 2D-grown hHpSC 
colonies or freshly isolated hHBs.  Statistical boundaries for CD44 gene expression in 
hHpSCS and hHBs overlap; nonetheless, CD44 expression significantly varies across KM-
HA formulations within the boundaries of either lineage stage.  Levels of mRNA expression 
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of NCAM, AFP and E-cadherin (CDH1) for hHpSCs in KM-HA hydrogels are significantly 
different from those of 2D-grown hHpSC colonies.  These expression levels, however, do not 
fall within statistical bounds of hHB expression and, in the case of AFP, are much lower than 
hHB mRNA expression levels (Figure 18).  Therefore, hHpSCs acquired an early hHB 
profile in KM-HA hydrogels, as shown by AFP, CDH1 and NCAM mRNA expression. 
Principal Component Analysis (PCA) of our quantitative measurements of gene 
expression of differentiation markers for hHpSCs (NCAM, AFP, CDH1) and markers 
common to hHpSCs and hHBs (CD44, EpCAM) shows that the expression variability in the 
hHpSC-to-hHB differentiation mechanism can be sufficiently described by only two 
principal components (96% cumulative variance) that are orthogonal to each other.  Principal 
Component 1 (PC1) is strongly influenced by AFP, EpCAM, NCAM and CDH1, 
characterizes the differentiation phenomenon, and accounts for roughly 77% of the total 
variability. Principal Component 2 (PC2), influenced mostly by CD44, characterizes the 
intra-phenotypic variation and accounts for about 19% of the total variability (Figure 19a). 
Data from KM-HA-grown hHpSCs projected onto the PC1-PC2 plane shows that their 
genetic expression profile is in an intermediate state between hHpSCs and hHBs, with all 
variation across KM-HA conditions orthogonal to the differentiation direction (Figure 19b).  
All data for KM-HA-grown hHpSCs are significantly distinct from either lineage stage 
(Figure 19c and d).  When compared amongst each other, gene expression profiles for KM-
HA-grown hHpSCs distribute in the PC plane distinctively with respect to the CMHA-S 
content of each KM-HA formulation, most significantly in PC2.  In other words, intra-
phenotypic variation in hHpSCs grown in KM-HAs is primarily dictated by the amount of 
HA in KM-HAs (Figure 19e and f).   In addition, the distribution of intra-phenotypic 
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variation (PC2) for KM-HA-grown hHpSCs suggests a trend, although not statistically 
significant (Table 11), that outlines a stiffness-dependent bifurcation with increasing PC2 
scores for KM-HA formulations with |G*| < 200 Pa that peaks at KM-HA formulation C 
(|G*| = 165 Pa) in our experiment, and decreasing PC2 scores for stiffer KM-HA hydrogels 
(Figure 19d).  This trend is not evident in the PC1 differentiation score (Figure 19c). 
In summary, this analysis shows that KM-HA-grown hHpSCs acquire comparable 
intermediate phenotypes in their differentiation progression from hHpSCs to hHBs across all 
KM-HA formulations.  When compared across KM-HA formulations, gene expression levels 
of KM-HA-grown hHpSCs are most distinct with respect to their intra-phenotypic variation.  
This intra-phenotypic variation, which is mainly described by CD44 expression, selectively 
distributes KM-HA-grown hHpSCs with respect to the HA content of their KM-HA hydrogel 
in PC space.  In addition, gene expression in KM-HA-grown hHpSCs also suggests a trend 
outlining a stiffness-dependent bifurcation with respect to intra-phenotypic variation, which 
is absent in the direction of differentiation in the PC space. 
5.4.2.4. Protein expression of differentiation markers in hHpSCs within KM-HA hydrogels 
We determined translational expression in hHpSCs by immunostaining for most targets.  
We found limited to null AFP staining, which agrees with low (yet positive) gene expression 
levels reported above (Figure 18).  Nevertheless, we were able to use ELISA, a more 
sensitive assay, to compare AFP accumulation in media with mRNA expression.  Although 
low, secretion rates of AFP by KM-HA hydrogel-seeded hHpSCs showed both increasing 
concentrations with time and qualitative correlation with mRNA expression levels at the 
experimental endpoint across KM-HA formulations (Figure 20). 
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Figure 17. Secretion of human AFP, albumin and urea by hHpSCs seeded into KM-HA 
hydrogels.  Colonies of hHpSCs in KM-HA exhibit some hepatic function with 
increasing concentrations of human AFP and albumin found in culture media (KM) 
and equilibration of urea synthesis by day 7 post-seeding.  The metabolic secretion rates 
of human AFP, human albumin and urea are distinctive by day 7 post-seeding amongst 
KM-HA formulations, with minimum rates for AFP, albumin and decreased urea 
synthesis in KM-HA hydrogels with 1.6% CMHA-S and 0.4% PEGDA (formulation E, 
Table 4).  Left column: metabolite concentration in culture media collected daily after 
24-hr incubation for each lettered formulation (Table 4).  Right column: metabolite 
mass secretion rate per hHpSC colony in culture media after 24-hr incubation; total 
metabolite mass in media is normalized to number of functional hHpSC colonies at 
each interval as calculated by relative viability and proliferation assay with alamarBlue 
reduction (Figure 16d; approximate number of colonies seeded per sample: 12).  All 
data reported as mean ± standard error. 
We studied EpCAM, NCAM, CD44 and CDH1 protein expression in thick sections of 
HA-grown hHpSC colonies by fluorescence microscopy to understand how their overall 
expression within colonies correlates with gene expression.  Expectably, all hydrogel 
 62 
formulations hosted EpCAM+ cells.  Cells also expressed NCAM and CD44; however, 
CD44 appeared enriched in KM-HA formulations with 1.2% CMHA-S or less, whereas 
NCAM remained rich in all KM-HA hydrogels.  For CDH1, protein expression paralleled 
mRNA expression in KM-HA formulations with |G*| < 200 Pa (A, B, E and C in Table 4).  
However, at higher stiffness levels, protein was undetectable (Figure 18 and Figure 20). 
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Figure 18. Gene expression levels by qRT-PCR for hepatic progenitor markers in KM-
HA-grown hHpSCs after 1 week of culture (previous page).  Comparisons between the 
mRNA expression levels of markers for hHpSCs and their immediate descendents 
hHBs (hepatic-specific AFP, EpCAM, NCAM, CD44 and CDH1) show that KM-HA-
grown hHpSCs acquire early hHB characteristics at the transcriptional level in passive 
culture for 1 week.  The expression ranges in hHpSCs and freshly isolated hHBs for 
CD44 are comparable; the expression levels for the remaining markers are statistically 
distinct, with approximately 2-fold decrease in EpCAM, 3-fold decrease in CDH1, 
NCAM silencing and AFP enrichment upon hHpSCs differentiation into hHBs.  In all 
KM-HA hydrogels, mean expression levels of seeded hHpSCs for AFP, NCAM and 
CDH1 shifted outside the hHpSC range towards the hHB range, while EpCAM 
expression is enriched throughout, after 1 week of culture.  KM-HA formulations 
ordered with respect to increasing stiffness (|G*|  = 25 Pa for A, |G*|  = 73 Pa for B, |G*|  
= 140 Pa for E, |G*|  = 165 Pa for C, |G*|  = 220 Pa for D, and |G*|  = 520 Pa for F).  
Expression levels (mean ± standard error) were normalized with respect to GAPDH.  
Measurements in lettered KM-HA formulations (Table 4) compared to hHpSC colonies 
(green) and freshly isolated hHBs (red) for significance (Student’s t-test). 
We next analyzed how these differentiation markers distributed within our cultures by 
confocal microscopy, both across hHpSC colonies in KM-HA hydrogels and within cells.  
We found that, in general, there was very little co-localization of EpCAM with all other 
surface markers (NCAM, CD44 and CDH1) across planes of colonies.  The few subsets of 
cells that expressed all these targets were usually exposed to external colony surfaces in 
direct contact with KM-HA hydrogel material (Figure 21).  Further confocal analysis 
revealed that EpCAM+ cells in colonies within KM-HA hydrogels distributed EpCAM at 
their basal surfaces and towards homotypic cell-cell interactions; in contrast, cells expressing 
NCAM, CD44 and CDH1 localized to “outer” surfaces of colonies and presented these 
proteins at their apical surface with no intracellular co-localization with EpCAM (Figure 22). 
5.5. DISCUSSION 
Liver histology reflects hepatic maturational lineage progression within each acinus, the 
functional unit of the liver.  Liver acini have hexagonal shape (in histological sections) and 
six sets of portal triads at the vertices.  Each portal triad contains a hepatic artery, portal vein 
and bile duct.  The center of each acinus is occupied by a central vein that is connected to the 
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vena cava [117].  Incoming blood flows from the gut and from the spleen into the liver via 
the portal triads.  It passes across plates of liver cells before discharging into the central vein 
to exit the liver.  By convention, three zones delineate liver acini: zone 1 is periportal; zone 2 
is midacinar; and zone 3 is pericentral.  Cell properties like size, ploidy, growth rates, ECM, 
and gene expression vary along these zones in gradient fashion.  In this respect, zones 1, 2 
and 3 correspond to cells in early, intermediate and late maturational stages, respectively. 
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Figure 19. Principal Component Analysis (PCA) of gene expression profile (previous 
page).  a) Two principal components (PCs) account for 96% of variance in gene 
expression profile between hHpSCs and hHBs with respect to hepatic progenitor 
markers (hepatic-specific AFP, EpCAM, NCAM, CD44 and CDH1); principal 
component 1 (PC1) describes differentiation and depends mostly on differences between 
hHpSCs and hHBs lineages with respect to differentiation markers (AFP, EpCAM, 
NCAM and CDH1) as shown by PC1 eigenvector; PC2 describes intra-phenotype 
variation and depends almost exclusively on CD44 expression.  b) KM-HA-grown 
hHpSCs show an intermediate phenotype between hHpSCs and hHBs in PC space.  
Gene expression profiles in all KM-HA-grown hHpSCs exhibit significant differences 
from hHpSCs and hHBs c) in PC1, and d) in PC2.  Expression trends in KM-HA-grown 
hHpSCs, as shown in c) and d), are not statistically significant with respect to KM-HA 
stiffness. The variation amongst KM-HA-grown hHpSCs is significantly largest 
between KM-HAs with different CMHA-S contents for both e) PC1 and f) PC2; highest 
significant differences amongst KM-HAs reside in intra-phenotype variation (PC2) that 
depends primarily on CD44 expression.  Measurements in lettered KM-HA 
formulations (Table 4) compared to hHpSC colonies (green) and freshly isolated hHBs 
(red) for significance (Student’s t-test).  Expression profile scores in PC space (error 
bars: mean ± standard error) for lettered KM-HA formulations (Table 4) are plotted in 
c) and d) against normalized KM-HA hydrogel shear modulus |G*|/G0 (G0 = 100 Pa) 
and compared to threshold ranges of expression in hHpSCs (green area, mean ± 
standard error) and freshly isolated hHBs (red area, mean ± standard error). 
The intrahepatic maturational gradient starts in zone 1 (periportal) and ends in zone 3 
(pericentral).  At least 8 maturational lineage stages can be distinguished within the acinar 
zones [122].  The phenotypic properties of each stage are dictated by paracrine signaling 
between parenchymal and mesenchymal cell partners whose maturation is coordinate.  
Adjacent to the portal triad, the stem cell niche is occupied by human hepatic stem cells 
(hHpSCs) – partnered with angioblasts (ABs) – that transition to hepatoblasts (hHBs) – 
partnered with precursors of both endothelial and hepatic stellate cells (hHpSTCs).  They 
mature outside the niche towards adult states into either hepatocytes – partnered with mature 
endothelia – or biliary epithelia – partnered with mature hHpSTCs and myofiboblasts [12, 
16, 21]. 
Studies on fetal and adult human livers show that hHpSCs constitute ~0.5-2% of the 
hepatic parenchyma in all age donors, form colonies with differentiation potential [8, 136], 
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and can be identified by expression of epithelial cell adhesion molecule (EpCAM) and neural 
cell adhesion molecule (NCAM) but lack of expression of alpha-fetoprotein (AFP) [12].  The 
hepatoblasts (hHBs) constitute more than 95% of the parenchymal cells in fetal tissues; they 
decline in numbers to <0.01% of the parenchymal cells with age in postnatal livers, but can 
expand during regenerative processes [123, 125].  The phenotypic properties of the hHBs 
overlap extensively with that of hHpSCs but are distinct, among other features, in that they 
express AFP but not NCAM.  Epithelial-mesenchymal interactions in hepatic tissue in vivo 
also dictate how to control expansion and differentiation of hepatic progenitors ex vivo.  Self-
replication of hHpSCs and hABs ex vivo requires KM [16, 20], occurs in culture on plastic, 
as long as the two subpopulations are associated [12], on substratum of type III collagen [31] 
or in uncross-linked HA [16].  Lineage restriction to hHBs occurs in KM and on type IV 
collagen or laminin or highly cross-linked HA hydrogels [16].  Using purified ECM 
components that replicate tissue-specific chemistries ex vivo can also mimic in vivo behavior 
[21]. 
In all tissues, the mechanical properties of the ECM have profound effects on signaling, 
transport, and on how cells respond to mechanical forces using mechanisms collectively 
known as mechanotransduction [137-139]. Mechanotransduction modulates cytoskeletal 
organization, cell cortex tension, cell adhesion, and shuttling of downstream targets between 
cell nuclei and cytoplasm by using different arrays of signals, for example the TGF-β 
superfamily [48, 50, 51, 140].  At higher scales, these cellular mechanisms influence tissue 
assembly through the roles of the cytoskeleton in cell migration, aggregation and 
proliferation [141], inducing cell aggregation on soft substrates and cell dispersion on stiff 
ones [142].  Mesenchymal stem cell (MSC) differentiation is also induced by substrate 
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stiffness [47].  However, information on how mechanical forces influence differentiation in 
soft tissues, such as liver, has remained limited despite our knowledge of matrix chemistry 
gradients across lineage stages.  These matrix changes also have mechanical significance, 
depending in part on local sulfation levels of GAGs in the ECM that could yield varying 
mechanical properties across maturational gradients [107]. 
Hyaluronic acid (HA) is a key component in the ECM chemistry of the liver stem cell 
niche.  HA belongs to the glycosaminoglycan (GAG) family, and is formed by disaccharide 
units linked with alternating β-1,4 and β-1,3 glycosidic bonds between glucosamine and 
glucuronic acid structures.  It is found in ECM, on the cell surface and inside the cell [143]. 
HA is conserved across all species, is biocompatible and elicits no inflammatory, 
immunologic or toxic responses [127]. These properties, along with high water saturation, 
make it a useful building block for biomaterials for tissue engineering therapies.  In addition, 
it can be easily modified, and is more cost effective than other ECM components [126-130]. 
HA is also abundant during cellular expansion events such as embryogenesis, wound repair, 
and organ regeneration.  Neural crest cell migration, cardiac development and prostate duct 
formation involve HA function as a scaffold component [144-147].  Rapidly dividing 
epithelial cells show an increased binding activity towards HA, and it is possible that 
transition from epithelial to mesenchymal phenotypes takes place through interactions 
mediated by HA binding [148, 149].  HA in hepatic tissue interacts with liver cells through 
two HA receptors that mediate cell attachment of liver progenitors to ECM: hHpSCs are 
positive for CD44; ABs are positive for LYVE-1 [150-152].  In fact, in primary cultures and 
in liver injury, hepatic stellate cells produce HA, which increases in parallel with expression 
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of its receptor CD44, and the resulting increased levels of HA in the blood correlate with 
hepatic regeneration in vivo [153]. 
 
Figure 20. Protein expression of differentiation markers in KM-HA-seeded hHpSCs 
after 1 week of culture.  Colonies of hHpSCs exhibit differential levels of expression for 
differentiation markers in hHpSCs at the translational level depending on KM-HA 
hydrogel characteristics.  Metabolic secretion rates of human AFP correlate mRNA 
expression levels across KM-HA formulations.  NCAM expression is positive for all 
KM-HA hydrogels, while CD44 expression is richest for KM-HA hydrogels with 
CMHA-S contents of 1.2% or less (lettered formulations A, B, C, D; Table 4).  CDH1 
expression is positive for KM-HA hydrogels with |G*| < 200 Pa and weak or negative 
for |G*| > 200 Pa.  Data for human AFP secretion rate reported as mean ± standard 
error.  Immunohistochemical staining for EpCAM, NCAM, CD44 and CDH1 
performed on 15 – 20 µm section and imaged by fluorescence microscopy [image 
frames: 100 µm × 100 µm]. KM-HA formulations ordered with respect to increasing 
stiffness (|G*|  = 25 Pa for A, |G*|  = 73 Pa for B, |G*|  = 140 Pa for E, |G*|  = 165 Pa for 
C, |G*|  = 220 Pa for D, and |G*|  = 520 Pa for F). 
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Figure 21. Co-localization of differentiation markers in KM-HA-seeded hHpSC 
colonies.  Colonies of hHpSCs exhibit low expression levels of AFP by 
immunohistochemistry.  Co-localization of EpCAM with other cell surface 
differentiation markers (NCAM, CD44, CDH1) is low or null across cells within KM-
HA-seeded hHpSC colonies.  Staining for AFP, EpCAM, NCAM, CD44 and CDH1 
performed on 15 – 20 µm sections and imaged by laser confocal microscopy.  Images 
depict average fluorescence collected across 11 confocal optical sections of 0.407 µm 
[mean filtering, total optical slice: 4.07 um; image frames: 300 µm × 300 µm].  KM-HA 
formulations sorted and displayed with respect to increasing shear modulus |G*|. 
Replicating mechanical properties of the cell environment is relevant to tissue 
regeneration applications [154, 155]. We chose HA-based hydrogels in our experiment 
because HA is ubiquitous across stem cell niches.  However, it is just as important to 
discriminate between biochemical and mechanical induction in order to understand lineage 
restriction phenomena. Tissues with normal physiology depend on cells living in 
environments with satisfactory mechanical properties because normal tissue assembly 
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requires successful signaling and mechanical sensitivity in cells [156-160].  We used tailored 
HA hydrogels in previous research [126-130] and found empirical evidence that human 
hepatic progenitors differentiated when seeded in mechanically rigid grafts [22, 26].  
Therefore, we determined the mechanical properties of KM-HA hydrogels to understand the 
effect of the mechanical environment on differentiation and expansion of hHpSCs. 
The HA hydrogels we used yield shear moduli ranging from 11 to 3500 Pa with 
different PEGDA and CMHA-S concentrations when mixed in buffered distilled water [130].  
Dissolving these gel components in culture medium could change the absolute values of the 
hydrogel’s mechanical properties. Therefore, measurements from water-mixed hydrogels 
could not quantitatively match KM-HA hydrogels since we use KM, a basal solution with 
different ionic properties.  Our results showed that the type of basal media play a role on the 
mechanical properties of the HA-based hydrogels as an environment for embedded cells.  
Still, our measurements match the qualitative trends of water-based HA hydrogels (e.g. linear 
variation in stiffness with PEGDA concentration, lack of viscoelastic damping), which 
supports the accuracy of our measurements and shows that the hydrogel chemistry is robust 
and predictable for tissue engineering purposes [130].  In addition to their predictable 
stiffness (Figure 15a), the mechanical properties of KM-HA hydrogels offer substantial 
advantages for grafting technologies: we can deliver them by extrusion or syringe-driven 
techniques because of their shear-thinning properties, and can immediately transmit external 
forces to embedded cells in culture without force loss or damping because of their elastic 
behavior (Figure 14).  All these features make KM-HA hydrogels an attractive culture model 
for mechanotransduction research as well, since researchers can directly control mechanical 
forces on KM-HA macroscopically that will be transduced equally to embedded cells. 
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Relevant molecular sizes for multiple paracrine signals in tissue development are in the 
order of 70 kDa or less [132].  For this reason, our FRAP experiments used molecules of 
fluorescein-labeled 70 kDa Dextran (D70) to calculate the lower limit on diffusion rates 
relevant to morphogenetic signals.  Our measurements indicate that all tested KM-HA 
hydrogels have roughly equivalent diffusion rates that match ordinary cell suspension 
cultures, therefore providing a 3D environment for cell embedding with optimal diffusion 
properties (Figure 15b).  In summary, our experiments permitted studies of mechanical 
properties of hydrogels and their effects on differentiation of hHpSCs by maintaining all 
other conditions (ECM molecular species, diffusivity and culture media) equivalent.  
Furthermore, the fact that several gels of varying rigidity had identical concentrations of 
either CMHA-S or PEGDA (Table 4) allowed us to distinguish between biochemical and 
mechanical regulation of gene expression. 
Our viability measurements indicate that hHpSC colonies have distinct metabolic 
activities in accordance with the composition of KM-HA hydrogel hosting them.  This 
analysis is complemented by our secretion assays.  Absolute secretion is comparable across 
KM-HA formulations for indicators of hepatic function (AFP, albumin and urea) throughout 
culture; however, absolute secretion coupled with metabolic efficiency depicts a selection 
process that depends on the HA content.  In this process, secretion rates increase under 
metabolic duress for KM-HA hydrogels with CMHA-S contents lower than 1.2%; in 
contrast, secretion rates are comparatively poor in KM-HA hydrogels with more CMHA-S 
(1.6%) and higher metabolic function – or even metabolic growth, as in fomulation E (Figure 
16d). Because hHpSCs and hHBs exhibit different metabolic capabilities, our data suggests 
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that certain KM-HA hydrogels can select for expansion or differentiation of hepatic 
progenitors. 
We also performed genetic expression analysis of differentiation markers in hepatic 
progenitors to determine formally whether and to what degree differentiation takes place 
within KM-HA hydrogels.  EpCAM is a common marker of hHpSCs and hHBs at both gene 
and protein expression levels that is characteristically found in hHpSC colonies within 
regions of homotypic cell-to-cell interactions in monolayer cultures [12, 16, 21].  Our data 
shows increased overall expression of EpCAM beyond established levels for hHpSC colonies 
on plastic plates.  However, we also know that these colonies acquire 3D structure within 
KM-HA hydrogels.  A cohesive hHpSC colony in this environment would require additional 
homotypic cell-cell interactions amongst cells within the colony and, for that purpose, could 
lead to increased transcriptional levels of EpCAM expression.  We believe these changes in 
EpCAM expression distinguish hHpSC function within a 3D environment. 
NCAM, unlike EpCAM, is a unique marker of hHpSCs in hepatic parenchyma. 
Colonies of hHpSCs in monolayer cultures express NCAM at the edges to establish 
heterotypic cell-cell interactions with mesenchymal companions such as ABs [12, 16, 21].  
Similarly, in our cultures, NCAM is expressed (Figure 20), heterogeneously across the 
colony towards the outer boundaries where heterotypic cell-cell interactions could take place 
(Figure 21).  Consistent with this finding, NCAM is found on the apical surface of those 
external cells (Figure 22).  The hyaluronan receptor molecule CD44 behaves similarly, even 
though it is common to both hHpSCs and hHBs at the mRNA expression level (Figure 18).  
CD44 differs from NCAM expression in that it exhibits higher enrichment levels for KM-HA 
hydrogels with CMHA-S contents of 1.2% or less (Figure 20).  We surmise that the 
 73 
localization of CD44 to cells in direct contact with HA and its heterogeneous distribution 
within or between colonies (Figure 21 and Figure 22) reflects its function as a HA receptor. 
AFP and E-cadherin are two markers of interest for hHpSCs reflecting early cell 
function.  A secretory protein similar to albumin [28], AFP is not expressed in hHpSCs at the 
transcriptional or translational levels and characterizes hHpSC differentiation to hHB [8, 12, 
122, 133].  E-cadherin is a stem cell marker for germline stem cells, induced pluripotent stem 
cells [161-163] and, unlike AFP, it is expressed by hHpSCs and other cells at early 
embryonic stages [21].  In our experiment, we show that mRNA expression levels vary 
across KM-HA hydrogels (Figure 18) and that AFP protein expression correlates with 
mRNA expression (Figure 20).  The effect is even more drastic for E-cadherin: protein 
expression is absent in KM-HAs with |G*| > 200 Pa despite strong mRNA expression levels 
that match those of softer hydrogels, in which there is protein expression of E-cadherin 
(Figure 18 and Figure 20). 
E-cadherin is a cell surface protein that establishes homophilic adhesions between cells 
for mechanosensation and induces mechanical responses through intracellular signaling 
cascades.  E-cadherin is thought to coordinate collective cell responses to mechanical forcing 
by allowing cells to sense mechanical variations in their neighbors [164].  In our 
experiments, we observe heterogeneous E-cadherin distribution: it is expressed at apical 
surfaces of cells in the outer surfaces of colonies that are directly exposed to KM-HA 
hydrogels (Figure 22).  The cells that are directly exposed to external mechanical forces are 
thus able to communicate the signal to adjacent cells at the external surface of the colony.  
Therefore, by showing that translational control of E-cadherin expression depends on 
environmental stiffness, we are linking signaling mechanisms in hHpSCs with their ability to 
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collectively adapt to the stiffness of their substrate.  We conclude protein expression of E-
cadherin is stiffness-dependent, even in hydrogels with equal concentrations of CMHA-S 
(formulations E and F; C and D), PEGDA (formulations A and E; B and F) or comparable 
mRNA expression levels (formulations A, B, E, D, F; Table 4, Figure 18 and Figure 20).  
Hence, the mechanical properties of the microenvironment can also dictate changes in 
hHpSC phenotype. 
Changes in gene expression for hHpSC colonies cultured in KM-HA hydrogels suggest 
gradual differentiation occurs within these 3D environments.  In our experiments, we assume 
differentiation takes place when mRNA expression of cells, originally in a hHpSC state, 
significantly shifts outside the statistical bounds of baseline hHpSC levels towards that of 
hHB for multiple differentiation markers – such as NCAM, AFP and E-cadherin – both 
individually and in a multivariate scheme, as shown by PCA.  The main source of gene 
expression variability across KM-HA formulations is orthogonal to the differentiation 
phenomenon and resides in HA content of KM-HAs (Figure 19).  Most importantly, the 
resulting genetic expression profiles fall within an intermediate state between purified 
populations of hHpSCs and hHBs. 
Our gene expression results, both in an individual marker basis (Figure 18) and through 
multivariate marker analysis (Figure 19), can only evaluate the cumulative expression profile 
within the entire cell population in KM-HAs.  In other words, our gene expression assays do 
not discriminate against expression heterogeneity because they average the expression profile 
across cells in populations that may be heterogeneous.  In that respect, our gene expression 
results suggest that differentiation measurements intermediate between hHpSC colonies and 
hHB populations correspond to heterogeneous collections of hepatic progenitors.  In other 
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words, this interpretation suggests that hHpSCs within colonies grown in KM-HAs 
differentiate into hHBs individually, and possibly in a stochastic fashion.  By reporting the 
relative amount of genetic expression for differentiation markers, our data also depicts a rate 
of conversion of an initial hHpSC population towards a hHB lineage by single differentiation 
events.  This conclusion is supported by heterogeneity in both cell morphology (Figure 16) 
and protein expression in KM-HA-grown hHpSC colonies (Figure 20 and Figure 21).  
Therefore, we conclude that differentiation is responsible for our genetic expression 
observations, that our measurements depict the pace at which it occurs within each KM-HA 
hydrogel formulation, and that his pace depends on the properties of KM-HA hydrogels. 
We also show that, for some markers, protein expression does not correlate with mRNA 
expression and depends on KM-HA hydrogel properties, as happens with stiffness-dependent 
E-cadherin (Figure 20).  These results suggest that the effects of KM-HA hydrogel properties 
on hHpSCs function operate at both transcriptional and translational levels.  The resulting 
heterogeneity in cell population in KM-HA hydrogels might be preferable for tissue 
engineering applications, since tissues require heterogeneous populations to perform 
specialized functions in vivo. 
Cell differentiation precedes cell determination.  These mechanisms differ in that cell 
determination describes the degree to which cells acquire functions that their 
microenvironment requires, while complying with restrictions on gene expression imposed 
by their differentiated state. For example, the difference between genetic expression of AFP 
in hHpSCs and hHBs in our experiments is, on a first-impression basis, insurmountable 
through KM-HA hydrogel seeding alone.  Even though our genetic expression assays for 
hHpSCs in KM-HA hydrogels suggest stochastic differentiation events within colonies, we 
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cannot predict how effectively differentiated hHpSCs acquire functional characteristics of 
hHBs with this information alone, even though they might have a gene expression profile 
able to comply with hHB function. 
 
Figure 22. Cellular distribution of cell surface differentiation markers in hHpSCs 
seeded in KM-HA hydrogels.  EpCAM is expressed in individual cells at “inner” 
surfaces of hHpSC colonies with homotypic cell-cell interactions.  NCAM (left frame, 
KM-HA formulation F from Figure 21) and CDH1 (right frame, KM-HA formulation B 
from Figure 21) are expressed only in cells at “outer” surfaces of hHpSC colonies, in 
direct contact with KM-HA hydrogels, and exposed to heterotypic cell-cell interactions.  
CD44 (middle frame, KM-HA formulation A from Figure 21) is expressed in a subset of 
cells having the smallest cell sizes, poor co-localization with EpCAM expression, and in 
contact with KM-HA hydrogels (folded colony).  Sagittal projections of full optical 
sections (Z-stack total optical slice: 4.07 um) show enriched EpCAM expression on the 
basal surfaces of individual cells; NCAM and CDH1 expression is exclusive to apical 
surfaces of individual cells.  Staining for EpCAM, NCAM, CD44 and CDH1 performed 
on 15 – 20 µm sections and imaged by laser confocal microscopy.  Images depict sagital 
projections (X and Y, through white crosshairs) of collected fluorescence across a Z-
stack of 11 confocal optical sections of 0.407 µm [cell nuclei in blue from DAPI 
counterstaining; Z-view frames: 225 µm × 225 µm, confocal section 6 of 11]. 
Once a cell has differentiated to a specific fate, the process of determination starts and is 
subject to intracellular regulatory mechanisms that depend on ECM composition, paracrine 
signaling and culture conditions ex vivo.  It also means that differences in protein expression 
and function between differentiated cells in culture with respect to their in vivo counterparts – 
for example, differentiated hHpSCs and freshly isolated hHBs – might arise from 
discrepancies between culture and in vivo conditions, not from the process of cell 
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differentiation itself.  Hence, it is vital that we identify genetic markers, including novel ones, 
that can distinguish between hHpSC differentiation and hHB determination. Future 
differentiation studies with our KM-HA hydrogels should define factors involved in 
epigenetics whose mRNA expression in hHpSCs within 3D environments confirms lineage 
restriction to hHBs as early as possible, while correlating with acquisition of hHB function 
under the right culture conditions – a process that may occur at longer time scales than 
hHpSC differentiation as shown by AFP.  These novel markers would allow rapid screening 
of hHpSC differentiation using gene expression assays alone. 
In summary, our experiments show that both the chemical and mechanical properties of 
the microenvironemnt can influence phenotypic changes – and possibly lineage restriction – 
of adult stem cells from parenchymal tissues such as liver.  To our knowledge, this is the first 
study effectively quantifying differentiation on a determined endodermal stem cell 
population by controlling the mechanical properties of the culture microenvironment.  Most 
notably, differentiation in our culture model occurs in the absence of biochemical 
supplementation.  These results indicated hHpSCs embedded in various KM-HA hydrogels 
exhibited differentiation to an intermediate hHB lineage within 1 week of static culture.  In 
addition, there was stiffness-dependent regulation of CDH1 protein expression, a 
differentiation marker in hHpSCs, which was distinctive after 1 week of culture in KM-HAs. 
The method presented for embedding hHpSCs in KM-HA hydrogels could be 
successfully translated to other cell culture applications, which would benefit from the 
inherent 3D structure, high diffusivity and the beneficial mechanical properties of the 
hydrogels for surgical grafting and delivery.  With this information, added to control over the 
mechanical properties of KM-HA hydrogels, we have established an ex vivo model for 
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mechanotransduction research on hepatic progenitors.  Our experimental model, which is 
based on hepatic stem cells, is also useful to stem cells from other soft organs because it 
reveals biological intricacies that are specific to stem cell function in 3D environments, 
unlike other culture methods currently available, and because assembling and controlling 
mechanical properties of KM-HA hydrogels is straightforward.  Ultimately, our findings 
have an impact on parenchymal tissue engineering, cell-based therapies and development of 
bioreactors for drug discovery bioreactor because they elucidate a novel approach to control 
differentiation in progenitor cells from soft organs, such as hHpSCs, by mechanical methods 
alone. 
 
CHAPTER 6. PRINCIPLES OF BIOMATHEMATICAL MODELING: FROM 
MECHANICAL PROPERTIES OF CELLS AND TISSUES TO 
COMPUTATIONAL MODELING OF TISSUE BIOLOGY 
Biomathematical models of tissues can elucidate mechanical foundations that control 
multivariate biological systems.  Constructing a model of tissue function is a process that 
integrates multiple components within a biological system and defines their interactions.  
One approach to this process starts with experiments quantifying how different input 
mechanisms, such as mechanical loading and biochemical processes, relate.  
Biomathematical models can implement this information to evaluate theoretical systems in 
cell function with respect to experimental observations.  When successful, biomathematical 
models are powerful tools that can predict biological behavior in testable, specific and 
quantifiable experiments.  Moreover, in certain cases, a simple biomathematical model can 
reveal complex phenomena that would be unexpected, or experimentally rare.  This feature is 
a cornerstone of physics: we can dissect a mechanism into single phenomena to describe its 
modules, each individual module modeled faithfully to correlate with experimental evidence 
and ultimately assembled into a multivariate snapshot of a complex natural process. 
One asset in unifying biomathematical models of tissue function is modularity in 
biological systems.  Biological modularity refers to the functioning of living organisms by 
collecting and coordinating smaller units with individual function.  In living organisms, those 
smaller units can be modular as well – for example, in the same way that organs consist of 
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collections of tissues, tissues consists of collections of cells and ECM, and those in turn can 
be analyzed with respect to smaller components or “modules”.  For the sake of parsimony, 
robustness, and efficiency in biomathematical models, building models of biological systems 
requires selecting an appropriate dimensional scale and justifying mechanistic assumptions 
that simplify models mathematically.  Because of biological modularity, we do not need to 
include every detail of every module, but only the ones whose variability is significant at the 
scale of the biomathematical model.  As a result, we can simplify biomathematical models by 
discriminating between those modules whose variability matters at the scale under study and 
those who do not.  This balancing act is very important: an oversimplified model risks losing 
fidelity, while an overdefined model risks increasing complexity without improving 
predictions that could be obtained from simpler models. 
Tissues respond to mechanical stimuli depending on the material properties of their 
cells and ECM that, one scale below, depend on cytoskeletal components and matrix 
molecules, respectively.  The material properties of the components in all these scales work 
in conjunction to determine, for example, how tissues react to periodic mechanical stimuli 
(viscoelasticity), experience recoverable or permanent deformations (plasticity), adapt to 
forces immediately or gradually (creep and relaxation), or flow under the influence of 
pressure gradients (fluidity). 
We can create a testable biomathematical model by introducing simplifying 
assumptions that average the effects of biological phenomena in different scales.  
Experimental research can enrich these biomathematical models by quantifying biological 
mechanisms under a common scale for parsimony.  Some mechanical properties of tissues 
have transient variations that can be simplified in biomathematical models of tissue growth.  
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Other assumptions can simplify biomathematical models of tissue mechanics by analyzing 
the size scale of the model.  In other words, the physical configuration of tissues dictates how 
mechanics affects them, but implementing tissue descriptions in models also depends on the 
mathematical vantage point: we can study a tissue as (1) a collection of individual cells, or 
cytoskeletal and extracellular fibers or linkages, or subcellular organelles or proteins (discrete 
mechanics); or as (2) a continuous structure with properties that may be averaged over the 
span of several of its components, which allow the structure to function as a single entity 
(continuum mechanics).   
The biomathematical model presented in this thesis, like others before, studies tissue 
growth and roles of epithelial-mesenchymal interactions in tissue morphogenesis.  In this 
model, we introduce a parsimonious assumption that describes the average behavior of 
developing tissues at the time scale of growth as a poroviscous fluid (as discussed later in 
Section 7.3.6).  These studies have relevance to developmental biology, stem cell research 
and tissue engineering applications.  Models of tissue growth address a mechanism that 
occurs throughout life and that is fundamental to medical applications.  In summary, our 
model links tissue growth with intracellular activity – two tiers of biology research that are 
usually quantified independently – by inspecting the effect on spheroid growth of epithelial-
mesenchymal interactions through signaling and proteolytic activity. 
 
CHAPTER 7. MECHANICAL CONTROL OF SPHEROID GROWTH: DISTINCT 
MORPHOGENETIC REGIMES19 
7.1. ABSTRACT 
We develop a model of transport and growth in epithelio-mesenchymal interactions. 
Analysis of the growth of an avascular solid spheroid inside a passive mesenchyme or gel 
shows that sustained volumetric growth requires four generic mechanisms: (1) growth factor, 
(2) protease, (3) control of cellularity, and (4) swelling. The model reveals a bifurcation 
delineating two distinct morphogenetic regimes: (A) steady growth, (B) growth arrested by 
capsule formation in the mesenchyme. In both morphogenetic regimes, growth velocity is 
constant unless and until a complete capsule forms. Comprehensive exploration of the large 
parameter space reveals that the bifurcation is determined by just two ratios representing the 
relative strengths of growth and proteolytic activity. Growth velocity is determined only by 
the ratio governing growth, independent of proteolytic activity. There is a continuum of 
interior versus surface growth, with fastest growth at the surface. The model provides a 
theoretical basis for explaining observations of growth arrest despite proteolysis of 
surrounding tissue, and gives a quantitative framework for the design and interpretation of 
experiments involving spheroids, and tissues which are locally equivalent to spheroids. 
 
                                                
19 Lozoya OA, Lubkin SR.  Mechanical control of spheroid growth: Distinct morphogenetic regimes.  
Submitted for publication; appears as this chapter with permission from the authors. 
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7.2. INTRODUCTION 
The importance of growth regulation cannot be overstated. It marks the difference 
between simple organisms that can only change size, and complex organisms with complex 
morphology and differentiated tissues. It is vital in maintaining stem cell niches.  It marks the 
difference between homeostasis and neoplasm. Growth regulation is so fundamental and 
universal that we would like to understand it from a fundamental level.  
Growth regulation is not solely dependent on autonomous genetic control, but is 
governed by environmental cues, including the mechanics in the microenvironment. In this 
paper, we focus on the relationship between the chemical and mechanical growth regulatory 
mechanisms in as simple a system as possible: solid spheroids. Many tissue systems can be 
modeled as growing solid spheroids, including primitive non-lumened epithelia such as those 
in branching morphogenesis of salivary gland lobules [165] and mammary terminal end buds 
[166], stem cell niches [167], solid avascular carcinomas [168], and embryoid bodies (EB) 
[169], used in basic research as well as in tissue engineering such as bioprinting [170].  In the 
normal epithelio-mesenchymal relationship, there is continuous regulation of each tissue by 
the other and by their shared environment. In mesenchyme-free experiments in vitro, an 
extracellular scaffold is preferred, or the tissue deteriorates. We aim to understand the 
morphogenetic and regulatory phenomena in as general a context as possible, and ask what 
the commonalities are in native tissues and in the simplified systems studied in vitro, i.e. 
solid confluent spheroids raised in a gel. 
Our approach in this paper is bottom-up, not top-down. We are not asking what happens 
in a specific organism at a specific stage. Rather, we are asking generically what is needed 
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and what is not to accomplish a certain task in development. With this bottom-up approach, 
we echo the evolutionary path from simple to complex. 
The purpose of this study is to elucidate the mechanics of generalized epithelio-
mesenchymal relationships in morphogenesis, and control of the mechanics by biochemical 
signals. To this purpose, we have developed a mathematical model of the mechanics and 
control of a growing avascular solid tissue in a passive mesenchyme or gel. The model 
focuses on regulation of growth by growth factors (GF), availability of raw materials, and 
availability of compliant space. Taking the simplest and most general approach possible, we 
focus on regulation of growth in a solid avascular spheroid. The mechanisms which regulate 
growth of a spheroid are some of the lower-level mechanisms that enable higher-level 
mechanisms to regulate morphogenesis of more complex structures - which may be locally 
spherical, such as the tip of a cylinder. These growth-regulating mechanisms in a mature 
organism can make the difference between a stable stem cell niche and a neoplasm. Our 
purpose in this paper is to ask and perhaps to answer the question, "What are minimal 
requirements for growing a solid spheroid and halting growth, given the physical world that 
growing tissues live in?" 
7.3. THE MODEL 
7.3.1. Model components 
Our model tracks the conservation and transport of generic cells, extracellular matrix 
(ECM) components, interstitial fluid, growth factors, and proteases. The model further 
distinguishes between the inner tissue (which, for definiteness, we refer to as epithelium) and 
the tissue/material surrounding it, either mesenchyme or nonliving culture gel (which, for 
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definiteness, we refer to as mesenchyme).  Model variables and parameters are described in 
Table 7 and Table 8. 
7.3.2. Mixture framework 
Because we track interstitial fluid flow and tissues of changing density, we use a 
mixture formulation [171]. We model a tissue as containing volume fractions of cells, ECM, 
and fluid. Because we do not track motion of cells relative to the ECM, we group cells and 
ECM components into a single phase of volume fraction (cellularity) !  and velocity   
! 
v . The 
interstitial fluid has volume fraction (porosity)  1!"  and velocity   
! 
w . 
Table 7. Model variables 
Variable Symbol Units 
time t s 
cell velocity v m/s 
interstitial velocity w m/s 
cellularity !  - 
porosity  1!"  - 
epithelial identity e - 
mesenchyme or gel identity 1-e - 
epithelial growth rate REG 1/s 
mesenchyme dissolution rate RMR 1/s 
interphase pressure P Pa 
hydraulic conductivity Κ Pa 
swelling pressure σ Pa 
effective unbound growth factor activity G - 
effective substrated protease activity N - 
 
7.3.3. Distinction between tissues 
To track the epithelio-mesenchymal interface, we use a diffuse interface (phase field) 
method. The cell/ECM phase is divided into a growing epithelial fraction e and a 
mechanically passive mesenchymal fraction   
! 
1"e . The tissue interface is represented by a 
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smooth but steep transition region between   
! 
e = 0 (mesenchyme) and   
! 
e = 1 (epithelium).  For 
parsimony, any basal lumina is lumped with the mesenchyme.  The conservation equations 
for epithelium and mesenchyme are 
  
! 
" #e( )
"t
+ $% #e v( ) = REG  
  
! 
" # 1$e( )( )
"t
+ %& # 1$e( )v( ) = $RMR  
where 
  
! 
R
EG
 is the epithelial growth rate and 
  
! 
R
MR
 the rate of dissolution of mesenchyme by 
MMP. The conservation equations for cellularity and porosity are then 
  
! 
"#
"t
+ $% # v( ) = REG &RMR  
  
! 
" 1#$( )
"t
+ %& 1#$( ) w( ) = RMR #REG  
yielding conservation of volume: 
  
! 
"# $ v + 1%$( ) w( ) = 0 . 
7.3.4. Control 
The system is controlled by interactions between generic growth factor, protease, and 
swelling.  We track the transport and activity of a generic transmembrane protease, bound to 
the epithelial cell surface, that digests the mesenchyme. Rather than include all known 
proteases, such as MMPs and all their known regulators such as TIMPs, we lump all net 
activity of substrated protease into a single variable N. We account for protease activation in 
the epithelium upon its interaction with mesenchymal substrate; similarly, we also define a 
rate of unsubstrated (or latent) transmembrane protease internalization. We only allow 
proteolysis to occur at the epithelium-mesenchyme interface. By Michaelis-Menten kinetics 
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at quasi-steady state, the conservation equation for net content of active protease in the tissue 
is then 
 
!
! t
N"e( ) +# $ N"e v( ) =
k
cat
N
K
M
N
$ C %N( )"e $F" 1% e( ) $& N( ) % kH
N
$
K
M
N
F
$N"e  
where C is the total concentration of protease at cellular steady state in the epithelium, F is 
ECM substrate concentration in the mesenchyme, 
 
! o( )  is a Heaviside step function, and the 
other parameters are defined and estimated in Table 8. Mesenchyme is remodeled by 
proteolysis at a rate  
 
R
MR
=
k
cat
N
F
!N"e !" 1# e( ) . 
Proteolytic digestion of mesenchyme releases (by solubilization) and activates growth 
factor, which is then transported through the aqueous phase. The soluble growth factor in the 
aqueous phase is consumed by the epithelium via internalization of ligand-receptor 
complexes.  We neglect endogenous GF synthesis. With quasi-steady state ligand-receptor 
dissociation kinetics, the conservation of unbound soluble growth factor in the tissue is then 
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where S = B + G is the total concentration of growth factor solubilized and activated by 
mesenchyme proteolysis, B and G are the concentrations of bound and unbound activated 
growth factor, and T is the concentration of ligand receptors at steady state in the epithelium. 
Growth of a crystal or stony coral proceeds from the surface outwards, and is modeled 
as a surface phenomenon. Soft tissues, however, grow volumetrically – interior locations 
move apart from each other. The key physical difference between volumetric and surface 
growth is transport. Cells cannot grow and divide without an influx of raw materials, 
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including water. Conservation of mass requires that as a tissue expands, an equal mass of 
substrates must move into it. This requires a net flow into the tissue, which is achieved 
through a variety of mechanisms, including diffusion, vesiculation, pressure-driven flow 
(swelling) between cells and, at a larger scale, via ducts. Physical impediments to transport, 
e.g. a dense glycocalyx, will inhibit growth. Since inflow of materials is impossible at zero 
porosity, we assume that a growing tissue has a regulatory mechanism that maintains a small 
porosity 
 
1!"
c
 to allow advection of raw materials (including water) and unbound soluble 
growth factor G into the tissue. That is, when porosity becomes too small (cellularity above 
confluence limit 
 
!
c
), growth stops. We model the local volumetric growth rate as 
proportional to the persistence level of bound cell receptors in the epithelium, as is 
recognized for the EGFR system [172-174]. Thus the ligand-dependent epithelial growth rate 
is modeled as 
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We assume that the tissue also has a regulatory mechanism that draws fluid into a 
growing tissue.  This appears in our model as the swelling pressure ! . The swelling pressure 
is modeled as an increasing function of cellularity, but is set to zero below a certain 
cellularity threshold !
"
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7.3.5. Initial conditions 
For definiteness, we define an initial 50 µm radius sphere of "confluent" epithelium 
(cellularity 
 
! = !
C
= 90% ) surrounded by mesenchyme (cellularity  ! = 20% ). Since we assume 
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that GF is mesenchyme-bound until released by protease activity, the model has G = 0 
initially.  Transmembrane protease activity is initially zero except in a thin band near the 
epithelial surface (Figure 23). 
 
Figure 23. Geometry and initial conditions in one-dimensional model.  (A) Schematic of 
model domain for epithelium spheroid surrounded by mesenchyme.  (B) Radial 
distributions of initial epithelium (Ep), mesenchyme (Ms) and interstitial aqueous (Aq) 
phases; grid area highlights region of protease (P) activity. Dot () represents location 
of epithelial surface, 
 
r
! e
S
t( ) , defined as where 
 
!e = !
c
/ 2 = 45% . 
7.3.6. Mechanics 
We must consider mechanical properties of developing tissues when modeling their 
morphogenesis. Soft tissues are viscoelastic, and their diverse behaviors are described by a 
variety of models. It is important to note that because they are living, tissues' mechanical 
behavior depends strongly on the time scale of interest.  
Mature soft tissues are well described as poroelastic, i.e. as a mixture of a solid and a 
fluid [175], deforming under mechanical stresses and returning to an equilibrium 
configuration. The coupling of growth with poroelasticity can lead to residual stresses, as 
seen for example in the cardiovascular system, whose function is to confine flow under high 
pressure without failure. Residual stresses are observed when an incision springs open.  
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Table 8. Parameters reported in literature with ranges used in multivariate random 
sampling 
Parameter Symbol Reported values Model Values 
Sampled Input Parameters 
Tissue shear modulus of viscosity 
[159, 176-178] 
µ  104 – 107 kg/m-s 104 – 107 kg/m-s 
Hydraulic conductivity [179] 
 
!
0
 10-14 – 10-12 m3-s/kg 10-14 – 10-12 m3-s/kg 
Ligand diffusivity [174, 180-183] 
 
D
G
 0.1 – 100 µm2/s 0.1 – 100 µm2/s 
Ligand supply from mesenchyme to 
aqueous phase [184]20  S  10-50 pM 100 pM – 1 µM 
Transmembrane protease density 
[185]21  C  ~ 50,000 receptors/cell 4.7 – 470 nM 
Protease catalytic rate [186] 
 
k
cat
N  16.2 hr-1 = 4.5 × 10-3 s-1 4.5 × 10-4 – 4.5 × 10-2 s-1 
Latent protease endocytic rate [187, 
188]  kH
N
! k
I
B  2.4 × 10-3 s-1 2.4 × 10-4 – 2.4 × 10-2 s-1 
Ligand-receptor dissociation constant, 
steady state EGFR system [173, 189]  KD
R  4.3 – 4.7 nM 450 pM – 45 nM 
Fixed Input Parameters 
Ligand receptors density, steady state 
EGFR system [173] 22  T  ~ 30,000 receptors/cell 28 nM 
Mesenchyme substrate content; 
collagen in early mesenchymal tissues 
[190] 
 F  < 5 mg/ml = 20 µM 10 µM 
Protease Michaelis constant [186] 
 
K
M
N  8.5 µM 8.5 µM 
Bound receptor endocytic rate, steady 
state EGFR system [173]  kI
B  2.4 × 10-3 s-1 2.4 × 10-3 s-1 
Specific solvation stress or “swelling 
pressure” [191-195]23  
h
0
 < 104 Pa 100 Pa 
Epithelial target fraction 
 
!
C
 N/A 90% 
Swelling threshold !"  N/A 65% 
Characteristic length 
 
L = 2R
0
 100 µm 100 µm 
Characteristic time [173]24 
! 
"  4.7 × 104 s = 13 hours 4.7 × 104 s 
 
In embryonic tissues [196], however, pressures are generally low, cell-cell adhesions 
are few and transient, and ECM turnover is rapid relative to the time scale of growth.  
                                                
20 10-50 pM in media during signaling in vivo; Continuous supply at 270 pM in vitro induces 100% 
mitogenic response 
21 Assuming spherical 15-µm diameter cells at ~ 50,000 receptors/cell; 8.3 fmoles per 105 cells; ~ 47 
nM  
22 Assuming spherical 15-µm diameter cells at ~ 30,000 receptors/cell; 5.0 fmoles per 105 cells; ~ 28 
nM 
23 Up to ~104 Pa (75 mmHg) in neoplastic tissues; much higher than normal tissues 
24 Reference 9-hour doubling rate ≈ 69% of τ under exponential growth 
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Embryonic tissues exhibit phase ordering that parallels behavior in liquid mixtures [159, 160, 
176-178, 190, 197, 198]: they can fuse, exhibit viscous behavior, and demonstrate 
incompressibility and surface tension [159, 176-178]. Their mechanical response to stress is 
viscoelastic with characteristic relaxation times of ~ 2 minutes and complex shear modulus 
G* of ~ 8 kPa. In other words, embryonic tissues behave more like Maxwell-class 
viscoelastic fluids – short-term elasticity with long-term viscosity – dissipating stress by 
making permanent cell rearrangements [159, 198, 199]. For example, stage 10 Xenopus 
chordamesoderm, ectoderm, and mesendoderm [200-202], and 5-day chick cardiac cushion 
[177] have a primarily viscous, rather than elastic, constitutive law.  Fragments of these 
tissues do not spring open, but rather round up. Since we are interested here in the time scale 
of development that is much larger than the relaxation time of developing tissues (small 
Deborah number), we neglect the short-term elastic component of embryonic viscoelasticity, 
and model the passive mechanics of the tissues as a mixture of two fluid phases, i.e. 
poroviscous. 
The level of cell-cell adhesion determines the viscosity of embryonic tissues, which is 
linear in cadherin levels [203].  It has been suggested that differences in mesenchymal 
viscosity may affect both the time course and the morphology seen in branching 
morphogenesis [158, 204, 205].  For simplicity, we assume a constant viscosity of both 
tissues. 
Because we are interested in the time scale of growth, at which internal tissue stresses 
are dissipated, we take the viscous limit of the viscoelastic formulation. Since the viscosity of 
the aqueous phase is negligible relative to the cell-ECM phase the momentum conservation 
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for the aqueous phase reduces to a generalization of Darcy’s law. The momentum balances 
for the cell-ECM phase and aqueous phase are written 
 
! " # 2µE
c
$
2
3
µ ! "v( )I
%
&'
(
)*
%
&
'
(
)
* $
1
+
v $ w( ) = # !P +! # ",( )  
 
1
!
v " w( ) = 1"#( )$P +$ 1"#( ) %&( )  
where 
 
E
c
 is the strain-rate tensor, µ is viscosity,  P  is interphase (capillary) pressure, !  is 
hydraulic conductivity, and !  is swelling pressure. We assume constant µ but we model !  
as an increasing function of porosity, of the form 
 
! = !
0
1"#
#
. Swelling pressure !  is a key 
regulatory term in our model and is described in the Control section above.  
7.3.7. Geometry and time 
All simulations are in a spherically symmetric geometry of radius 300 µm, and were run 
to 1 day. 
7.4. RESULTS  
7.4.1. Requirements for volumetric growth 
If epithelium is allowed to grow with zero swelling pressure, its cellular volume fraction 
increases locally up to saturation, after which growth is confined to the surface, as in a 
crystal. Volumetric growth requires both (a) epithelial target fraction 
 
!
c
 below 100% and (b) 
nonzero swelling pressure ! . Without both of these features, new material cannot reach the 
interior of the epithelium, and growth is restricted to the surface. We refer to the equilibrium 
cellularity of an epithelium that can still sustain interstitial transport as the confluence limit. 
7.4.2. Capsule formation and dissolution 
When a tissue is growing volumetrically, it is pulling materials into itself, as discussed 
above. If there is no lumen or vasculature, new material can only come to an epithelium from 
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outside, from the interstitium of the surrounding mesenchyme (or gel). As interstitial fluid is 
drawn into a volumetrically growing epithelium, the neighboring mesenchyme (gel) becomes 
denser unless it is remodeled at a pace that matches epithelial growth. If the condensing 
tissue does not remodel itself, and is not dissolved by proteases, it will form a capsule around 
the growing tissue, as we have previously shown [206]. This capsule inhibits transport into 
the epithelium. If the capsule reaches 100% volume fraction, interstitial transport to the 
epithelium halts, and growth is arrested. Therefore sustained epithelial growth requires 
dissolution of the inevitable capsule formed as a byproduct of volumetric growth. The model 
uses variable protease activity to perform this function.  
7.4.3. Distinct morphogenetic regimes 
The model exhibits three distinct morphogenetic regimes (Figure 24). In bulk growth 
(BG), the densest tissue is at the center of the spheroid, cellularity remains below the 
confluence limit everywhere (
 
!e < !
c
), and growth is spatially distributed throughout the 
epithelium. In surface growth (SG), the epithelium is of uniform density, at the confluence 
limit (
 
!e = !
c
), and all growth is at the surface. In capsule formation (CF), the epithelium is 
above the confluence limit (
 
!e > !
c
), the capsule is densest at the surface and some of the 
tissue is pressed centripetally as its interstitial fluid is drawn centrifugally (Figure 28). When 
the capsule reaches 100% cellularity (zero porosity), transport is halted, and growth is 
arrested. 
7.4.4. Bifurcation 
In the parameter space tested, surface growth (SG) formed the bifurcation boundary 
between bulk growth (BG) and capsule formation (CF) (Figure 25). The subset of 8-
dimensional parameter space corresponding to SG models was fitted by a compound-expon-
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ential function 
 
! = K
EG
exp " a + b # K
MR( )
c( )$%&
'
()
 (a = 1.2, b = 0.2, c = 0.7) where  ! = 1 for SG, 
 ! <1 for BG, and  ! >1 for CF. The bifurcation parameter !  relates two nondimensional 
ratios, for epithelial growth 
 
K
EG
=
k
I
B
S!
T
 and mesenchyme removal 
 
K
MR
!
k
cat
N
C"
F
. Several of 
the sampled parameters did not influence the bifurcation: tissue modulus of viscosity µ , 
hydraulic conductivity 
 
!
0
, ligand diffusivity 
 
D
G
, latent protease endocytic rate 
 
k
H
N , and 
ligand-receptor dissociation constant 
 
K
D
R .  Varying the initial cellularities (from 90% and 
20%) did not qualitatively affect the results. 
7.4.5. Surface vs. interior growth 
In bulk growth (BG), the ratio 
 
!
CS
 of mitotic rates at the spheroid core and surface was 
always less than 1, and went to 0 as the tissue approached the confluence limit (SG) at  ! = 1 
(Figure 25B and Figure 26B). Hence in BG much of the growth is at the surface, and in SG, 
all of the growth is at the surface (Figure 26). The more interstitial space in the epithelium, 
the higher the fraction of core growth (linear relationship) (Figure 25B). 
7.4.6. Growth velocity 
The epithelial spheroid expanded at a constant radial velocity (µm/day) in all cases 
except when capsule formation had arrested growth (Figure 24). The surface velocity 
 
V
! e
S  is 
linear in the nondimensional epithelial growth ratio 
 
K
EG
 (Figure 27A): 
 
V
! e
S
= p "K
EG
 (p = 8.1 
µm/day, R2 = 0.93) during steady growth (BG, SG and CF models until capsular growth 
arrest). The total epithelium content E increases with epithelial surface velocity 
 
V
! e
S  with a 
relationship characteristic of a sphere dilating at a constant radial velocity 
 
V
! e
S  such that 
 
!E " E
f
# E
0( ) E0 = 3$ + 3$
2 +$3  where 
 
! =V
" e
S
# t
f
$ t
0( ) R0  (R
2 = 0.998) (Figure 27B).  
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Figure 24. Time series of cellularity profile showing examples of fundamental 
morphogenetic outcomes: bulk growth (BG), which can be slow or fast (sBG, fBG); 
surface growth (SG); capsule formation (CF); and complete capsule with growth arrest 
(CA). BG is subconfluent (
 
!
max
< 90% ); SG is constant at the confluence limit 
 
!
max
= !
C
= 90% ; CF and CA are superconfluent (
 
!
max
> 90% ). CF progresses to CA as it 
completes encapsulation ( ! = 100% ) at the surface. The surface, defined at 
 
!e = !
c
/ 2 = 45% , exhibits radial displacement that is linear in time (R2 = 1) and 
corresponds to a constant epithelial surface velocity 
 
V
! e
S . The exception is CA models:  
their overall velocity 
 
V
! e
S  is bilinear (R2 < 1) with fast initial displacement followed by 
immediate stalling after complete encapsulation, thus exhibiting growth arrest. Data in 
time series plots: solid curve represents initial conditions (same for all models, as 
described in Figure 23); dashed line is the confluence limit 
 
! = !
C
= 90% ; curve spacing 
every 2 hours; all plots correspond to 1 day except for CA displayed until time of arrest. 
7.5. DISCUSSION 
The simple bifurcation criterion provides a guide to the design and interpretation of 
experiments.  For example, if the aim is to grow a spheroid without encapsulation, then 
ensuring that  ! <1 ensures that the capsule will not form. That is achieved by reducing 
 
K
EG
, 
but can also be achieved by increasing 
 
K
MR
 (Figure 25C). 
 
K
EG
 and 
 
K
MR
 can each be 
regulated independently by regulating several different factors. For example, 
 
K
EG
 can be 
halved experimentally by halving the ligand supply S, doubling the receptor density T, or 
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doubling the bound receptor endocytic rate 
 
k
I
B . Some of these manipulations may be 
substantially easier to perform than others; some are endogenous to the cells and some are 
external.  
 
Figure 25. Morphogenetic bifurcation surface in parameter space. Data correspond to 1 
day except for CA models that are displayed in A-C until time of encapsulation. (A) 
Smooth surface describes the relations among the non-dimensional ratios for epithelium 
growth and mesenchyme removal 
 
K
EG
 and 
 
K
MR
, the core:surface mitotic ratio 
 
!
CS
" R
EG
C
R
EG
S  and the minimum observed interstitial fraction 
 
1!"
max
.  Bifurcation at 
 
!
C
= 90%  (equivalent to 
 
1!"
max
= 10%  and corresponding to SG models with 
 
!
CS
= 0 ) 
demarcates between subconfluent models with 
 
!
CS
> 0  (BG) and superconfluent models 
with 
 
!
CS
< 0  (CF and CA). (B) The relationship between 
 
1!"
max
 and 
 
!
CS
 for 
subconfluent models is linear (R2 = 0.98). (C) The bifurcation in A is fitted by a smooth 
function 
 
! = K
EG
exp a + b " K
MR( )
c#
$%
&
'(
 in the projected 
 
K
EG
,K
MR( )  plane  (a = 1.2, b = 0.2, c = 
0.7) where  ! <1 for BG,  ! = 1 for SG, and  ! >1 for CF and CA. Asterisk (
! 
") shows a 
hypothetical encapsulating system; one could experimentally block its encapsulation by 
either dramatically increasing 
 
K
MR
 or slightly reducing 
 
K
EG
.  Square markers 
correspond to examples from Figure 24.  (D) The bifurcation parameter !  discrim-
inates between subconfluent models with constant 
 
V
! e
S  (BG,  ! <1, 
 
!
max
< !
C
, R2 = 1 for 
 
r
! e
S
t( )  linear in time) and superconfluent encapsulation models with bilinear spheroid 
radius 
 
r
! e
S
t( )  (CF and CA,  ! >1, 
 
!
max
> !
C
, R2 < 1 for 
 
r
! e
S
t( )  nonlinear in time) as depicted 
in Figure 24.  Colors shown for subconfluent models in A (colormap: 
 
!
CS
) and C (color-
map: 
 
!
max
) are equivalent as a result of the linear correspondence shown in B between 
 
!
CS
 and 
 
!
max
. 
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We previously showed how swelling pressure creates capsules around a growing 
epithelium [206]. In this paper we see how proteases can prevent encapsulation.  Note that 
the mere presence of proteases is not sufficient. The protease activity 
 
K
MR
 must be 
sufficiently large relative to the epithelial growth 
 
K
EG
. It is also worth noting that crossing 
the bifurcation – going from steady growth to capsule formation or vice-versa – may be 
easier or harder depending on where in parameter space a system begins. For example, the 
hypothetical system represented by the * in Figure 25C will form a capsule because it has 
 ! >1. A 50% reduction in 
 
K
EG
 will prevent capsule formation, yet even a 10-fold increase in 
 
K
MR
 would not suffice to prevent encapsulation. The slope of the bifurcation curve implies 
that inducing a qualitative change in the system – crossing the bifurcation – is experimentally 
harder to achieve by changing growth factor or protease kinetics alone. We see this in 
experiments in which either (a) GF signaling mechanisms or (b) protease activity levels are 
modified (by gene knock-out, silencing or amplification), but typically not both (a) and (b).  
Single-variable manipulations mostly modulate the rates of morphogenesis but rarely change 
the fundamental morphogenetic outcomes.  
Specificity and relative importance of model components.  The model is constructed 
from a simplified perspective, with the aim of constructing a minimal mechanism of growth 
regulation by transport.  Tissue mechanical properties do vary over lineage and time, but we 
focus on a short enough time scale to ignore such changes.  The numerous regulatory 
molecules are lumped into generic "growth factor" and "protease" activities. Real systems are 
more complex at the cellular level but can for practical purposes be considered in the 
simplified context of net effects. For example, if multiple growth factors are at work, 
doubling the effective "growth factor activity" may require more than doubling a specific 
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growth factor. It is well established that MMPs (matrix metalloproteinases) and their 
regulators regulate epithelial growth. MMPs are regulated by GF and TIMP (tissue inhibitors 
of metalloproteinases).  Timp-1-reduced mammary epithelia, with greater MMP activity, 
grew 55% faster than control, and rTimp-1 elevation inhibited growth [207]. Our simplified 
(parsimonious) model allows a quantitative interpretation of these experiments and the effect 
of the experimental factors on the net mesenchyme removal rate 
 
K
MR
. 
 
Figure 26. Growth and expansion of a spheroid distinguish between steady growth and 
encapsulation mechanics.  Square markers correspond to examples from Figure 24.  (A) 
Measured at the core, epithelium expansion 
  
! 
"# $e v( )  matches the mitotic rate 
 
R
EG
C  
during steady bulk growth (BG); surface growth (SG) models show no growth or 
epithelium flux at the core; capsule formation (CF) both breaks down and compresses 
core until encapsulation halts transport and growth, when 
! 
"  reaches 100% (CA). 
Superconfluent models (CF, CA) have 
 
R
EG
C
! 0  as a result of the logistic form of growth 
(carrying capacity defined as the confluence limit 
 
!
C
= 90% ).  (B) The core:surface 
mitotic ratio  
 
!
CS
" R
EG
C
/ R
EG
S  discriminates between BG and SG.  The transition between 
BG and SG corresponds to decreasing growth rate at the spheroid core. All 
observations from SG models result exclusively from maximal growth at the surface 
(
 
!
CS
= 0 , 
 
R
EG
S
> 0 ). All data corresponds to 1 day, except for CA models halted at time of 
encapsulation. 
It is not an essential assumption of our model that the growth factor be bound, released 
by protease, and subsequently diffuse and advect. A variety of mechanisms can lead to the 
same morphogenetic gradients [208]. Insoluble growth factors external to the epithelium can 
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be transported into the tissue by being solubilized, vesiculated, probed by filopodia, 
transported on a motile cell, or induced in a relay [183]. 
 
Figure 27. Surface velocity and volumetric change during steady spheroid growth.  (A) 
The surface velocity is linear in the growth ratio 
 
V
! e
S
= p "K
EG
  (p = 8.1 µm/day, R2 = 0.93) 
during steady growth (BG, SG and CF models).  CA models yield piecewise 
 
V
! e
S  (Figure 
24 and Figure 25D) that halt at complete encapsulation (
 
!
max
= 100% ). (B) The total 
cellular content of a growing spheroid, represented in terms of the volumetric change 
 !E , increases with a relationship characteristic of a sphere dilating at constant 
epithelial surface velocity 
 
V
! e
S  (dotted red line, R2 = 0.99). All data corresponds to 1 day. 
The proteases promote growth in three ways. First, the GF cannot stimulate the 
epithelium until the protease releases them from the ECM. Second, dissolution of the ECM 
creates more interstitial material, which is then available for conversion to cells. Third, 
dissolution of the ECM raises the hydraulic conductivity and enhances transport of raw 
materials into the growing tissue.   
The epithelial swelling pressure is critical to growth in two ways. First, a tissue cannot 
grow volumetrically without transport of new material into its interior; this requires the 
swelling pressure. Second, transport of soluble growth factors into the epithelium is by 
advection and diffusion. In this context, diffusion is a much slower process than advection, 
which is why the ligand diffusion coefficient 
 
D
G
, varied over 4 orders of magnitude in the 
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model, does not affect either the speed of growth or the tendency to encapsulate.  The fluid 
flow is the product of the hydraulic conductivity and the pressure gradient; the epithelial 
swelling pressure regulates the latter.  
 
Figure 28.  Expanded outputs of model examples from Figure 24.  Epithelium (top, red), 
mesenchyme (top, blue), cellularity (middle) and cell phase velocity v (bottom).  In 
Surface Growth regime, epithelila growth matches mesenchyme proteolysis.  Capsule 
Formation and subsequent Complete Arrest regimes have epithelium growth 
overriding mesenchyme proteolysis, leading to localized densification at the interface.  
This densification imposes physical constraints on the epithelium, which in turn 
exhibits backward motion (v<0) and further condensation, driving cellularity above the 
epithelium confluence limit.  Since backward cell motion requires forward aqueous 
transport (w>0) this encapsulation mechanism is irreversible; Capsule Formation leads 
to Complete Arrest.  Solid curve: initial conditions (same for all models, as described in 
Figure 23); dashed reference line: confluence limit 
 
! = !
C
= 90% .  Curve spacing 2 hours; 
all plots show 1 day except CA halted at arrest (thick curve). 
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Systems that are at the bifurcation grow only at their surface, even if their interior has 
some interstitial space. Because a bifurcation marks a curve in a larger space, a system at a 
bifurcation will be rare, unless it has been specifically control-engineered to be there. 
Therefore, spheroids exhibiting steady surface growth and no encapsulation must have some 
feature not included in our model. For example, we make the point that volumetric growth 
cannot occur unless there is both interstitial space to permit transport and a swelling pressure 
to drive it. Systems lacking these features can only grow at the surface, like an evolutionarily 
primitive stromatolite. 
7.6. CONCLUSIONS 
The major finding of this study is the surprisingly simple bifurcation criterion that 
distinguishes between steady bulk volumetric epithelial growth and capsule-limited growth. 
Our bifurcation parameter !  determines whether a spheroid grows indefinitely or halts when 
capsule completion blocks transport. Although the model was constructed with a large 
number of parameters (Table 8), the bifurcation parameter !  delineates regions of a 2-
dimensional subset of the 8-dimensional sampled parameter space. The two key parameters 
are the nondimensional ratios 
 
K
EG
!
k
I
B
S"
T
 and 
 
K
MR
!
k
cat
N
C"
F
 governing epithelial growth and 
mesenchyme removal. Other factors that we examined were unimportant in distinguishing 
bulk growth from capsule formation; for example, tissue permeability and viscosity were 
each varied over 2-3 orders of magnitude without affecting the bifurcation.  
In many contexts such as tissue engineering, spheroid growth rate is important [209].  
The speed of growth in our model spheroids was found to be dependent only on 
 
K
EG
, and is 
linear in 
 
K
EG
. The implications for tissue engineering are clear: to grow tissue rapidly, 
increase any factor that increases 
 
K
EG
. However, if 
 
K
EG
 is above the bifurcation criterion, the 
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growth will be rapid only until encapsulation, when it will cease. Sustainable rapid growth 
requires not just large 
 
K
EG
 but sufficiently large 
 
K
MR
 to prevent encapsulation. Thus our 
study reveals an interesting paradox: increasing growth factor supply speeds up growth, but 
too much can arrest growth, by outrunning mesenchyme removal.  Our results provide 
quantitative criteria for these regulatory mechanisms. 
7.7. APPENDIX: MODEL DETAILS 
7.7.1. Boundary conditions 
The core of the spheroid has symmetry BC, with hydrostatic pressure set to 0. The 
outside of the mesenchyme is considered to be sufficiently far away from the area of growth 
that we set its BC to zero normal transport.  
7.7.2. Numerical methods 
PDE were solved by the finite element method using Comsol 3.5. Because of 
instabilities inherent in the diffuse interface method, we used a minimal numerical isotropic 
diffusion to stabilize the algorithm. MATLAB was used for parameter space sampling, 
postprocessing, graphics, and statistics. 
7.7.3. Nondimensional model 
The complete model describes an equation system for volume continuity, force balance 
and conservation of transmembrane proteases, active soluble ligands and tissue phases. A 
nondimensional version allows us to probe multidimensional parameter space effectively. 
Using characteristic length L, time τ and viscosity µ, with 
 
P = P !" µ  and 
 
v = v !" L , the 
nondimensional system is  
 
! " #v + 1$#( )w( ) = 0  
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using normalized active ligand 
 
g = G S( ) ! 1"#( )  for 0 ≤ G ≤ S and normalized active protease 
 
m = N C( ) !"e  for 0 ≤ N ≤ C. Nondimensional parameters ! , ! , ! , 
 
K
A,m
, 
 
K
I,m
, 
 
K
I,g
, 
 
K
EG
 and 
 
K
MR
= K
A,g
 are as defined in Table 9. 
7.7.4. Parameter ranges and sampling 
Multivariate studies relate model results to the parameters that describe the model. 
Parameter values must lie within ranges justified by experimental data. The study should also 
minimize bias in the choice of these values. Random sampling reduces bias in parameter 
value selection. There are eight characteristic nondimensional ratios describing the equation 
system: ! , ! , ! , 
 
K
A,m
, 
 
K
I,m
, 
 
K
I,g
, 
 
K
EG
 and 
 
K
MR
 (Table 3). We selected six dimensional 
parameters for sampling that allow unique and independent sampling of six of these 
nondimensional ratios; we chose two additional dimensional parameters that sample each of 
the remaining ratios !  and 
 
K
MR
 separately in exclusive combination with only one of the 
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other sampling parameters. We used simple random sampling without repetition for each and 
all of these eight parameters independently to define multiple unique models with respect to 
the nondimensionalized system. Molecular kinetics were considered to vary logarithmically, 
e.g. ligand diffusivity 
 
D
G
 spans 0.1 – 100 µm2/s [174, 180, 183]. 
Fixed model parameters used values in agreement with experimental measurements 
(Table 8). Values for parameters sampled in the multivariate study stay within a few orders 
of magnitude of their reported measurements. 
• Hydraulic conductivity of various tissues has been measured (reviewed in [179]), and 
can range from 10-4 - 1 mm2/Pa-s, depending on tissue type [179, 192, 206]. It is 
established that hydraulic conductivity is generally higher in neoplastic than in normal 
tissues [192].  We have no relevant estimates for specific embryonic tissues, other than 
to surmise that embryonic tissues, like neoplastic tissues that are also rapidly growing, 
likely have higher hydraulic conductivity than mature tissues. 
• Many embryonic tissues have viscosity in the range 105-107 Poise [159, 176-178, 210]; 
5- and 6-day chick liver, heart, and retina aggregates relax at 0.1 MPoise [159]; embry-
onic limb bud [159] and pigmented epithelial tissue [176] at 1 MPoise; and 5-day chick 
cardiac cushion at 10 MPoise [177].  
• Interstitial pressure h0 has been measured in tumors to be in the range ~ 0 - 10 kPa 
[191]; subcutaneous swelling pressure in mammals and birds has been measured at ~10 
kPa [193]; inflammatory swelling pressure ranges from 0.1 - 18 kPa [195]; blood 
plasma has an oncotic pressure of about 3 kPa.  Swelling pressure has not been 
measured in embryonic tissues; we assume it to be at the lower end of these ranges. 
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• A pressure of 1 kPa with a viscosity of 1 MPoise gives a relaxation time scale of 1-2 
minutes. Since the morphogenetic time scale is 8-72 hours (see above), the Deborah 
number is 10-2 - 10-1, and we are justified in using the approximation of a viscous fluid. 
7.7.5. Derived quantities 
We calculated the total volume occupied by the epithelial fraction by integrating over 
the model domain. By tracking the epithelial surface 
 
r
! e
S
t( )  as the location of the reference 
fraction 
 
!
c
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 are equivalent; i.e. these events are simultaneous. 
This is because in the model both mesenchyme removal and ligand activation are driven by the same 
proteolytic reaction. 
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7.7.6. Statistical regression 
Radial growth velocity was fitted to a linear function with R2 = 0.98 except for models 
that ran past complete encapsulation (Figure 24 and Figure 25D). The bifurcation surface 
(Figure 25A and Figure 25C) was fitted using a nonlinear least squares regression of an 
exponential function of transformed data for 
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!
+ b " X
c  (
 
Y = logK
EG
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X = logK
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).  The 
value of 
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 is dependent on the level of 
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max
= !  with constant b and c for all values of 
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The bifurcation parameter !  defines the bifurcation surface at 
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to SG. 
 
CHAPTER 8. DISCUSSION 
8.1. ORIGIN OF MECHANICAL STIMULUS IN LIVER 
We can deduce the types of forces a tissue experiences in vivo from the anatomical 
placement of the tissue.  It is important to identify these forces because their effects on 
tissues can influence differentiation and physiology.  We can understand which types of 
mechanical forces influence cells by understanding the origin of these mechanical forces and 
their relationship with tissue physiology. 
The adult human liver is a soft intraperitoneal organ.  It is lined by peritoneum on 
multiple surfaces.  The peritoneal lining helps fix the liver in place within the abdominal 
cavity while false ligaments – made of peritoneum folds – attach the liver to the diaphragm, 
the anterior abdominal wall and the muscular walls of abdominal viscera that maintain 
continuous contractile tone [116].  During development (3 to 4 weeks after fertilization in 
humans), liver arises as a hollow diverticulum from the ventral region of the endodermal 
foregut that grows underneath the septum transversum.  Interactions between the hepatic 
diverticulum and splanchnopleural mesenchyme at the inferior surface of the septum 
transversum give rise to the mature liver stroma and parenchyma, respectively [211]. 
Liver experiences compression from the diaphragm during the breathing cycle [212-
214].  These cyclic deformations are one element of normal physiological function that 
introduces mechanical forces to liver cells.  Also, liver is a secretory organ with fenestrated 
microvascularity (or endothelial sinusoids), which implies that shear effects, pressure 
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gradients and other effects of fluid flow could participate in liver function.  One hypothetical 
outcome of changing ECM chemistries across the hepatic maturational gradient is 
microenvironments with varying rigidities; this variation in local mechanics is biologically 
relevant – e.g. matrix rigidity is a mechanical property that induces lineage specification in 
mesenchymal stem cells [47].  In sum, we can surmise that differentiation in hepatic 
progenitors depends on at least two mechanical influences: gradients in ECM composition 
within the maturational gradient that establish gradients in tissue mechanics, and shear 
effects on cells from fluid flow across hepatic tissues. 
Liver arises during development as an early endodermal derivative.  It has vital 
functions that regulate homeostasis, including bile secretion and toxin removal. Homeostatic 
balance in liver is a physiological consequence of maturational biology, which controls tissue 
formation, regeneration and epithelial-mesenchymal interactions across lineages [1, 114].  
Cell lineages are concomitant with characteristic matrix compositions and each maturational 
stage must contain specific epithelial and mesenchymal cell lineages in an appropriate 
environment for normal function.  In fact, epithelial metaplasias originate from toxic insults 
or diseases that disturb local signaling profiles in epithelial organs [114].  Moreover, cell 
survival and proliferation improve with ectopic cell scaffolding in decellularized biomatrices 
in which lineage specification agrees with biomatrix chemistry [23, 215-217]. 
8.2. TRENDS IN TISSUE MECHANICS RESEARCH ON DEVELOPING TISSUES 
Research on embryonic mechanics has become increasingly important to developmental 
biologists and the field of stem cell biology because embryonic mechanisms occur through 
biochemical activity in controlled physical environments [157].  On the one hand, 
developmental biology studies processes by which cells and tissues, originating from the 
 109 
embryo, evolve towards adult function.  These processes are complex, strictly controlled in 
time and space and, most notably, conserved across multiple species as a result of evolution.  
In other words, the role of developmental biology is to identify physiological factors 
directing biochemical responses that control embryonic mechanisms.  On the other hand, the 
role of tissue mechanics is both to determine how forces modulate the physical context in 
which physiological factors perform biological functions, and also to actuate those forces.  
These two types of mechanisms, biochemical signaling and tissue mechanics, act in 
coordination at all stages of development – including the developing embryo – and determine 
how tissues mature and acquire specialized function. 
We can use lineage specification processes in strategies for tissue regeneration in adult 
organs if we understand the mechanisms underlying differentiation control, including 
mechanotransduction, from the onset of development and throughout their homeostatic 
control in postnatal function and disease.  In order to analyze lineage specification under a 
mechanotransduction viewpoint, we first need to recognize that cells, including embryonic 
stem cells, are mechanically sensitive in all stages of development because they possess 
mechanosensitive organelles such as primary cilia and gated ionic channels [218].  In the 
blastocyst, nodal cilia produce asymmetric flow across the ventral node, which is responsible 
for establishing left-right asymmetry during early body plan establishment.  Other non-motile 
primary cilia localize along the paths of the nodal flow and sense it, which results in 
differential expression patterns of early morphogens from, among others, the Hh signaling 
pathway [219].  All these events lead to lineage specification mechanisms poorly understood 
under mechanical terms.  Therefore, we need to outline differentiation principles within 
mechanical frameworks in order to understand maturation mechanisms in terms of tissue 
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mechanics.  This is especially pressing for endodermal tissues, whose function is not 
traditionally interpreted in terms of mechanical action. 
Research on embryonic tissue mechanics advances in parallel with the advent of 
technologies able to test at appropriate scales of cellular and tissue function.  Research on 
tissue mechanics of embryos and stem cells has revealed, for example, that differentiation is 
a stiffness-dependent mechanism [47] accompanied by loss of mechanical compliance in 
cells [196], and that embryos exhibit phase ordering that parallels behavior in liquid mixtures 
[159, 160, 176-178, 190, 197, 198]. Differentiation patterns during embryonic development 
arise, in part, from induction of active flow by mechanical organelles like cilia [219].  In 
addition, we also know tissue formation and maintenance depends on controlled mechanisms 
of interstitial flow throughout life [179]. 
In the recent past, research on human developmental biomechanics had limited access 
to embryonic tissues.  In fact, most developmental biology research has been performed in 
model species, which includes non-mammalian species (e.g zebrafish) and invertebrates (e.g. 
roundworm C. elegans).  Induced pluripotent stem (iPS) cells provide an alternate source for 
human embryonic-like cells that can be used to advance this type of research.  Since their 
invention, iPS cells have redefined our understanding of differentiation as a unidirectional 
process by showing, for example, that a handful of genes suffice to reconstitute pluripotency 
in somatic cells.  This process, usually performed in human foreskin fibroblasts and also 
possible with other primary cells, consists of retroviral transfection of Oct3/4, Sox2 and 
either Nanog and Lin28 [220] or c-Myc and Klf4.  The current belief is that transfecting 
these genes in somatic cells induces pluripotency because they participate in global 
demethylation of the chromatin, which propels the genome into a pluripotent de-
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differentiated state.  Transfected somatic cells, when fully developed into iPS cells, exhibit 
trademark characteristics of ES cells such as teratoma formation, asymmetric division and 
differentiation into all germlines [221].  These characteristics help developmental biologists 
because iPS cells are more accessible than ES cells as experimental models. 
Although many of the biochemical mechanisms in ES and iPS cells match with 
remarkable precision, there are some differences between them.  First of all, iPS cells 
originate from retroviral transfection of pluripotency genes, thus inducing genomic 
alterations in iPS cells that ES cells do not share.  In addition, homogeneity within iPS 
populations depends not only on successful transfection of all pluripotency genes in all cells, 
but also on cells successfully rescuing a functional pluripotent state beyond gene expression.  
Therefore, variations in pluripotency potential of iPS cells indicate that the process requires 
further optimization, including improved iPS cell isolation in terms of functional 
requirements like EpCAM and E-cadherin expression, and shows that degrees of global 
demethylation could vary across iPS cell preparations [161].  In comparison, cells from a 
single ES cell source are defined by their homogeneous pluripotency and equivalent genomic 
characteristics [221]. 
As long as we recognize functional differences between iPS cells and ES cells a priori, 
the iPS model can enhance our understanding of embryonic development with respect to 
mechanotransduction.  To our knowledge, there is only a handful of electrophysiological 
studies on iPS cell function that explicitly search for differences in mechanical and 
physiological mechanisms between ES cells and iPS cells.  Those studies found only minimal 
distinctions in electrophysiological activity [222, 223].  For that reason alone, and without 
further evidence, we can only assume that iPS cells model ES cell responses to mechanical 
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stimuli that replicate mechanotransduction mechanisms in embryonic stages with acceptable 
homology. 
8.3. ALTERNATIVE MECHANOTRANSDUCTION AMPLIFICATION SYSTEMS 
Mechanotransduction signaling pathways in cells operate as amplification systems.  By 
definition, an amplification system requires transduction mechanisms that relay small stimuli 
for interpretation with high efficiency and fidelity.  In the context of cellular signaling, 
mechanotransduction complies with three amplification requirements: first, transduction 
traverses along interconnected “paths” using adaptable and networked stable structures; 
second, transduction modes are highly specific to avoid loss of fidelity; and third, conversion 
of physical stimuli into biological activity generates global responses as a result of 
networking. 
Cells from soft organs interpret small changes in their mechanical state through 
mechanotransduction in organelles with sensorial amplification machinery [111].  For 
example, cells can transduce local shear effects into dense signaling with primary cilia that 
increase flow sensitivity.  When primary cilia are stimulated, they use polarized signal 
transduction pathways residing within them to transmit signals down the cytoskeleton and 
into the nucleus, triggering gene expression in cells.  To ensure amplification of shear effects, 
cells enrich mechanotransduction signaling machinery (such as gated channels and cell 
receptors) within primary cilia; in addition, primary cilia machinery uses shuttling 
mechanisms with motor proteins that ensure non-diffusible signal trafficking to the nucleus, 
which confers specificity, fidelity and efficiency to signal transduction in primary cilia [53].  
The signaling mechanisms in primary cilia have physiological relevance, as defective cilia 
characterize a large array of diseases known as ciliopathies [224]. 
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The determining feature of primary cilia function is the molecular ultrastructure at their 
base, which consists of the axoneme, the centriole and the alar shields.  These elements only 
allow passage of cytoplasmic proteins under 10 kDa in size when assembled in to primary 
cilia.  That space restriction eliminates the possibility of protein synthesis within cilia [53].  
To operate, primary cilia acquire proteins and molecular machinery with an intraflagellar 
transport (IFT) mechanism that uses molecular rafts (called IFT proteins).  IFT proteins move 
along the axoneme using motor proteins such as kinesin II and cytoplasmic dyneins.  Kinesin 
II moves in the minus-to-plus (anterograde) direction with respect to the basal body of the 
centriole, while cytoplasmic dyneins move in the opposite (retrograde) direction [225-227].  
This transport machinery of kinesin II and cytoplasmic dyneins effectively cargoes proteins 
along primary cilia at speeds of 2 to 4 µm/s, which are fast at the intracellular scale since 
ordinary lengths of primary cilia are between 5 µm in vivo up to 30 µm in culture [53]. 
Cells project primary cilia into luminal spaces in tissues.  Upon bending, primary cilia 
trigger mechanosensing responses that respond to cilia deformation in the presence of flow.  
In cultured Madin-Darby canine kidney (MDCK) cells, internal Ca2+ concentration increases 
by both deforming cilia with micropipette aspiration or increasing perfusate flow rate, a 
response absent from cells without primary cilia after chloral hydrate treatment [228, 229].  
Mechanosensation in hepatic cholangiocytes results from bending by activation of 
polycystin-1 (PC-1, a cell surface receptor) and polycystin-2 (PC-2, a Ca2+ channel) during 
Ca2+ signaling, which leads to cAMP signaling suppression through Ca2+-dependent adenylyl 
cyclase 6 (AC6) inhibition [230]. 
Research on cholangiocytes from intrahepatic biliary ducts reveals that the proteins 
enriched in cilia also allow primary cilia to operate as osmosensors and chemosensors.  
 114 
Osmosensation in cholangiocytes results from hypotonic activation of TRPV4 in anisosmotic 
conditions.  TRPV4 is a Ca2+-permeable channel expressed in cilia that induces ATP release 
and bicarbonate secretion, thus increasing bile flow [231].  For chemosensation, primary cilia 
use purinergic receptors, mainly ciliary P2Y12, that detect biliary nucleotides and inhibit 
cAMP signaling in a cilia-dependent fashion [232]. 
Nodal cilia are an intermediate specialized version of primary cilia found in the 
blastocyst that do not possess the central microtubule pair but conserve the remaining motile 
components [53].  This alternate conformation results in propeller motion that induces 
leftward fluid flow from the ventral node (thus the name nodal flow), distributes secreted and 
vesiculated morphogens preferentially, and determines left-right body asymmetry during 
development [219]. 
Cilia respond to flow, but this function is not exclusive of cilia.  In fact, normal arterial 
flow can disassemble cilia in endothelial cells [233].  In this case, response to flow is a result 
of drastic cytoskeletal rearrangements and microfilament reorganization in cells.  These 
structural reorganization in cells parallels observations during the formation of mitotic 
spindles that are ordinarily preceded by ciliary resorption [234].  Another cellular component 
involved in mechanotransduction is the plasma membrane.  Flow forces on the plasma 
membrane induce purinergic signaling through P2 receptors in cells without primary cilia 
[45].  These cells can still maintain purinergic tone because flow forces deform their plasma 
membrane and activate ionic exchange through mechanically gated ion channels. Ionic 
channels opened by straining the plasma membrane explain how cAMP signaling responds to 
mechanical forces to initiate secretory functions and regulate the cell cycle through protein 
kinase A (PKA).  Under these mechanical conditions, other secondary messengers like Ca2+ 
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can respond to mechanical stimuli and initiate signaling cascades equivalent to those induced 
by neurotransmitters or hormones [235, 236]. 
Effects of mechanical forces in stem cells also include electrophysiological responses.  
Ion gated channels exist in cells at all stages of development.  Recent evidence suggests that 
the profile of ionic channels that cells use varies across lineage specification. Comparisons 
between embryonic (ES), induced pluripotent (iPS), mesenchymal stem cells (MSCs) and 
somatic cells show that ES and iPS cells act exclusively through K+ channels, without 
voltage-gated Na+ or Ca2+ currents, and with marked preference for proliferation over 
metabolic effects [222, 223]. 
Matrix gradients in tissues provide, in addition to a specialized mechanical context, a 
physical indicator for orderly maturational progression that cells establish during 
development and follow thereafter.  In addition to matrix gradients within tissues, cross-talk 
between cells at different lineage stages maintains pluripotency of progenitors in vivo 
through feedback loops.  Cells can monitor these feedback loops along specific histological 
routes in healthy conditions.  Conversely, diseases that perturb the integrity of these feedback 
loops activate differentiation and expansion of determined stem cells.  Because maturational 
gradients span across tissues, homeostatic signals must reach all cells that communicate 
through feedback loops using transport mechanisms besides diffusion.  Bile is an example of 
a physiological carrier of homeostatic signals in adult liver [1]. 
Broadly speaking, cells require specific machinery to sustain forces. Cells can regulate 
their functions through soluble signaling, but cell attachment and compliance to external 
forces also affect their survival. Mechanical adaptation of cells includes cytoskeletal 
reorganization and ionic exchange that respond to forces via stress-sensitive organelles.  
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Some of these organelles include integrin receptors and gated ionic channels that are directly 
activated by distensions in the plasma membrane and tension on focal complexes [49, 111].  
Some cells, under external forces, reorganize their intracellular function to acquire 
mechanical competence.  If we accept that these intracellular changes could manifest as 
lineage specification towards more mechanically resistant cell types, then we can interpret 
differentiation as a cellular mechanism aimed towards adaptation of cells to their 
microenvironment.  In fact, cell mechanosensors can regulate secondary signaling pathways 
with roles in differentiation, such as specific Ca2+ concentrations that dictate growth or 
differentiation in epithelial cells [1]. 
Mechanical competency of cells would suggest that their mechanical compliance 
matches rigidity gradients in tissues and correlates with lineage specification.  In other 
words, cells could acquire more rigid configurations as they differentiate. This is true in ES 
cells – differentiation plasticity matches mechanical plasticity – in which cyclic mechanical 
stress leads to differentiation.  Cyclic mechanical stress promotes spreading, downregulates 
Oct3/4 expression and induces a ten-fold increase in ES cell rigidity through pathways 
controlling cell shape and proliferation [196].  Other experiments show that embryonic cell 
sorting obeys differential adhesion properties that correlate with the cell-cortex tension of 
germline cells [48].  These results imply that stem cells might be exquisitely susceptible to 
mechanical induction. Hence, mechanical forces can bias lineage specification to preferential 
fates, in combination with signaling, by preparing stem cells to comply with mechanical 
functions that their differentiated state requires [112, 237]. 
Mechanical plasticity of stem cells suggests that deviations from canonical forcing can 
alter morphogenesis and differentiation, whether through mechanotransduction or through 
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perturbations in transport.  This happens with Twist, a powerful morphogen that participates 
in β-catenin signaling in fruit flies, which regulates mesoderm invagination during 
gastrulation and midgut differentiation.  Stomodeal cells in fruit fly gastrula, after ablation of 
the neighboring cells that compress them in vivo, recover Twist expression with controlled 
deformations induced by indentation or magnetic forcing [238, 239].  In another remarkable 
example, experiments that reverse nodal flow in mouse embryos perturb endogenous 
expression patterns of signals during body axis planning, such as Shh and retinoic acid, 
which leads to situs inversus [219, 240]. 
8.4. SIGNALING WITH MECHANICAL BASIS IN STEM CELL BIOLOGY 
Mechanical interpretation of signaling during organ development links endoderm 
differentiation with maintenance and homeostatic control of its derivatives in adult stages.  
This approach to stem cell biology could help control cell differentiation in tissue 
engineering applications through reproducible mechanical stimuli.  Successful translational 
medicine strategies using stem cell biology will depend on biochemical signaling in 
appropriate physical environments, which underlines the role of tissue mechanics in 
therapeutic applications.  We can surmise which developmental mechanisms also respond to 
mechanical effects on cells by inspecting which mechanisms use signaling involved in 
mechanotransduction.  The analysis below focuses on endoderm progression because, in 
comparison to ectodermal and mesodermal derivatives, there have been few efforts to study 
endodermal derivatives under mechanical perspectives. 
An obvious mechanical process during development – and the signature step at the 
beginning of gastrulation – is formation of the primitive streak on the posterior surface of the 
epiblast.  Within the primitive streak, mesendoderm regulates genetic expression of Foxa2, 
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Sox17 and PDGFRα, among others [60].  Progression of the definitive endoderm and its 
derivatives requires Sox17, which has important roles in soft organ development [241].  At 
this point in development, a delicate concert of endogenous signals demarcates regions along 
the endodermal gut that generate each of the organs in the gastrointestinal tract.  
Activin/Nodal signaling in ES cells regulates Nanog expression that competes for RSmads 
with Smad4.  FGF2 signals also target RSmads, which makes Activin/Nodal signaling a 
mechanism that modulates endodermal progression through competition [242].  Later in 
endodermal progression, FGF2 (but also FGF4) induces proliferation of anterior definitive 
endoderm (ADE) cells that express Hex and Cxcr4; FGF signaling also increases expression 
of Foxa2 and Sox17 in ADE cells.  This expression profile in ADE cells suggests that they 
are differentiated endodermal progenitors for hepatic and pancreatic fates.  These signaling 
mechanisms, in conjunction, determine differentiation fates in the anterior-posterior direction 
within the definitive endoderm [243].  These types of competition mechanisms in signaling 
are prominent in neuroectoderm, namely the notochord, and help tissues adjacent to 
endoderm in regulating endodermal differentiation [60]. 
Developing gut endoderm expresses Shh, suggesting that Shh participates in activation 
of the Activin-FGF signaling concert within the notochord.  After gastrulation, definitive 
endoderm with differential Shh expression flanks the notochord and interacts with the 
surrounding neuroectoderm.  The regions with positive Shh expression eventually develop 
into duodenum and stomach in a cranio-caudal orientation [60].  Because some of the most 
important genetic targets of Hh signaling are ligands of the TGF-β family that participate in 
Activin/Nodal signaling [57], we surmise that Hh signaling also determines ADE anterior-
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posterior orientation, in addition to establishing left-right asymmetry and cranio-caudal 
differential expression [219]. 
Hh signaling participates in body plan establishment by regulating differentiation and 
morphogenesis of endodermal tissues [211].  The Hh cellular machinery is enriched in 
primary cilia, which suggests that they are an element of mechanotransduction in endodermal 
development [54-56].  This has significant implications, because it supports the notion that 
embryonic development is a mechanism that involves mechanical forces from fluid flow, 
cellular deformation and ionic exchange. 
Some of the most important genetic targets of Hh signaling are signals from the TGF-β 
family, which regulate responses to mechanical stimuli in liver development.  It has been 
reported that primary cilia in postnatal liver tissues are exclusive of intrahepatic biliary ducts 
– one per cholangiocyte – and primary cilia length correlates with the dimensions of the bile 
duct [244].  These reports disagree with Hh expression in hepatic progenitors (hHpSCs and 
hHBs) around the periportal area [8, 12, 21, 133, 245].  In either case, distribution of primary 
cilia in hepatic tissues unveils a feedback mechanism that operates by monitoring bile 
tonicity, flow or viscosity with primary cilia to regulate biliary function [45].  This would 
define bile as both a carrier of homeostatic signals and a mechanical probe for liver function 
within the hepatic maturational gradient. 
8.5. MATHEMATICAL DESCRIPTIONS OF DEVELOPING TISSUE MECHANICS 
Tissue mechanics modeling requires understanding the mechanical properties of tissues.  
We can start by assuming that tissues are made of at least two fundamental phases: cells 
(with or without ECM) and interstitial fluids.  Also, to understand the mechanics of tissues, 
we must consider how tissues respond to stress.  Viscoelasticity describes how a material 
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responds to forces in time and whether material deformation exhibits a delay with respect to 
applied stress.  The scale of this delay is a measure of viscoelasticity.  This information helps 
determine the constitutive law, which defines the mechanical behavior of materials 
mathematically. 
During development, permanent tissue deformations define morphogenesis.  With that 
respect, there are three time scales to consider when implementing mathematical models of 
developing tissues.  We can account for viscoelastic responses of ECM and cellular materials 
in a rapid time scale.  In a slower time scale, tissues can be modeled as elastic since they 
return to a rest state after forces are removed, which defines a poroelastic model 
characteristic of mature tissues that store residual stresses.  On an even longer time scale 
accounting for cell rearrangements, motility, mitosis and ECM remodeling, the poroelastic 
description can be substituted for a poroviscous one to express the mechanobiological active 
remodeling at the scale of tissue growth.  This last time scale is especially suited for stem cell 
niches and embryoid bodies that do not store residual stresses comparable to those in mature 
tissues.  In fact, early embryonic tissues exhibit behavior that parallels liquid mixtures (as 
discussed in Section 7.3.6).  By using a poroviscous description in mathematical models of 
early embryonic morphogenesis, we can track permanent tissue deformations at the scale of 
growth, which is multiple orders of magnitude larger than the characteristic relaxation time 
of cells under stress in developing tissues [196].  In other words, for parsimony we can 
implement mechanics of developing tissues using a poroviscous description, since 
deformation stresses in developing tissues are dissipated over time scales of tissue growth. 
The length scale of tissue development is also important.  If we decide to model cells in 
tissues as part of purely viscous fluid continuum, we must qualify the characteristics of flow 
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in the dimensional scale of tissues.  Force balance equations for fluid flow, the Navier-Stokes 
equations, determine that the qualitative behavior of viscous flow can be evaluated in terms 
of a nondimensional ratio between inertial and viscous forces, the Reynolds number 
! 
Re = "VL # .  This ratio is defined in terms of the density ρ, flow velocity V, length scale L 
and dynamic viscosity η of the flowing fluid. We can estimate Re < 1×10-3 in the 
physiological context of tissue development with the density and viscosity of water (ρ=1000 
kg/m3; η=0.001 Pa-s) in conjunction with length scales (~100 µm) and velocities for cell 
rearrangements and growth during embryonic development, which are slower than 
developmental fluid flow – e.g. 10 to 20 µm/s for embryonic nodal flow [240].  Deformations 
in embryonic tissues, when described in terms of viscous flow, also have higher viscosities 
than fluid flow in embryonic development, giving even lower 
! 
Re . 
Fluids with constant viscosity and flowing with 
! 
Re <<1 are known as Stokes fluids, in 
which flow is laminar, does not exhibit vorticity and primarily depends on viscous forces.  
These features simplify equations of motion.  The Navier-Stokes equations dictate that this 
type of flow is time-invariant, which means that fluids with rate-dependent viscosities do not 
qualify under Stokes flow.  In fluid mechanics terms, Stokes flow applies exclusively to 
Newtonian (rate-independent) fluids and, only under specific conditions, can approximate the 
behavior of non-Newtonian (rate-dependent) fluids. 
When modeled as viscous fluids, the small length scales and flow velocities associated 
with developmental tissues are representative of Stokes flow.  For example, the fluid 
properties of nodal flow suggest that fluids interacting with the embryo can be modeled as 
Stokes fluids.  The same has been proposed for bile, since luminal flow is also low Reynolds 
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flow in secretory organs like liver [62].  We can use this information to define parsimonious 
descriptions of force balance equations for developing tissues in biomathematical models. 
8.6. KM-HA HYDROGELS AS MODELS FOR TISSUE MECHANICS RESEARCH 
One of the main characteristics of KM-HA hydrogels is that they exhibit no viscoelastic 
damping. Chemical modifications performed in HA for these hydrogels yield a high density 
of cross-linking sites.  These modifications result in constant shear modulus G across a wide 
range of frequencies (0.05 – 5 Hz) that differs from the behavior of native hyaluronans [246].  
High water content of KM-HA hydrogels (over 98%) results in mechanical incompressibility 
and effective diffusion that matches culture media.  In addition, it is apparent that KM-HA 
hydrogels exhibit creeping response under fixed loads at time scales of hours, although we 
are not certain whether there is recovery after load removal or whether this response is 
exclusively due to water expulsion under compression (Appendix C.2, Figure 29).  All this 
mechanical characterization advances our understanding of the behavior of KM-HAs, but is 
yet insufficient in formalizing a constitutive law description of their mechanical behavior.  
Hence, future experiments in KM-HA mechanics should be aimed towards establishing a 
constitutive law description for KM-HA hydrogels for their implementation in 
biomathematical models. 
One advantage of using KM-HA hydrogels with determined stem cell populations, such 
as hHpSCs, is that KM-HA hydrogels provide a mechanical environment with predictable 
properties.  In the specific case of our experimental research, our approach provides a 
successful model to quantify differentiation directed by mechanical stimuli in determined 
stem cell populations.  However, this experimental in vitro model has a broader impact: by 
using a cell source from fetal origin and surveying lineage specification between a stem cell 
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stage (hHpSCs) and a transit amplifying cell stage with high proliferation capabilities 
(hHBs), our experimental approach studies cell types from developmental tissues within a 
predictable mechanical environment that could be implemented in biomathematical models.  
Currently, we can only hypothesize that this mechanical environment behaves as a polymeric 
solution at the time scale of differentiation as a first-order approximation, while we continue 
to model stem cell populations as developing tissues with purely viscous behavior. 
In order to bridge between the experimental and computational models presented in this 
thesis in the future, it is fundamental that we understand the constitutive mechanical behavior 
of KM-HA hydrogels from experimental evidence.  These efforts would not only describe 
how hHpSCs behave in established 3D environments, but also which types of forces can be 
applied onto these hydrogels sustainably for tissue engineering purposes.  Furthermore, 
bridging between both models provides two exciting opportunities: first, it could be possible 
to investigate novel modes of mechanotransduction at the cellular level and expand them to 
broader tissue assembly mathematical schemes with our experimental approach; and second, 
we can either test experimental hypotheses computationally or design experiments, optimized 
using mathematical criteria expressed in terms of cellular function, that control variables at 
the tissue level. 
8.7. CONCLUSION 
The work presented in this thesis is relevant because it demonstrates two distinct 
approaches for surveying how mechanics affects developing tissues and the cells that 
assemble them. In one approach, by using a computational approach that models biological 
systems in developing tissues, we not only acquire understanding of the biology of growth 
regulation, but also provide a generic tool that describes quantitative requirements to expand 
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stem cell populations.  Following a different approach, our experimental model explores how 
a mechanical variable, the stiffness of the microenvironment, can influence phenotypic 
properties of hepatic stem cells, which are isolated from liver tissue that does not have 
obvious mechanical roles.  In that regard, the knowledge acquired from our experimental 
model does not improve our current biomathematical models of tissue growth, but does 
represent a step in that direction.  In the end, by evaluating stem cell biology from two 
distinct perspectives – with justifiable individual merits – the work presented here explores 
both empirical and predictive aspects of tissue engineering, brings these aspects closer to 
each other and, in doing so, creates two useful models – one in vivo and one in silico – to 
close the gap. 
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APPENDIX A. COMSOL SOFTWARE NOTATION 
Implementation of models in COMSOL is achieved by means of two fundamental 
equation forms: PDE general form and PDE coefficient form.  All application modes in the 
COMSOL Multiphysics environment are properly arranged to follow either one of these two 
input forms because the numerical solver is designed to operate using equation structures of 
either one of these modes.  Additionally, COMSOL translates PDE input into a variational 
calculus (or weak form) expression that can be analyzed and enriched by the user to add 
customized numerical solver features.  These numerical features can help enhance 
stabilization and convergence, include mixed or higher order derivative terms than those 
allowed by the PDE general or coefficient forms, and other customized improvements to the 
numerical solver. 
When an equation-based model that is not covered by available pre-defined modes 
needs to be analyzed (e.g. pre-determined PDE modes for conduction, convection, diffusion, 
heat and mass transport, etc.), both the PDE General Form and PDE Coefficient Form can be 
used.  The PDE General Form is defined by the following description for a scalar variable 
! 
u , 
flux vector 
! 
"  and coefficients 
! 
R, 
! 
G and 
! 
F : 
! 
e
a
" 2u
" t 2
+ d
a
"u
" t
+ # $ % = F in &
'n $ % =G +
"R
"u
( 
) 
* 
+ 
, 
- 
T
µ on "&
0 = R on "
2
&
. 
/ 
0 
0 
0 0 
1 
0 
0 
0 
0 
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On the other hand, the PDE Coefficient Form, which represents a mathematical 
expansion of the PDE General Form, is defined as follows: 
! 
ea
" 2u
" t 2
+ da
"u
" t
+ # $ %c#u %&u + '( ) + ( $#u+ au = f in )
n $ c#u+&u % '( ) + qu = g % hTµ on ")
hu = r on "
2
)
* 
+ 
, 
, 
, 
- 
, 
, 
, 
 
 In both cases, the first equation is the PDE, while the Neumann and Dirichlet boundary 
conditions are represented by the second and third equations, respectively.  In all cases, the 
parameter 
! 
µ represents a Lagrange multiplier.  All coefficients in both forms can be 
functions of the solution 
! 
u , space and time derivatives of 
! 
u , or any of the spatial coordinates. 
Choosing a PDE form for the equation-based model in COMSOL is rarely sufficient in 
accurately representing a desired system.  In addition to knowing how to properly use the 
COMSOL Multiphysics software, it is necessary to understand an important principle of 
model implementation in COMSOL Multiphysics regarding mathematical orthodoxy: 
notation of fundamental vector and tensor operations in the COMSOL Multiphysics software 
environment exclusively obeys a fundamental Cartesian geometry.  Due to this feature, 
vector and tensor operations in different coordinate systems requiring geometric 
transformations are not implicitly defined by COMSOL and need to be explicitly defined in 
the model by the user following a fixed orthonormal coordinate system scheme – unless a 
pre-defined application mode is used. 
In COMSOL, performing a divergence operation on a vector 
! 
A  in a Cartesian (fixed 
orthonormal) coordinate system recapitulates the mathematical meaning of this operation, 
since 
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! 
" #A =
$
$x
1
A
1
+
$
$x
2
A
2
+
$
$x
3
A
3
 
where the coordinate system basis and the vector are defined as follows: 
! 
x
1
,x
2
,x
3
" x,y,z  
! 
A = A
1
e
1
+ A
2
e
2
+ A
3
e
3
= Axex + Ayey + Azez  
As it is evident from this example, COMSOL performs vector and tensor operations 
following differentiation rules of Cartesian coordinate systems.  The same Cartesian rules 
apply to other tensor operations, such as gradients, covariant derivatives and tensor 
divergence for a scalar function 
! 
F , a vector 
! 
A  and a second-degree tensor 
! 
˜ T : 
! 
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Other coordinate systems such as cylindrical and spherical coordinate systems are better 
suited for certain geometries.  In such cases, however, COMSOL allows users to redefine the 
nomenclature of the independent variables in accordance with the coordinate system in use, 
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but only goes as far as renaming the independent variables and does not impose any required 
geometric transformations of its vector and tensor operations.  In order to distinguish 
between them, let 
! 
r," ,z
M
#  and 
! 
r," ,#
M$  represent the vector differential del operator with 
orthodox mathematical interpretations in cylindrical and spherical coordinate systems, 
respectively, while 
! 
r," ,z
S
#  and 
! 
r," ,#
S$  represent their counterparts as interpreted by the 
software architecture (i.e. COMSOL).  In such cases, the following vector and (symmetric) 
tensor operations are mathematically true in a cylindrical coordinate system for a scalar 
function 
! 
F , a vector 
! 
A  and a second-degree tensor 
! 
˜ T : 
! 
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In the case of a spherical coordinate system these vector and (symmetric) tensor 
operations are mathematically true as follows: 
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Nonetheless, interpretation of these operations in COMSOL is limited to independent 
variable name substitution.  This particular feature ensures that, at all times, in a Cartesian 
coordinate system, 
! 
x,y,z
S
" # x,y,z
M
"  
as we have shown before.  However, this same property introduces significant issues when a 
model in a different coordinate system is preferred; i.e. vectorial rules are mathematically 
unorthodox in COMSOL because the software is not suited to perform geometric 
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transformations when coordinate systems are changed.  For example, the gradient operation 
for a scalar function 
! 
F , once the independent variables have been changed to a basis relevant 
to cylindrical coordinate systems, 
! 
x
1
,x
2
,x
3
" r,# ,z  
is interpreted by COMSOL as 
! 
r," ,z
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or in the case of spherical coordinate systems, with a coordinate system basis such that 
! 
x
1
,x
2
,x
3
" r,# ,$  
the gradient operation for a scalar function 
! 
F  is interpreted by COMSOL as 
! 
r," ,#
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%F
% x
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%F
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2
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2
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e
r
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%"
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These interpretations are mathematically incorrect, but as long as we can recognize the 
software-specific interpretation of these vector and tensor operations it is possible to translate 
cylindrical and spherical models to a suitable interpretation through COMSOL. 
The same rules apply to boundary conditions.  Any vectorial operations that define 
boundary conditions (e.g. Cauchy, Neumann, Dirichlet, Robin) must be explicitly expanded 
into each of their (orthodox) vectorial components.  Once the components are fully 
expressed, they can be reassembled following the Cartesian-exclusive COMSOL vectorial 
rules. 
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APPENDIX B. COMSOL IMPLEMENTATION OF SPHERICAL SYMMETRY 
EQUATIONS 
B.1. FORCE BALANCE EQUATION 
The simplified force balance expression for spherically symmetric geometry 
! 
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can be implemented in COMSOL using its fixed orthonormal basis by means of the PDE 
coefficient form where 
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by defining the following coefficients with respect to the radial velocity 
! 
v
r
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e
a
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"
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for the implementation in COMSOL of the force balance equation 
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B.2. GROUP INCOMPRESSIBILITY CONDITION EQUATION 
The group incompressibility condition equation 
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can be implemented in COMSOL using its fixed orthonormal basis by means of the PDE 
coefficient form where 
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by defining the following coefficients with respect to the interstitial pressure 
! 
P : 
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for the group incompressibility condition implemented in COMSOL as follows: 
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B.3. GENERAL CONSERVATION EQUATIONS 
In order to implement general conservation equations into COMSOL for spherically 
symmetric geometries: 
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we must recall that the interpretation of the vector differential del operator in COMSOL for a 
scalar gradient and Laplacian in the spherical coordinate system still follows a fixed 
orthonormal basis: 
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Therefore, the relevant representation of the equation for 
! 
u  in COMSOL using a fixed 
orthonormal description is as shown below: 
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which corresponds to the mathematically orthodox equation 
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where 
! 
r," ,#
M$ %$
M
 is the vector differential del operator subject to geometric transformations 
into a spherical coordinate system. 
It is possible to implement this equation through the Convection and Diffusion 
Application Mode in COMSOL such that 
! 
"
ts
#u
# t
+ $ % &D$u+ uv( ) = R  
with the corresponding coefficients in COMSOL 
! 
"
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by rewriting the fixed orthonormal model description as 
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On the other hand, by using the PDE coefficient form, we can define the PDE in 
COMSOL for implementation as follows: 
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One advantage of using a pre-defined application mode such as the Convection and 
Diffusion application mode is that solver stabilization techniques are also included and 
available for user implementation.  Therefore, using proper mathematical care with regards to 
vector differential rules, numerical stabilization is easily added to the model by defining a 
coefficient as opposed to implementing the stabilization technique in the context of the full 
PDE definition, especially for mathematically intricate stabilization techniques. 
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APPENDIX C. SUPPLEMENTARY EXPERIMENTAL DATA 
C.1. ANALYSIS OF STATISTICAL SIGNIFICANCE OF GENE EXPRESSION 
DATA FOR HEPATIC STEM CELLS IN KM-HA HYDROGELS 
Quantitative Real Time PCR assays for differentiation markers in KM-HA-grown 
hHpSCs was analyzed for significance, both for each individual marker and with respect to 
their multivariate PCA scores.  We previously reported the statistical significance of mRNA 
expression levels of hHpSCs in KM-HA after 1 week of culture with respect to 2D-grown 
hHpSC colonies and freshly isolated hHBs (Figure 18).   Analyses for statistical significance 
also included comparisons amongst conditions, not only for variation around the mean (two-
tailed Student’s t-test), but also for equality of variances (two-tailed F-test).  In conjunction, 
these statistical routines measure two statistical properties of mRNA expression levels in 
each gene of interest: first, whether the levels measured in each hHpSC seeding condition – 
i.e. each KM-HA hydrogel formulation – differs from the levels measured in each of the 
remaining seeding conditions; and second, whether we can confirm that the data spread for 
mRNA expression level in each condition is different from the rest.  Simply put, both tests in 
combination confirm whether the average mRNA expression levels of two conditions are 
statistically different (Student’s t-test), and whether this significance arises from two distinct 
outcomes or a random bias between two separate measurements of a single outcome (F-test). 
Full inspection of mRNA expression levels for all genes of interest confirms that all 
data from KM-HA-grown hHpSCs are statistically distinct from either hHpSCs or hHBs.  In 
general, on an individual marker basis, there are no significant differences across 
formulations, and any resulting trends in mRNA expression levels across the experimental 
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range of KM-HA hydrogel with respect to KM-HA hydrogels stiffness are not statistically 
significant.  The highest statistical significance levels acquired arise from CD44 expression 
(Table 10).  These significance levels agree with evaluation of gene expression profile by 
PCA, where the main source of variation across formulations corresponds to PC2 (Table 11), 
which measures intra-phenotype variation and is mostly dictated by CD44 expression as well 
(Figure 19). 
Table 10.  Full statistical significance analysis (two-tailed Student's t-test and two-tailed 
F-test) of gene expression levels for differentiation markers in KM-HA-grown hHpSCs. 
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Table 11.  Full statistical significance analysis (two-tailed Student's t-test and two-tailed 
F-test) of multivariate principal component (PC) scores of gene expression for 
differentiation markers in KM-HA-grown hHpSCs. 
 
 
C.2. CREEP BEHAVIOR OF KM-HA HYDROGELS UNDER CONFINED 
COMPRESSION 
One of our preliminary efforts to characterize the mechanical properties of KM-HA 
hydrogels was to use confined compression testing, which determines two mechanical 
properties of hydrated porous materials in a single test: the aggregate stiffness modulus HA 
and the hydraulic permeability k [247].  The mechanical response of the hydrogels, which 
exhibited no equilibration under initial setup loading, influenced the decision to change our 
characterization method to a rheometrical approach (Figure 14).  Raw data from confined 
compression tests showed that KM-HA hydrogels exhibit a creep response under fixed 
compression at time scales of hours (Figure 29).  However, this experimental setup did not 
distinguish whether this creep response reflected expulsion of media under compression or 
true aggregate deformation, since we could not measure deformation recovery. 
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Figure 29.  KM-HA hydrogels exhibit a creep response under fixed compressive load 
with a porous platen.  Raw data from confined compression testing on a sample of KM-
HA hydrogels (formulation C, Table 4) illustrates how these hydrogels do not to reach 
strain equilibrium under a fixed compressive load for hours and exhibit a creep 
response characteristic of fluid-like behavior.  The confined compression uses a fixed 
setup load of 5 grams.  Testing is performed with the experimental sample setup 
submerged in Kubota’s medium (KM) throughout testing, which prevents loss of fluid 
from samples and ensures that samples maintain isotonic balance.  The geometry of the 
sample, obtained with a circular biopsy punch from a KM-HA hydrogel cast in a 35-
mm Petri culture plate, was a cylindrical plug approximately 6 mm in diameter and 2 
mm thick.  Points in plot correspond to data acquired from experimental setup at 
regular intervals; solid curve is the analytical solution to the confined compression 
problem, fitted by optimized least-squares regression to experimental data (R2 = 0.989).  
Optimized regression for this sample determined aggregate modulus HA = 3.22 kPa and 
hydraulic permeability k = 5.84 × 10-15 m4/N-s. 
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